UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 

FORM 10-K

(Mark One) 

þANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2014

2016

or

¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period fromto

Commission file number: 0-26272

001-36849

NATURAL HEALTH TRENDS CORP.

(Exact name of registrant as specified in its charter) 

 Delaware

 59-2705336

 (State

Delaware59-2705336
(State or other jurisdiction of

 (I.R.S.(I.R.S. Employer

incorporation or organization)

Identification No.)

4514 Cole Avenue

609 Deep Valley Drive
Suite 1400     

Dallas, Texas 75205

395

Rolling Hills Estates, California 90274
(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code:(972) 241-4080

(310) 541-0888

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Name of each exchange on which registered

Common Stock, par value $0.001 per share

 

The NASDAQ Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act:

None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ¨ No 

þ

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ¨ No 

þ

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No

¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No

¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.

¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

¨

Accelerated filer 

þ

Non-accelerated filer ¨ (Do not check if a smaller reporting company)

Smaller reporting company 

¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ¨ No 

þ

The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the closing price of such common equity on June 30, 2014: $48,917,062

2016: $202,402,875

At February 27, 2015,March 7, 2017, the number of shares outstanding of the registrant’s common stock was 12,482,35611,341,890 shares.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant’s definitive proxy statement to be filed with the United States Securities and Exchange Commission no later than 120 days after the end of the registrant’s fiscal year end to which this report relates are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated.







NATURAL HEALTH TRENDS CORP.
Annual Report onForm 10-K
December 31, 2014

2016

TABLE OF CONTENTS

  

Page

 

9

19

20

20

20

   

 

21

23

24

31

32

54

54

55

   

 

55

55

55

55

55

   

 

55

   

56





FORWARD-LOOKING STATEMENTS
 

FORWARD-LOOKING STATEMENTS

This Annual Report on Form 10-K, in particular “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and “Item 1. Business,” include “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). When used in this report, the words or phrases “will likely result,” “expect,” “intend,” “will continue,” “anticipate,” “estimate,” “project,” “believe” and similar expressions are intended to identify “forward-looking statements” within the meaning of the Exchange Act. These statements represent our expectations or beliefs concerning, among other things, future revenue, earnings, growth strategies, new products and initiatives, future operations and operating results, and future business and market opportunities.

Forward-looking statements in this report speak only as of the date hereof, and forward-looking statements in documents incorporated by reference speak only as of the date of those documents. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. We caution and advise readers that these statements are based on certain assumptions that may not be realized and involve risks and uncertainties that could cause actual results to differ materially from the expectations and beliefs contained herein.

For a summary of certain risks related to our business, see “Item 1A. Risk Factors” in this report. Additional factors that could cause actual results to differ materially from our forward-looking statements are set forth in this report, including under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and in our financial statements and the related notes.

Unless otherwise noted, the terms “we,” “our,” “us,” and “Company,” refer to Natural Health Trends Corp. and its subsidiaries.Referencessubsidiaries. References to “dollars” and “$” are to United States dollars.



Part I
 

Part I

Item 1. BUSINESS


Overview of Business

Natural Health Trends Corp. is an international direct-selling and e-commerce company headquartered in Dallas, Texas.Rolling Hills Estates, California. Subsidiaries controlled by the Companyus sell personal care, wellness, and “quality of life” products under the “NHT Global” brand. In most markets, we sell our products to a network of consumers or business builders that either uses the products themselves or resells them to consumers.

Our wholly-owned subsidiaries have an active physical presence in the following markets: North America; Greater China, which consists of Hong Kong, Taiwan and China; South Korea; Singapore; Malaysia; Japan; and Europe, which consists of Italy and Slovenia.Europe. We also operate within certain Commonwealth of Independent States (Russia,in Russia and Kazakhstan and Ukraine) through our engagement with a local service provider.

We seek See Note 10 of the Notes to sellConsolidated Financial Statements in “Item 8. Financial Statements and Supplementary Data” of this report for further information about our products into many markets, primarilynet sales by geographic area.

Most of our order volume, particularly in our Hong Kong subsidiary, is for personal consumption through our network marketing operations.existing members’ referrals. The exception is China,our Chinese entity, where we sell directly to consumers through an e-commerce retail platform. Our objectives are to enrich the lives of the users of our products and enable our distributorsmembers to benefit financially from the sale of our products.

We were originally incorporated as a Florida corporation in 1988. We merged into one of our subsidiaries and re-incorporated in Delaware effective June 29, 2005.

Our common stock is currently traded on the NASDAQ Capital Market under the symbol “NHTC.”

Available Information

We maintain executive offices at 4514 Cole Avenue,609 Deep Valley Drive, Suite 1400, Dallas, Texas 75205395, Rolling Hills Estates, California 90274 and our telephone number is (972) 241-4080.(310) 541-0888. Our website is located at www.naturalhealthtrendscorp.com. Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to such reports are available, free of charge, on our website as soon as reasonably practicable after we file electronically such material with, or furnish it to, the United States Securities and Exchange Commission, or SEC. The information provided on our website should not be considered part of this report. The public may read and copy any materials we file with the SEC at the SEC’s Public Reference Room at 100 F Street, N.E., Room 1580, Washington, DC 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1–800–SEC–0330. The SEC maintains an internet website athttp://www.sec.gov that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.

Our Principal Products

We offer a line of “NHT Global” branded products in threefive distinct categories: wellness, herbal, beauty, lifestyle, and lifestyle.home, our newest category. These product categories, along with the business opportunity we offer in most of our markets, provide our members a platform to further their goal of achieving and maintaining healthy, quality lifestyles complete with product supplementation and the opportunity for financial rewards.



The following table summarizes our product offering by category:

Product Category

 

Description

 

Products

     
Wellness

Products formulated and designed to meet specific wellness goals of our customers. Includes targeted nutrition such as joint health, antioxidant support, digestive health, heart health, vision health, immune support and cellular health.

 

Liquid, encapsulated, tableted and powder dietary and nutritional supplements, herbal supplements, vitamins, minerals

 

Premium Noni Juice,, Triotein®, Cluster X2®, Children’s Chewable MultiVitamin, ReStor Silver®, ReStor Silver, ReStorVital®, HerBalance®, Trifusion Max, Glucosamine 2200,, FibeRich®, Energin,, Enhanced Essential Probiotics®, LivaPro, Cordyceps Mycelia CS-4, Purus, and our recently launched Omega 3 Essential Fatty Acids,

Memory Burst®, StemRenu®, OcuFocus, FE Enzyme Toothpaste
     
BeautyHerbal
Products formulated incorporating ingredients commonly found in traditional Chinese medicineHerbal supplements
LivaPro®, Cordyceps Mycelia CS-4, Purus
    

Beauty

Products to help improve skin health and bring an appearance of youthful vibrancy. This product line includes anti-aging and hydrating cleansers, creams, lotions, serums and toners to moisturize, protect and improve the appearance of skin.

 

Facial skin care and body care

 

Skindulgence® 30-Minute Non-Surgical Facelift System, Time Restore Eye Cream and Essence, BioCell Mask, 24K Renaissance Rejuvenation Serum, Valesce®, Soothe, Soothe, Floraeda Hydrating Series,

NHT Homme®, Complete Renewal 8 Shampoo, Conditioner and Hair Mask
     

Lifestyle

Products uniquely formulated to improve overall quality of life and to support active, physical and healthy lifestyles including weight management, intimacy support and energy enhancing supplements.

 

Supplements and topical gels for improved vitality

 

Alura® Lux by NHT Global, Valura Lux, LaVie Vibrant Energy drink, Twin Slim Diet Jelly®, NaturalGlo

Home
Products designed to create a clean and natural living environment for the homeHome and car appliancesPurAir Air Purifier, AquaPur Water Purifier


We continuously source unique, proprietary and immediate impact products to offer to our members and customers. Our product development is an ongoing process that is fueled by marketplace trends, and new scientific findings, members’ input, research and research.

vendor proposals.

Working closely with raw material manufacturers and leading domestic and international contract manufacturers, our mission is to co-develop and bring to market the highest quality products. Our manufacturers are primarily located in the United States, as well as a few in South Korea, Hong Kong and China.OurChina. Our raw materials (including botanical ingredients) are sourced from reputable suppliers around the world. In addition, raw material Certificates of Analysis are reviewed in our effort to assure that the appropriate testing has been performed and are within ingredient specification requirements.

Operations of the Business

Operating Strategy

Our objective is to help our members succeed in achieving their life objectives; be it personal health, beauty, happiness or financial security. The Company consists ofOur professionals who focus on assisting our members in attaining their goals.


We believe that, since early 2010, we have completely changed our corporate identity and are building a competitive business model applicable to the markets in which we operate based on six key competencies:

��

Our field leaders are experienced and culturally coherent. They work effectively with the Company’s management, implementing our strategies and providing continuous feedback to improve the Company’s services.

The Company has implemented a commission structure that makes it as easy as possible to join the Company’s business, while giving existing members a chance to start making money as quickly as possible in multiple ways.

We have developed and rolled out a comprehensive training system that provides a complete career path appropriate for our members. Our training material covers the needs of all of our members, be they prospects, new recruits, product evangelists, sales leaders or dream builders.

The continuously improving mentality and methodology in our customer services have not only distinguished us as an organization, but have also given us a constant flow of information as to how we can do better to service our members.

We have developed a year-round, multi-faceted promotional plan that targets different segments of our membership and has proven most effective in the last few years.

Last, a discipline and capability has been established to continue launching high-quality consumer products that are designed to facilitate the accomplishment of our corporate objective.

 

Our field leaders are experienced and culturally coherent. They work effectively with our management, implementing our strategies and providing continuous feedback to improve our services.

A discipline and capability has been established to continue launching high-quality consumer products that are designed to facilitate the accomplishment of our corporate objectives.

We have developed and rolled out a comprehensive training system that provides a complete career path appropriate for our members. Our training material covers the needs of our members, be they prospects, new recruits, product evangelists, sales leaders or dream builders.

We have developed a year-round, multi-faceted promotional plan that targets different segments of our membership and has proven most effective in the last few years.

We have implemented a commission structure that makes it as easy as possible to join our business, while giving existing members a chance to start making money as quickly as possible in multiple ways.

The continuously improving mentality and methodology in our customer services have not only distinguished us as an organization, but have also given us a constant flow of information as to how we can do better to service our members.

Sourcing of Products

Our corporate staff works with research and development personnel of our manufacturers and other prospective vendors to create product concepts and develop the product ideas into actual products. We then may enter into supply agreements with the vendors pursuant to which we obtain rights to sell the products under private labels (or trademarks) that are owned by us. Because our current main products all came to us originally as proposals from our vendors, we have incurred minimal “out-of-pocket” research and development costs through December 31, 2014. In addition, some of our local markets introduce their own products from time to time and these products are sometimes adopted by our other markets.

We or certain of our subsidiaries generally purchase finished goods from manufacturers and sell them to our distributorsmembers for their resale or personal consumption. We believe that in the event we are unable to source products from our current or alternate suppliers, our revenue, income and cash flow could be adversely and materially impacted. We have a contract with Two Harbors Trading Company (forPremium Noni Juice)one of our suppliers through December 2017February 2019 with automatic renewal rights and a contract with 40Js LLC (forAlura) through July 2016.

rights.

Marketing and Distribution

We distribute our products internationally primarily through a network marketing system, which is a form of person-to-person direct selling.  Under this system, distributorsmembers primarily refer our products to prospective consumers or they may buy at wholesale prices for personal consumption or for resale to consumers and for personal consumption.consumers.  The concept of network marketing is based on the strength of personal recommendations that frequently come from friends, neighbors, relatives, and close acquaintances.  We believe that network marketing is an effective way to distribute our products because it allows person-to-person product education and testimonials as well as higher levels of customer service, all of which are not as readily available through other distribution channels. In this document, we generically use the term “distributor”“member” to refer to distributorsmembers who purchase for their own consumption or for resale, or both, as well as to members who only sign up to consume our products.

Each of our products is designated a specified number of bonus volume points. Commissions are based on total personal and group bonus volume points per weekly sales period. Bonus volume points are essentially a percentage of a product’s wholesale price.

Our distributorsmembers are independent full-time or part-time contractors who purchase products directly from our subsidiaries via the internet for their own personal consumption or for resale to retail consumers (other than in China and certain other markets) or for their own personal consumption.consumers. Purchasers of our products in China and certain other markets may purchase only for their own personal consumption and not for resale.


The following table sets forth the number of active distributorsmembers by market foras of the time periodsdates indicated. We consider a distributormember “active” if they have placed at least one product order with us during the preceding year.

  

December 31,

 
  

2013

  

2014

 
         

North America

  1,720   1,660 

Hong Kong

  20,190   46,710 

Taiwan

  1,710   2,370 

South Korea

  510   450 

Japan

  150   130 

Russia, Kazakhstan and Ukraine

  2,970   2,600 

Europe

  270   440 

Total

  27,520   54,360 

Members may not necessarily reside in the market for which they sign up as a member.

 December 31,
 2016 2015
North America3,720
 2,870
Hong Kong (including those members residing in China)1
108,570
 100,820
Taiwan4,030
 3,280
South Korea290
 420
Japan100
 100
Singapore80
 
Russia, Kazakhstan and Ukraine2
940
 1,460
Europe1,230
 410
Total118,960
 109,360
1Substantially all of our Hong Kong revenues are derived from the sale of products that are delivered to members in China. See “Item 1A. Risk Factors”.

NHT Global distributors

2We discontinued our Ukraine operations during the second quarter of 2015.

Members must agree to the terms and conditions of our distributormember agreement posted on our website and generally pay an annual enrollment fee. The distributormember agreement sets forth our policies and procedures, and we may elect to terminate a distributormember for non-compliance.

We pay commissions to eligible NHT Global distributorsmembers based on product purchases by such distributors’members’ down-line distributorsmembers during a given commission period. To be eligible to receive commissions, distributorsmembers in some countries may be required to make nominal monthly or other periodic purchases of products. See “Working with DistributorsMembers.

Distributors

Members generally place orders through the internet and pay by credit card prior to shipment. Accordingly, we carry minimal accounts receivable and credit losses are historically minimal.

negligible.

We sponsor promotional meetings and motivational training events for current and potential NHT Global distributors.members. These events are designed to inform prospective and existing distributorsmembers about both existing and new product lines, our latest marketing and promotional plans, and new services improvements. These events also serve as a venue for recognition of distributormember accomplishments. DistributorsMembers typically share their experiences in using our products and developing their business at these events. We are continually developing or updating our marketing strategies and programs to motivate our distributors.

members.

Management Information Systems

The NHT Global

Our business uses a proprietary web-based system to process orders and to communicate bonus volume activity and commissions to distributors. Other than this proprietary system, we have not fully automated and integrated other critical business processes such as inventory management.members. We have automated a substantial amount of our financial reporting processes through implementation of Oracle’s E-Business Suite.

Suite, and have integrated other critical business processes such as inventory management in our most significant markets.

Employees

At December 31, 2014,2016, we employed 113143 total full-time employees worldwide, of which 1425 were located in North America, 79101 in Greater China (Hong Kong, China, and Taiwan), 13five in Commonwealth of Independent States (Russia, Kazakhstan and Ukraine), threeRussia, two in Singapore, two in Malaysia, four in South Korea, three in Europe, and one in Japan.


Seasonality

From quarter to quarter, we are somewhat impacted by seasonal factors and trends such as major cultural events and vacation patterns. For example, most Asian markets celebrate their respective local New Year in the first quarter, whichquarter. This generally has a significant impact on that quarter.the services of our third-party providers, and can negatively impact our net sales. We believe that net sales arecan also generallybe negatively impacted during the third quarter, when many of our distributorsmembers traditionally take time off for vacations. In addition, the national holidays in Hong Kong, China and Taiwan in early October tend to have an adverse effect on sales in those markets.

Our spending, as well as to some extent revenue, is materially affected by the major events planned at different times of the year. A major promotional event could significantly increase the reported expenses during the quarter in which the event actually takes place, while the revenue that might be generated by the event may not occur in the same reporting period.


Intellectual Property

Most of our products are packaged under a "private label"“private label” arrangement. We have obtained or applied for trademark registration for certain names, logos and various product names in several countries in which we are doing business or considering expanding. We also rely on common law trademark rights to protect our unregistered trademarks. These common law trademark rights do not provide us with the same level of protection as afforded by a United States federal trademark. Common law trademark rights are limited to the geographic area in which the trademark is actually utilized, while a United States federal registration of a trademark enables the registrant to discontinue the unauthorized use of the trademark by a third party anywhere in the United States even if the registrant has never used the trademark in the geographic area where the trademark is being used; provided, however, that the unauthorized third party user has not, prior to the registration date, perfected its common law rights in the trademark within that geographic area.

We have a foreign holding and operating company structure for our non-United States businesses, which involves the division of our United States and non-United States operations. Under this structure, we and some of our United States subsidiariesentities have granted an exclusive license to some of our non-United States subsidiaries to use outside of the United States all of their intangible property, including trademarks, trade secrets and other proprietary information.


Working with Members
 

Sponsorship

Working with Distributors

Sponsorship

Sponsoring

Enrolling new distributorsmembers creates multiple levels in theour direct selling structure of NHT Global.structure. The persons that a distributor sponsorsmember enrolls within the network are referred to as "sponsored" distributors,“sponsored” members, who may purchase solely for their own personal consumption, for resale, or both. Persons newly recruitedenrolled are assigned by sponsoring distributors into network positions that can be “under” other distributors,members, and thus they can be called “down-line” distributors.members. If down-line distributorsmembers also sponsorenroll new distributors,members, they create additional levels within the structure, but their down-line distributorsmembers remain in the same down-line network as theirthe original sponsoring distributor.

member that introduced them to our business.

While we provide product samples, brochures and other sales materials, distributorsmembers are primarily responsible for recruitingenrolling and educating their new distributorsmembers with respect to products, the compensation plan and how to build a successful distributorshipmembership network.

Distributors

Members are not required to sponsorenroll other distributorsmembers as their down-line, and we do not pay any commissions for sponsoringenrolling new distributors.members. However, because of the financial incentives provided to those who succeed in building a distributormember network that consumes and resells products, we believe that many of our distributorsmembers attempt, with varying degrees of effort and success, to sponsorenroll additional distributors.members. Because they are seeking new opportunities for income, people are often attracted to become distributorsmembers after using our products or after attending introductory seminars. Once a person becomes a distributor,member, he or she is able to purchase products directly from us at wholesale prices via the internet. The distributormember is also entitled to sponsorenroll other distributorsmembers in order to build a network of distributorsmembers and product users.


Compensation Plans

NHT Global employs

We employ what is commonly referred to as a binary compensation plan, enhanced with certain unilevel features. Under the NHT Globalour compensation plan, distributorsmembers are paid weekly commissions by our subsidiary, in which they are enrolled for product purchases by their down-line distributormember network across all geographic markets, exceptmarkets. Our China where we maintainsubsidiary maintains an e-commerce retail platform and dodoes not pay any commissions. This “seamless” compensation plan enables a distributormember located in one country to sponsor other distributorsmembers located in other countries. Currently, there are basically two ways in which NHT Global distributorsmembers can earn income:

Through retail markups on sales of products purchased by distributors at wholesale prices (in some markets, sales are for personal consumption only and income may not be earned through retail mark-ups on sales in that market); and

Through commissions paid on product purchases made by their down-line distributors.


Through commissions paid on product purchases made by their down-line members; and

Through retail markups on sales of products purchased by members at wholesale prices (in some markets, sales are for personal consumption only and income may not be earned through retail mark-ups on sales in that market).
Each of our products is designated a specified number of bonus volume points. Commissions are based on total personal and group bonus volume points per sales period. Bonus volume points are essentially a percentage of a product’s wholesale price. As the distributor’smember’s business expands, the distributormember receives higher commissions from purchases made by an expanding down-line network. To be eligible to receive commissions, a distributormember may be required to make nominal monthly or other periodic purchases of our products. Certain of our subsidiaries do not require these nominal purchases for a distributormember to be eligible to receive commissions. In determining commissions, the number of levels of down-line distributorsmembers included within the distributor'smember’s commissionable group increases as the number of distributorshipsmemberships directly below the distributormember increases. Under our current compensation plan, certainsome of our commission payout may be limited to a hard cap dollar amount per week or a specific percentage of the total product sales. In some markets, commissions may be further limited.

In some markets, we also pay certain bonuses on purchases by up to three generations of personally sponsored distributors,members, as well as bonuses on commissions earned by up to three generations of personally sponsored distributors. Distributorsmembers. Members can also earn income, trips and other prizes in specific time-limited promotions and contests we hold from time to time.

From time to time

Occasionally, we make modifications and enhancements to our compensation plan to help motivate distributors,members, which can have an impact on distributormember commissions. From time to time weWe may also enter into agreements for business or market development, which maycould result in additional compensation to specific distributors.

Distributormembers.

Member Support

We are committed to providing a high level of support services tailored to the needs of our distributorsmembers in each marketplacemarket we are serving. We attempt to meet the needs and build the loyalty of distributorsmembers by providing personalized distributormember services and by maintaining a generous product return policy (see “Product Warranties and Returns”). We believe that maximizing a distributor’smember’s efforts by providing effective distributormember support has been, and could continue to be, important to our success.



Through product training meetings, regular conventions, web-based messages, distributormember focus groups, regular telephone conference calls and other personal contacts with distributors,members, we seek to understand and satisfy the needs of our distributors.members. Via our websites, we provide product fulfillment and tracking services that result in user-friendly and timely product distribution.

To help maintain communication with our distributors,members, we offer the following support programs:

Teleconferences – we hold teleconferences with associate field leadership on various subjects such as technical product discussions, distributor organization building and management techniques.

Internet –we maintain a website at www.nhtglobal.com. On this website, the user can read company news, learn more about various products, sign up to be a distributor, place orders, and track the fulfillment and delivery of their orders.

Product Literature – we offer a variety of literature to distributors, including product catalogs, informational brochures, pamphlets and posters for individual products.

Broadcast E-mail and Text Messages – we send announcements via e-mail and/or text messages to all active distributors.

Social Media tools – in some countries we maintain country-specific social media sites to foster a community environment around our product offering and business opportunity.


Teleconferences – we hold teleconferences with associate field leadership on various subjects such as technical product discussions, member organization building and management techniques.

Internet – we maintain a website at www.nhtglobal.com. On this website, the user can read company news, learn more about various products, sign up to be a member, place orders, and track the fulfillment and delivery of their orders.
Product Literature – we offer a variety of literature to members, including product catalogs, informational brochures, pamphlets and posters for individual products, which are both printed and available online.
Broadcast E-mail and Text Messages – we send announcements via e-mail and/or text messages to members who opt in to receive this form of communication.

Social Media Tools – in some countries we maintain country-specific social media sites to foster a community environment around our product offering and business opportunity.

Technology and Internet Initiatives

We believe that the internet is important to our business as more consumers communicate online and purchase products over the internet as opposed to traditional retail and direct sales channels. As a result, we have committed significant resources to our e-commerce capabilities and the abilities of our distributorsmembers to take advantage of the internet. Substantially all of our sales take place via the internet. NHT Global offersWe offer a global web page that allows a distributormember to have a personalized replicating website through which he or she can sell products in all of the countries in which we do business. Links to these websites can be found at our main website for distributorsmembers at www.nhtglobal.com. The information provided on these websites should not be considered part of this report.

Rules Affecting Distributors

Members

Our distributormember policies and procedures establish the rules that distributorsmembers must follow in each market. We also monitor distributormember activity in an attempt to provide our distributorsmembers with a “level playing field” so that one distributormember may not be disadvantaged by the activities of another. We require our distributorsmembers to present products and business opportunities in an ethical and professional manner. DistributorsMembers further agree that their presentations to customers must be consistent with, and limited to, the product claims and representations made in our literature.

We require

Our policies and procedures state that we produce or pre-approve all sales aids used by distributorsmembers such as presentations videotapes, audiotapes, brochures and promotional clothing. Further, distributorsmembers may not use any form of media advertising to promote products unless it is pre-approved by us. Products may be promoted only by personal contact or by literature produced or approved by us. DistributorsMembers are not entitled to use our trademarks or other intellectual property without our prior consent.

Our compliance and member services department reviews reports of alleged distributormember misbehavior. If we determine that a distributormember has violated our distributormember policies or procedures, we may terminate the distributor’smember’s rights completely. Alternatively, we may impose sanctions, such as warnings, probation, withdrawal or denial of an award, suspension of privileges of the distributorship,membership, fines, withholding commissions, until specified conditions are satisfied or other appropriate injunctive relief. Our distributorsmembers are independent contractors, not employees, and may act independently of us. Further, our distributorsmembers may resign or terminate their distributorshipmembership at any time without notice. See “Item 1A. Risk Factors.”


Government Regulations
 

Government Regulations

Direct Selling Activities

Direct selling, or multi-level marketing, activities are regulated by various federal, state and local governmental agencies in the United States and other countries. These laws and regulations are generally intended to prevent fraudulent or deceptive schemes, often referred to as “pyramid” schemes, which compensate participants for recruiting additional participants irrespective of product sales, use high-pressure recruiting methods and/or do not involve legitimate products.schemes. The laws and regulations in our current markets often:

impose cancellation/product return, inventory buy-backs and cooling-off rights for consumers and distributors;

require us or our distributors to register with governmental agencies;

impose reporting requirements; and

impose upon us requirements, such as requiring distributors to maintain levels of retail sales to qualify to receive commissions, to ensure that distributors are being compensated for sales of products and not for recruiting new distributors.

impose cancellation/product return, inventory buy-backs and cooling-off rights for consumers and members;

require us or our members to obtain a license from, or register with, governmental agencies;

impose reporting requirements; and

impose upon us requirements, such as requiring members to maintain levels of retail sales to qualify to receive commissions, to ensure that members are being compensated for sales of products and not for recruiting new members.
The laws and regulations governing direct selling are modified from time to time, and, like other direct selling companies, we aremay be subject from time to time to government reviews, examinations or investigations in our various markets related to our direct selling activities. This can require us to make changes to our business model and aspects of our global compensation plan in the markets impacted by such changes and investigations.

examinations.

Based on advice of our engaged outside professionals in existing markets, the nature and scope of inquiries from government regulatory authorities and our history of operations in those markets to date, we believe our method of distribution complies in all material respects with the laws and regulations related to direct selling of the countries in which we currently operate.

As a result of restrictions in China on direct selling activities, we are not conducting direct selling in China. Consumers and members purchase the Company’s products via our Hong Kong-based website or our e-commerce platform in China. The regulatory environment in China is complex. Because we operate a direct selling model outside of China, our operations in China have received regulatory and media attention.


At the end of 2005, China adopted new direct selling and anti-pyramiding regulations that are restrictive and contain various limitations, including a restriction on the ability to pay multi-level compensation to independent distributors. Regulationsmembers. We are subject to discretionary interpretation by municipal and provincial level regulators. Interpretations of what constitutes permissible activities by regulators can vary from province to province and can change from time to time because of the lack of clearly defined rules regardingnot conducting direct selling activities.

Because of thein China. Rather, consumers and members purchase our products via our Hong Kong-based website or our e-commerce retail platform in China. The regulatory environment in China is complex, and our operations in China can receive regulatory and media attention.

The Chinese government’s significant concerns about direct selling activities and its adoption of direct selling and anti-pyramiding regulations, itgovernment scrutinizes very closely activities of direct selling companies. Our business continues to be subject to reviewsregulations and investigationsexaminations by municipal and provincial level regulators. At times, investigations and related actions by government regulators have caused an obstruction toimpacted our members’ activities in certain locations, and have resulted in a few cases of enforcement actions. In each of these cases, we helped our members with their defense in the legality of their conduct. So far, no material changes to our business model have been required. We expect to receive continued guidance and direction as we work with regulators to address our business model and any changes that need to be made to comply with the direct selling regulations.

To augment

We believe that neither our businessHong Kong-based website nor our e-commerce platform in China our Chinese subsidiary appliedrequire a direct selling license in China, which we currently do not hold. We have previously sought to obtain a direct selling license, and in August 2015 initiated the process for submitting a new preliminary application for a direct selling license first in 2005, providedChina. If we are able to obtain a revised versiondirect selling license in June 2006, and then updated againChina, we believe that the incentives inherent in the direct selling model in China would incrementally benefit our applicationexisting business. Increased sales in November 2007. AfterChina that could be derived from obtaining a direct selling license may be partially offset by the approval from the municipal and the provincial authorities, the application did not progress furtherhigher fixed costs associated with the central government.  Eventually, the information containedestablishment and maintenance of required service centers and branch offices. We are unable to predict whether and when we will be successful in our most recent application became staleobtaining a direct selling license to operate in China, and if we withdrew the license application in February 2009 with the intention of filing an updated application in the future.

are successful, when we will be permitted to conduct direct selling operations and whether such operations would be profitable.

Regulation of Our Products

Our products and related promotional and marketing activities are subject to extensive governmental regulation by numerous governmental agencies and authorities in the United States, including theU.S.the U.S. Food and Drug Administration (the “FDA”), the Federal Trade Commission (the “FTC”), the Consumer Product Safety Commission, the United States Department of Agriculture, State Attorneys General and other state regulatory agencies.  In our foreign markets, the products are generally regulated by similar government agencies.



Our personal care products are subject to various laws and regulations that regulate cosmetic products and set forth regulations for determining whether a product can be marketed as a “cosmetic” or requires further approval as an over-the-counter (OTC) drug. In the United States, regulation of cosmetics is under the jurisdiction of the FDA.  The Food, Drug and Cosmetic Act defines cosmetics by their intended use, as “articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body . . . for cleansing, beautifying, promoting attractiveness, or altering the appearance.”  Among the products included in this definition are skin moisturizers, eye and facial makeup preparations, perfumes, lipsticks, fingernail polishes, shampoos, permanent waves, hair colors, toothpastes and deodorants, as well as any material intended for use as a component of a cosmetic product.  Conversely, a product will not be considered a cosmetic, but may be considered a drug if it is intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, or is intended to affect the structure or any function of the body. A product’s intended use can be inferred from marketing or product claims.  The other markets in which we operate have similar regulations.  In Japan, the Ministry of Health, Labour and Welfare regulates the sale and distribution of cosmetics and requires us to have an import business license and to register each personal care product imported into Japan.  In Taiwan, all “medicated” cosmetic products require registration.  In China, personal care products are placed into one of two categories, “general” and “drug.”  Products in both categories require submission of formulas and other information with the health authorities, and drug products require human clinical studies.  The product registration process in China for these products can take from nine to more than 18 months or longer.  Such regulations in any given market can limit our ability to import products and can delay product launches as we go through the registration and approval process for those products.  The sale of cosmetic products is regulated in the European Union under the European Union Cosmetics Directive, which requires a uniform application for foreign companies making personal care product sales.


The markets in which we operate all have varied regulations that distinguish foods and nutritional health supplements from “drugs” or “pharmaceutical products.”  Because of the varied regulations, some products or ingredients that are recognized as a “food” in certain markets may be treated as a “pharmaceutical” in other markets.  These regulations may require us to either modify a product or refrain from selling the product in a given market. As a result, we must oftenregularly modify the ingredients and/or the levels of ingredients in our products for certain markets.  In some circumstances, the regulations in foreign markets may require us to obtain regulatory approval prior to introduction of a new product or limit our uses of certain ingredients altogether. Because of negative publicity associated with some supplements, thereThere has been an increased movement in the United States and other markets to expand the regulation of dietary supplements, whichsupplements. This could impose additional restrictions or requirements in the future.  In general, theBecause of this increased regulatory environment is becoming more complexfocus, our internal review efforts have been enhanced in order to comply with increasingly strict regulations each year.

our understanding of current regulations.

FDA regulations require current good manufacturing practices (cGMP) for dietary supplements.  The regulations ensure that dietary supplements are produced in a quality manner, do not contain contaminants or impurities, and are accurately labeled. The regulations include requirements for establishing quality control procedures for us and our vendors and suppliers, designing and constructing manufacturing plants, and testing ingredients and finished products.  The regulations also include requirements for record keeping and handling consumer product complaints.  If dietary supplements contain contaminants or do not contain the type or quantity of dietary ingredient they are represented to contain, the FDA would consider those products to be adulterated or misbranded.  

Our business is subject to additional FDA regulations, such as those implementing an adverse event reporting system (“AER’s”), which requires us to document and track adverse events and report serious adverse events, which are events involving hospitalization or death, associated with consumers’ use of our products.  

Most of our major markets also regulate advertising and product claims regarding the efficacy of products. This is particularly true with respect to our dietary supplements because we typically market them as foods or health foods. For example, in the United States, we are unable to claim that any of our nutritional supplements will diagnose, cure, mitigate, treat or prevent disease. In the United States, the Dietary Supplement Health and Education Act, however, permits substantiated, truthful and non-misleading statements of nutritional support to be made in labeling, such as statements describing general well-being resulting from consumption of a dietary ingredient or the role of a nutrient or dietary ingredient in affecting or maintaining a structure or a function of the body. Most of the other markets in which we operate have not adopted similar legislation, although we may be subject to more restrictive limitations on the claims we can make about our products in these markets.

Other Regulatory Issues

As a United States entity operating through subsidiaries in foreign jurisdictions, we are subject to foreign exchange control, transfer pricing and custom laws that regulate the flow of funds between our subsidiaries and us for product purchases, management services and contractual obligations, such as the payment of distributormember commissions. As is the case with most companies that operate in our product categories, we might receive inquiries from time to time from government regulatory authorities regarding the nature of our business and other issues, such as compliance with local direct selling, transfer pricing, customs, taxation, foreign exchange control, securities and other laws.



Product Warranties and Returns

NHT Global

Our refund policies and procedures closely follow industry and country-specific standards, which vary greatly by country. For example, in the United States, the Direct Selling Association recommends that direct sellers permit returns during the twelve-month period following the sale, while in Hong Kong the standard return policy is 14 days following the sale. Our return policies typically conform to local laws or the recommendation of the local direct selling association. In most cases, distributorsmembers who timely return unopened product that is in resalable condition may receive a refund. The amount of the refund may be dependent on the country in which the sale occurred, the timeliness of the return, and any applicable re-stocking fee. NHT Global must be notified of the return in writing and such written requests would be considered a termination notice of the distributorship. From time to time, wemembership. We may alter our return policy in response to special circumstances.

Significant Customers

Sales are made to our members and no single customer accounted for 10% or more of our net sales. However, our business model can result in a concentration of sales to several different members and their network of members. Although no single member accounted for 10% or more of net sales, the loss of a key member or that member’s network could have an adverse effect on our net sales and financial results.

Our Industry

We are engaged in the direct selling industry, selling wellness, herbal, beauty, lifestyle enhancement products, cosmetics, personal care and dietary supplements.home products. More specifically, we are engaged in what is called network marketing or multi-level marketing. This type of organizational structure and approach to marketing and sales include companies selling lifestyle enhancement products, cosmetics and dietary supplements, or selling other types of consumer products. Generally, direct selling is based upon an organizational structure in which independent distributors ofmembers purchasing a company’s products are compensated for sales made directly to consumers.

NHT Global distributors

Our members are compensated based on sales generated by distributorsmembers they have recruitedenrolled and all subsequent distributors recruitedmembers enrolled by their "down-line"“down-line” network of distributors.members. The experience of the direct selling industry has been that once a sizeable network of distributorsmembers is established, new and alternative products and services can be offered to those distributorsmembers for sale to consumers and additional distributors.

members.

Competition

The network marketing industry is very diverse, with giant multinational corporations as well as smaller, local operators. Big network marketing companies include Nu Skin Enterprises, Inc., USANA Health Sciences, Inc., Mannatech, Incorporated., Reliv’ International, Inc, and Herbalife, Ltd, which have much greater name recognition and financial resources than we do and also have many more distributors.members. They are publicly traded and therefore serve as informational benchmarks. Butbenchmarks, but we don’t overlap with them in terms of marketplace or product range. On the other hand, many medium- and small-sized privately held Chinese, Taiwanese and Hong Kong companies are fierce competitors and are much closer to directly competing with us. Also, a number of our former employees and distributorsmembers now work for competitors, and sometimes try to use relationships and knowledge obtained to compete with us.

Our ability to compete with other network marketing companies depends, in significant part, on our success in attracting and retaining distributors.members.  There can be no assurance that our programs for attracting and retaining distributorsmembers will be successful.  The pool of individuals interested in network marketing is limited in each market and is reduced to the extent other network marketing companies successfully attract these individuals into their businesses.  Although we believe that we offer an attractive opportunity for our distributors,members, there can be no assurance that other network marketing companies will not be able to recruit our existing distributorsmembers or deplete the pool of potential distributorsmembers in a given market.

The direct selling channel tends to sell products at a higher price compared to traditional retailers, which poses a degree of competitive risk. There is no assurance that we would continue to compete effectively against retail stores, internet-based retailers or other direct sellers.

Item 1A.

RISK FACTORS

Item 1A. RISK FACTORS

We are exposed to a variety of risks that are present in our business and industry. The following are some of the more significant factors that could affect our business, results of operations and financial condition.

We could be adversely affected by management changes or an inability to attract and retain key management, directors and consultants.

We incur a low level of overhead and are run by a small number of executives, who rely on a small group of employees. Our future success depends to a significant degree on the skills, experience and efforts of our top management and directors.  We also depend on the ability of our executive officers and other members of senior management to work effectively as a team.  The loss of one or more of our executive officers, members of our senior management or directors could have a material adverse effect on our business, results of operations and financial condition.  Moreover, as our business evolves, we may require additional or different management members, directors or consultants, and there can be no assurance that we will be able to locate, attract and retain them if and when they are needed.



Because our Hong Kong operations account for a majoritysubstantial portion of our overall business, and mostsubstantially all of our Hong Kong business is derived from the sale of products to members in China, any material adverse change in our business relating to either Hong Kong or China would likely have a material adverse impact on our overall business.

In 20132016, 2015 and 2014, approximately 77%92%, 93% and 89% of our revenue, respectively, was generated in Hong Kong. MostSubstantially all of our Hong Kong revenues are derived from the sale of products that are delivered to members in China. This geographic concentration in our business means that events or conditions that could negatively impact this geographic region or our operations in this region would have a greater adverse impact upon our overall business and financial results than would be the case with a company having greater geographic diversification.  


Our operations in China are subject to compliance with a myriad of applicable laws and regulations, and any actual or alleged violations of those laws or government actions otherwise directed at us could have a material adverse impact on our business and the value of our company.

In contrast to our operations in other parts of the world, we have not implemented a direct sales model in China. The Chinese government permits direct selling only by organizations that have a license, thatwhich we do not have,are in the process of applying for, and has also adopted anti-multilevel marketing legislation. We operate an e-commerce direct selling model in Hong Kong and recognize the revenue derived from sales to both Hong Kong and Chinese members as being generated in Hong Kong. Products purchased by members in China are delivered to third parties that act as the importers of record under agreements to pay applicable duties.  In addition, through a Chinese entity, we sell products in China using an e-commerce retail model. The Chinese entity operates separately from the Hong Kong entity, althoughand a Chinese member may elect to participate separately or in both.

We

After consulting with outside professionals, we believe that theour e-commerce direct selling model in Hong Kong does not violate any applicable laws and regulations in China, regarding direct selling and multi-level marketing are not specifically applicable toeven though it is used for the internet purchase of our Hong Kong-based e-commerce activity, andproducts by members in China. We also believe that our Chinese entity, including its e-commerce retail platform, is operating in compliance with applicable Chinese laws. However, there can be no assurance that the Chinese authorities will agree with our interpretations of applicable laws and regulations or that China will not adopt new laws or regulations. Should the Chinese government determine that our e-commerce activity violatesactivities violate China’s direct selling or anti-multilevel marketing legislation, or should new laws or regulations be adopted, there could be a material adverse effect on our business, financial condition and results of operations.

Because of

The Chinese government scrutinizes the Chinese government’s significant concerns about direct selling activities, it scrutinizes very closely activities of direct selling companies. Our business continues to be subject to regulations and examinations by municipal and provincial level regulators. At times, investigations and related actions by government regulators have impacted our members’ activities in certain locations and have resulted in a few cases where we have paid substantial fines.of enforcement actions. In each of these cases, we have been allowed to recommence operations afterhelped our members with their defense of the government’s investigation,legality of their conduct, and no material changes to our business model were requiredrequired.
However, our business operations and the value of our company can be adversely affected by Chinese government scrutiny of our operations, even if that scrutiny does not result in connection with these finesinvestigations of our operations. For example, one or more parties encouraged the Beijing City governmental authorities to conduct an investigation of our business, which resulted in a meeting in January 2016 involving members of our Beijing office staff, Beijing City governmental officials, and impediments.

two complainants. Even though the Beijing City governmental officials advised our staff and the complainants at that meeting that there was insufficient evidence to warrant an investigation of us, gross mischaracterizations of the meeting immediately appeared in several “news reports.” Similarly, a subsequent meeting between several Guangzhou City government officials and members of our Guangzhou office staff that resulted in our providing routine information about our operations to the government officials was also grossly mischaracterized in an online posting made immediately following the meeting. Although we attemptremain in regular contact with Chinese government officials and take other steps to work closely with both national and local Chinese governmental agencies in conductingaddress the risks posed by these events, our business and the value of our effortscompany remain vulnerable to comply with national and local laws may be harmed by a rapidly evolving regulatory climate, concerns about activities resembling violationsChinese government scrutiny of direct selling or anti-multi-level marketing legislation, subjective interpretations of laws and regulations, and activities by individual distributors that may violate laws notwithstanding our strict policies prohibiting such activities. Any determination that our operations, whether or activities, or the activities of our individual distributors or employee sales representatives, or importers of record are not in compliance with applicable laws and regulations could result in the imposition of substantial fines, extended interruptions of business, restrictions on our future ability to obtain business licenses or expand into new locations, changes to our business model, the termination of required licenses to conduct business, or other actions, any of which could materially harm our business, financial condition and results of operations.

initiated by third parties.


Various other factors could harm our business in Hong Kong and China, such as worsening economic conditions in Hong Kong or China, adverse local publicity or other events that may be out of our control.  For example, we were advised to voluntarily suspend marketing activities in China during the third quarter of 2007 when the Chinese government was expected to impose a more intense enforcement program against illegal chain sales activities.  We did not want to run the risk of being inadvertently entangled in the government enforcement actions and voluntarily withdrew all marketing activities from China during that period.  It may be necessary or advisable to repeat this or similar actions from time to time in the future, and such periods of reduced activity could have a material adverse effect on our business.



Although we attempt to work closely with both national and local Chinese governmental agencies in conducting our business, our efforts to comply with national and local laws may be harmed by a rapidly evolving regulatory climate, concerns about activities resembling violations of direct selling or anti-multi-level marketing legislation, subjective interpretations of laws and regulations, and activities by individual members that may violate laws notwithstanding our strict policies prohibiting such activities. Any determination that our operations or activities, or the activities of our individual members or employee sales representatives, or importers of record are not in compliance with applicable laws and regulations could result in the imposition of substantial fines, extended interruptions of business, restrictions on our future ability to obtain business licenses or expand into new locations, changes to our business model, the termination of required licenses to conduct business, or other actions, any of which could materially harm our business, financial condition and results of operations. 

Our failure to maintain and expand our distributormember relationships could adversely affect our business.

We distribute our products through independent distributors,members, and we depend upon them directly for all of our sales in most of our markets. Accordingly, our success depends in significant part upon our ability to attract, retain and motivate a large base of distributors.members. Our direct selling organization is headed by a relatively small number of key distributors.members. The loss of a significant number of distributors, especiallymembers, or the loss of one or more key distributors,members, could materially and adversely affect sales of our products and could impair our ability to attract new distributors.members. Moreover, the replacement of distributorsmembers could be difficult because, in our efforts to attract and retain distributors,members, we compete with other direct selling organizations, including but not limited to those in the personal care, cosmetic product and nutritional supplement industries. Our distributorsmembers may terminate their services with us at any time and, in fact, like most direct selling organizations, we have a high rate of attrition.



The number of active distributorsmembers or their productivity may not increase and could decline in the future.  We cannot accurately predict any fluctuation in the number and productivity of distributorsmembers because we primarily rely upon existing distributorsmembers to sponsorenroll and train new distributorsmembers and to motivate new and existing distributors.members. Operating results could be adversely affected if our existing and new business opportunities and products do not generate sufficient economic incentive or interest to retain existing distributorsmembers and to attract new distributors.

members.

The number and productivity of our distributorsmembers could be harmed by several factors, including:

adverse publicity or negative perceptions regarding us, our products, our method of distribution or our competitors;


adverse publicity or negative perceptions regarding us, our products, our method of distribution or our competitors;

lack of interest in, or the technical failure of, existing or new products;

lack of interest in, or the technical failure of, existing or new products;

lack of interest in our existing compensation plan for distributors or in enhancements or other changes to that compensation plan;

our actions to enforce our policies and procedures;

regulatory actions or charges or private actions against us or others in our industry;

general economic and business conditions;

changes in management or the loss of one or more key distributor leaders;

entry of new competitors, or new products or compensation plan enhancements by existing competitors, in our markets; and

potential saturation or maturity levels in a given country or market which could negatively impact our ability to attract and retain distributors in such market.

The high level of competition in our industryexisting compensation plan for members or in enhancements or other changes to that compensation plan;


our actions to enforce our policies and procedures;

regulatory actions or charges or private actions against us or others in our industry;

general economic and business conditions;

changes in management or the loss of one or more key member leaders;

entry of new competitors, or new products or compensation plan enhancements by existing competitors, in our markets; and

potential saturation or maturity levels in a given country or market which could negatively impact our ability to attract and retain members in such market.


We are currently being sued in three lawsuits alleging, among other things, that we made materially false and misleading statements regarding the legality of our business operations in China.

We, together with our executive officers, have been named as defendants in three complaints (one of which also names our directors as defendants) relating to alleged materially false and misleading statements regarding the legality of our business operations in China, among other things. These complaints seek an indeterminate amount of damages, and one of the complaints also seeks various equitable remedies. Notwithstanding potentially applicable insurance coverage, these complaints, or others filed alleging similar facts, could result in monetary or other penalties that may adversely affect our business.

Theoperating results and financial condition. Moreover, the negative publicity stemming from these complaints and the allegations they make could harm our business of marketing personal care, cosmetic, nutritional supplements, and lifestyle enhancement products is highly competitive.  This market segment includes numerous manufacturers, distributors, marketers, and retailers that actively compete foroperations. Accordingly, any adverse determination against us in these suits, or even the business of consumers bothallegations contained in the United Statessuits regardless of whether they are ultimately found to be without merit, could harm our business, operations and abroad.  The market is highly sensitivefinancial condition.


We are currently involved in, and may in the future face, litigation claims and governmental proceedings and inquiries that could harm our business.
We are currently, and have in the past, been a party to lawsuits, claims and governmental proceedings and inquiries.  Prosecuting and defending these matters may require significant expense and attention of our management.  There can be no assurance that we will be able to successfully defend or resolve any such litigation, claims or governmental proceedings or inquiries, or that the introduction of new products, which may rapidly capture a significant share of the market.  Sales of similar products by competitors may materiallymoney, time and effort spent in defending these matters will not adversely affect our business, financial condition and results of operations.

We


Although our members are subject to significant competition for the recruitment of distributors from other direct selling organizations, including thoseindependent contractors, improper member actions that market similar products.  Many ofviolate laws or regulations could harm our competitorsbusiness.
Our members are substantially larger thanindependent contractors and, accordingly, we are offernot in a wider array of products, have far greater financial resources and many more active distributors than we have.  Even more numerous are thosemedium- and small-sized, all privately held Chinese, Taiwanese and Hong Kong companies that are fierce competitors and are much closerposition to directly competing with us. Our ability to remain competitive depends, in significant part, onprovide the same direction, motivation and oversight as we would if members were our success in recruiting and retaining distributors with our products, attractive compensation plan and other incentives.  We believe that we have an attractive product line and that our compensation and incentive programs provide our distributors with significant earning potential.  However, we cannot be sure that our programs for recruitment and retention of distributors would be successful.

Some of our competitors have employed or otherwise contracted for the services of our former officers, employees, consultants, and distributors, who may try to use information and contacts obtained while under contract with us for competitive advantage.  While we seek to protect our information through contractual and other means,own employees.  As a result, there can be no assurance that weour members will timely learn of such activity, have the resources to attempt to stop it,participate in our marketing strategies or have adequate remedies available to us.

An increase in the amount of compensation paid to distributors would reduce profitability.

A significant expense is the payment of compensation toplans, accept our distributors, which represented approximately 46% of net sales during each of 2013 and 2014.  We compensate our distributors by paying commissions, bonuses, and certain awards and prizes.  Factors impacting the overall commission payout include the growth and depth of the distributor network, the distributor retention rate, the level of promotions, local promotional programs and business development agreements.  Any increase in compensation payments to distributors as a percentage of net sales will reduce our profitability.  


Our compensation plan includes a cap that may be enforced on distributor compensation paid out on a weekly dollar limit or as a percentage of product sales. There can be no assurance that enforcement of this cap will ensure profitability (which depends on many other factors).  Moreover, enforcement of this cap could cause key distributors affected by the cap to leave and join other companies.

Failureintroduction of new products, or comply with our member policies and procedures.  Extensive federal, state, local and foreign laws regulate our business, our products and our network marketing program.  Because we have expanded into foreign countries, our policies and procedures for our members differ due to the different legal requirements of each country in which we do business.  While we have implemented member policies and procedures designed to govern member conduct and to protect the goodwill associated with our trademarks and trade names, it can be difficult to enforce these policies and procedures because of the large number of members and their independent status.  

Given the size and diversity of our member force, we experience problems with members from time to time, especially with respect to our members in foreign markets. For example, if our members engage in illegal activities in China, those actions could be attributed to us. Chinese laws regarding how and when members may assemble and the activities that they may conduct, or the conditions under which the activities may be conducted, are subject to interpretations and enforcement that sometimes vary from province to province, among different levels of government, and from time to time. Members can be accused of violating one or more of the laws regulating these activities, notwithstanding training that we attempt to provide. Enforcement measures regarding these violations, which can include arrests, raise the uncertainty and perceived risk associated with conducting this business, especially among those who are aware of the enforcement actions but not the specific activities leading to the enforcement action. We believe that this has led some existing members in China - who are signed up as members in Hong Kong - to leave the business or curtail their selling activities and has led some potential members to choose not to participate. Among other things, we are managing this risk with more training and public relations efforts that are designed, among other things, to distinguish our company from businesses that make no attempt to comply with the law. This environment creates uncertainty about the future of doing this type of business in China generally and under our business model, specifically.

In addition, members often desire to enter a market before we have received approval to do business in order to gain distributoran advantage in the marketplace.  Improper member activity in new geographic markets could result in adverse publicity and market acceptance could harm our business.

An important component of our business iscan be particularly harmful to our ability to develop newultimately enter these markets.  Violations by our members of applicable law or of our policies and procedures in dealing with customers could reflect negatively on our products and operations, and harm our business reputation.  In addition, it is possible that create enthusiasm amonga judicial or administrative body could hold us civilly or criminally accountable based on vicarious liability because of the actions of our distributor force.members.  If we fail to introduce new products on a timely basis,any of the above or related events involving our distributor productivitymembers occur, our business, financial condition, or results of operations could be harmed.  In addition, if any new products fail to gain market acceptance, are restricted by regulatory requirements, or have quality problems, this would harm our results of operations.  Factors that could affect our ability to continue to introduce new products include, among others, limited capital and human resources, government regulations, proprietary protections of competitors that may limit our ability to offer comparable products and any failure to anticipate changes in consumer tastes and buying preferences.

materially adversely affected.


Direct-selling laws and regulations may prohibit or severely restrict our direct sales efforts and cause our revenue and profitability to decline, and regulators could adopt new regulations that harm our business.

Our direct selling system is subject to extensive laws, governmental regulations, administrative determinations, court decisions and similar constraints.  These laws and regulations are generally intended to prevent fraudulent or deceptive schemes, often referred to as “pyramid” schemes, which compensate participants for recruiting additional participants irrespective of product sales, use high pressure recruiting methods and/or do not involve legitimate products.

They also seek to ensure that claims regarding the ability of participants to earn money are truthful and substantiated.

Complying with these widely varying and sometimes inconsistent rules and regulations can be difficult and may require the devotion of significant resources on our part.  There can be no assurance that we or our distributorsmembers are in compliance with all of these regulations.  Our failure or our distributors’members’ failure to comply with these regulations or new regulations could lead to the imposition of significant penalties or claims and could negatively impact our business.  If we are unable to continue business in existing markets or commence operations in new markets because of these laws, our revenue and profitability may decline.

We are also subject to the risk that new laws or regulations might be implemented or that current laws or regulations might change, which could require us to change or modify the way we conduct our business in certain markets.  This could be particularly detrimental to us if we have to change or modify the way we conduct business in markets that represent a significant percentage of our revenue.  For example,

The high level of competition in our industry could adversely affect our business.
The business of marketing personal care, cosmetic, nutritional supplements, and lifestyle enhancement products is highly competitive.  This market segment includes numerous manufacturers, members, marketers, and retailers that actively compete for the Federal Trade Commission (the “FTC”) released a proposed New Business Opportunity Rulebusiness of consumers both in April 2006.  As initially drafted, the proposed rule would have required pre-sale disclosures for all business opportunities,United States and abroad.  The market is highly sensitive to the introduction of new products, which may rapidly capture a significant share of the market.  Sales of similar products by competitors may materially and adversely affect our business, financial condition and results of operations.
We are subject to significant competition for the recruitment of members from other direct selling organizations, including those that market similar products.  Many of our competitors are substantially larger than we are, offer a wider array of products, have included network marketing compensation plans such as ours.  However, in November 2011, the FTC issued a final rule that does not apply to multi-level marketingfar greater financial resources and many more active members than we have.  Even more numerous are those medium- and small-sized, all privately held Chinese, Taiwanese and Hong Kong companies that do not representare fierce competitors and are much closer to directly competing with us. Our ability to remain competitive depends, in significant part, on our success in recruiting and retaining members with our products, attractive compensation plan and other incentives.  We believe that theywe have an attractive product line and that our compensation and incentive programs provide our members with significant earning potential.  However, we cannot be sure that our programs for recruitment and retention of members will be successful.
Some of our competitors have employed or another designated person will do any of the following:  (a) provide locationsotherwise contracted for the operationservices of equipment, displays, vending machinesour former officers, employees, consultants, and members, who may try to use information and contacts obtained while under contract with us for competitive advantage.  While we seek to protect our information through contractual and other means, there can be no assurance that we will timely learn of such activity, have the resources to attempt to stop it, or similar devices owned, leased, controlled or paid for by the purchaser of the opportunity; (b) provide outlets, accounts, or customers (including but not limitedhave adequate remedies available to internet outlets, accounts, or customers) for the purchaser’s goods or services (advertising and general advice about business development and training is not considered as “providing locations, outlets, accounts, or customers”); or (c) buy back any or all of the goods or services that the purchaser makes or provides.  As we understand the final regulation, the Company does not make any of these representations and therefore is not covered by the final rule, which took effect on March 1, 2012.

us.

Challenges by third parties to the formlegality of our business modeloperations could harm our business.


We are also subject to the risk of private party challenges to the legality of our operations, including our direct selling system.  The regulatory requirements concerning direct selling systems generally do not include “bright line” rules and are inherently fact-based and subject to judicial or administrative interpretation. An adverse judicial or administrative determination against us with respect to our direct selling system, or in proceedings not involving us directly but which challenge the legality of other direct selling marketing systems, could have a material adverse effect on our business.  There is also risk that challenges and settlements involving other parties could provide incentives for similar actions by distributorsmembers against us and other direct selling companies.  Moreover, challenges to our business system and operations in important markets may come from short sellers, hedge funds, other investors, bloggers and other investors.reporters.  Other companies in our industry have recently faced such challenges.  Any challenges regarding us or others in our industry could harm our business if such challenges result in the investigation of our business model and operations or the imposition of any fines or damages on our business, create adverse publicity, increase scrutiny or investigations of us or our industry, detrimentally affect our efforts to recruit or motivate distributorsmembers and attract customers, or interpret laws in a manner inconsistent with our current business practices.



An increase in the amount of compensation paid to members would reduce profitability.
 
A significant expense is the payment of compensation to our members, which represented approximately 44%, 48% and 46% of net sales during 2016, 2015 and 2014, respectively.  We compensate our members by paying commissions, bonuses, and certain awards and prizes.  Factors impacting the overall commission payout include the growth and depth of the member network, the member retention rate, the level of promotions, local promotional programs and business development agreements.  Any increase in compensation payments to members as a percentage of net sales will reduce our profitability.  

Our compensation plan includes a cap that may be enforced on member compensation paid out on a weekly dollar limit or as a percentage of product sales. There can be no assurance that enforcement of this cap will ensure profitability (which depends on many other factors).  Moreover, enforcement of this cap could cause key members affected by the cap to leave and join other companies.
Currency exchange rate fluctuations could lower our revenue and net income.
In 2016, 98% of our revenue was recorded by subsidiaries located outside of North America.  Revenue transactions and related commission payments, as well as other incurred expenses, are typically denominated in the local currency.  Accordingly, our international subsidiaries use the local currency as their functional currency.  The results of operations of our international subsidiaries are exposed to foreign currency exchange rate fluctuations during consolidation since we translate into U.S. dollars using the average exchanges rates for the period.  As exchange rates vary, revenue and other operating results may differ materially from our expectations.  Additionally, we may record significant gains or losses related to foreign-denominated cash and cash equivalents and the re-measurement of inter-company balances.  
Our most significant foreign exchange exposure, the Hong Kong dollar, is for now pegged to the U.S. dollar.  We also purchase a significant majority of inventories in U.S. dollars.  Our foreign currency exchange rate exposure to South Korean won, Taiwan dollar, Japanese yen, Chinese yuan, Russian ruble, Kazakhstani tenge, Singaporean dollar, Malaysian ringgit, Canadian dollar and European euro represented approximately 7%, 6% and 10% of our revenue in 2016, 2015 and 2014, respectively.  Our foreign currency exchange rate exposure may increase in the near future as we develop opportunities in Southeast Asia, Canada, Central America, South America and Europe.  Additionally, our foreign currency exchange rate exposure would significantly increase if the Hong Kong dollar were no longer pegged to the U.S. dollar.  Finally, we also experience indirect exchange rate exposure due to the concentration of our sales in China and the recent performance of the Chinese yuan. Following the 2015 devaluation of the Chinese yuan, the Chinese yuan experienced depreciation against the Hong Kong dollar of 7% for the year ended December 31, 2016, the cumulative effect of which has been to erode our Chinese members’ purchasing power and, we believe, to adversely affect our product sales.

Given our inability to predict the degree of exchange rate fluctuations, we cannot estimate the effect these fluctuations may have upon future reported results, product pricing or our overall financial condition.  Further, to date we have not attempted to reduce our exposure to short-term exchange rate fluctuations by using foreign currency exchange contracts.
Changes in tax or duty laws, and unanticipated tax or duty liabilities, could adversely affect our net income.
In the course of doing business we may be subject to various taxes, such as sales and use, value-added, and franchise. We are also subject to income taxes in the United States and numerous foreign jurisdictions. We earn a substantial portion of our income in foreign jurisdictions. If our capital or financing needs in the United States (including the repurchase of our stock and payment of dividends in the United States) require us to repatriate earnings from foreign jurisdictions, our effective income tax rates for the affected periods could be negatively impacted. Economic and political conditions make tax rules in any jurisdiction, including the United States, subject to significant change. There have been proposals to reform U.S. and foreign tax laws that could significantly impact how U.S. multinational corporations are taxed on foreign earnings. Although we cannot predict whether or in what form these proposals will pass, several of the proposals considered, if enacted into law, could have an adverse impact on our income tax expense and cash flows.
Our principal domicile is the United States. Under tax treaties, we are eligible to receive foreign tax credits in the United States for taxes paid abroad. Taxes paid to foreign taxing authorities may exceed the credits available to us, resulting in the payment of a higher overall effective tax rate on our worldwide operations.
Our effective income tax rate in the future could be adversely affected by a number of factors, including changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities, changes in tax laws, the outcome of income tax audits in various jurisdictions around the world, and any repatriation of non-U.S. earnings for which we have not previously provided for U.S. taxes.

We may also be subject to examinations of our tax returns and other tax matters by the Internal Revenue Service and other tax authorities and governmental bodies. We regularly assess the likelihood of an adverse outcome resulting from these examinations to determine the adequacy of our provision for taxes, which is subject to significant discretion. There can be no assurance as to the outcome of these examinations. If our effective tax rates were to increase, particularly in the U.S., or if the ultimate determination of taxes owed is for an amount in excess of amounts previously accrued, our financial results or operations could be adversely affected.
In addition, our operations are subject to regulations designed to ensure that appropriate levels of customs duties are assessed on the importation of our products. The failure to properly calculate, report and pay such duties when we are subject to them could have a material adverse effect on our financial condition and results of operations. Any change in the laws or regulations regarding such duties, or any interpretation thereof, could result in an increase in the cost of doing business.

Transfer pricing regulations affect our business and results of operations.
In many countries, including the United States, we are subject to transfer pricing and other tax regulations designed to ensure that appropriate levels of income are reported as earned by our United States or local entities and are taxed accordingly. We have adopted transfer pricing agreements with our subsidiaries to regulate inter-company transfers, which agreements are subject to transfer pricing laws that regulate the flow of funds between the subsidiaries and the parent corporation for product purchases, management services, and contractual obligations, such as the payment of member compensation. We believe that we operate in compliance with all applicable transfer pricing laws, and we intend to continue to operate in compliance with such laws. However, there can be no assurance that we will continue to be found to be operating in compliance with transfer pricing laws, or that those laws would not be modified, which, as a result, may require changes in our operating procedures or otherwise may have a material adverse effect on our financial results or operations.

Our products and related activities are subject to extensive government regulation, which could delay, limit or prevent the sale of some of our products in some markets. 

The formulation, manufacturing, packaging, labeling, importation, advertising, distribution, sale and storage of certain of our products are subject to extensive regulation by various federal agencies, including the Food and Drug Administration (the “FDA”), the FTC, the Consumer Product Safety Commission and the United States Department of Agriculture and by various agencies of the states, localities and foreign countries in which our products are manufactured, distributed and sold.  For example, the FDA requires us and our suppliers to meet relevant current good manufacturing practice (cGMP) regulations for the preparation, packing and storage of foods and over-the-counter (OTC) drugs.  We are also now required to report serious adverse events associated with consumer use of certain of our products.  Other laws and regulations govern or restrict the claims that may be made about our products and the information that must be included and excluded on labels.

In markets outside the United States, prior to commencing operations or marketing new products, we may be required to obtain approvals, licenses, or certifications from a ministry of health or a comparable agency. Moreover, a foreign jurisdiction may pass laws that would prohibit the use of certain ingredients in their particular market.  Compliance with these regulations can create delays and added expense in introducing new products to certain markets.

Failure by our distributorsmembers or us to comply with those regulations could lead to the imposition of significant penalties or claims and could materially and adversely affect our business.  If we are not able to satisfy the various regulations, then we would have to cease sales of that product in that market.  In addition, the adoption of new regulations or changes in the interpretation of existing regulations may result in significant compliance costs or discontinuation of product sales and may adversely affect the marketing of our products, resulting in significant loss of revenues.

We cannot predict the nature of any future laws, regulations, interpretations, or applications, nor can we determine what effect additional governmental regulations or administrative orders, when and if promulgated, could have on our business.  These potential effects could include, however, requirements for the reformulation of certain products to meet new standards, the recall or discontinuance of certain products, additional recordkeeping and reporting requirements, expanded documentation of the properties of certain products, expanded or different labeling, or additional scientific substantiation.  Any or all of these requirements could have a material adverse effect on our business, financial condition, or results of operations.



Failure of new products to gain member and market acceptance could harm our business.
An important component of our business is our ability to develop new products that create enthusiasm among our member force.  If we fail to introduce new products on a timely basis, our member productivity could be harmed.  In addition, if any new products fail to gain market acceptance, are restricted by regulatory requirements, or have quality problems, this would harm our results of operations.  Factors that could affect our ability to continue to introduce new products include, among others, limited capital and human resources, government regulations, proprietary protections of competitors that may limit our ability to offer comparable products and any failure to anticipate changes in consumer tastes and buying preferences.
New regulations governing the marketing and sale of nutritional supplements could harm our business.

There has been an increasing movement in the United States and other markets to increase the regulation of dietary supplements, which could impose additional restrictions or requirements in the future.  In the United States, for example, some legislators and industry critics continue to push for increased regulatory authority by the FDA over nutritional supplements.  Our business could be harmed if more restrictive legislation is successfully introduced and adopted in the future.  In particular, the adoption of legislation requiring FDA approval of supplements or ingredients could delay or inhibit our ability to introduce new supplements.  We face similar pressures in our other markets.  In the United States effective December 1, 2009, the FTC approved revisions to its Guides Concerning the Use of Endorsements and Testimonials in Advertising (“Guides”) that require disclosure of material connections between an endorser and the company they are endorsing and do not allow marketing using atypical results.require the disclosure of typical results when these are different from those reported by the endorser.  The requirements and restrictions of the revised Guides may diminish the impact of our marketing efforts and negatively impact our sales results.  If we or our distributorsmembers fail to comply with these Guides, the FTC could bring an enforcement action against us and we could be fined and/or forced to alter our operations.  Our operations also could be harmed if new laws or regulations are enacted that restrict our ability to market or distribute nutritional supplements or impose additional burdens or requirements on nutritional supplement companies or require us to reformulate our products.

Regulations governing the production and marketing of our personal care products could harm our business.

Our personal care products are subject to various domestic and foreign laws and regulations that regulate cosmetic products and set forth regulations for determining whether a product can be marketed as a “cosmetic” or requires further approval as an over-the-counter drug.  A determination that our cosmetic products impact the structure or function of the human body, or improper marketing claims by our distributors,members, may lead to a determination that such products require pre-market approval as a drug.  Such regulations in any given market can limit our ability to import products and can delay product launches as we go through the registration and approval process for those products.  Furthermore, if we fail to comply with these regulations, we could face enforcement action against us and we could be fined, forced to alter or stop selling our products and/or required to adjust our operations.  Our operations also could be harmed if new laws or regulations are enacted that restrict our ability to market or distribute our personal care products or impose additional burdens or requirements on the contents of our personal care products or require us to reformulate our products.



If we are found not to be in compliance with good manufacturing practices our operations could be harmed.

FDA regulations

Regulations on good manufacturing practices and adverse event reporting requirements for the nutritional supplement industry are in effect and require good manufacturing processes for us and our vendors, including stringent vendor qualifications, ingredient identification, manufacturing controls and record keeping.   We are also now required to report serious adverse events associated with consumer use of our products.  Our operations could be harmed if regulatory authorities make determinations that we or our vendors are not in compliance with the new regulations.  A finding of noncompliance may result in administrative warnings, penalties or actions impacting our ability to continue selling certain of our products.  In addition, compliance with these regulations has increased and may further increase the cost of manufacturing certain of our products as we work with our vendors to assure they are qualified and in compliance.

Failure to comply with domestic and foreign laws and regulations governing product claims and advertising could harm our business.

Our failure to comply with FTC or state regulations, or with regulations in foreign markets that cover our product claims and advertising, including direct claims and advertising by us, as well as claims and advertising by distributorsmembers for which we may be held responsible, may result in enforcement actions and imposition of penalties or otherwise materially and adversely affect the distribution and sale of our products.  DistributorMember activities in our existing markets that violate applicable governmental laws or regulations could result in governmental or private actions against us in markets where we operate.  Given the size of our distributormember force, we cannot ensure that our distributors wouldmembers will comply with applicable legal requirements.

Although our distributors are independent contractors, improper distributor actions that violate laws or regulations could harm our business.

Our distributors are independent contractors and, accordingly, we are not in a position to directly provide the same direction, motivation and oversight as we would if distributors were our own employees.  As a result, there can be no assurance that our distributors will participate in our marketing strategies or plans, accept our introduction of new products, or comply with our distributor policies and procedures.  Extensive federal, state and local laws regulate our business, our products and our network marketing program.  Because we have expanded into foreign countries, our policies and procedures for our distributors differ due to the different legal requirements of each country in which we do business.  While we have implemented distributor policies and procedures designed to govern distributor conduct and to protect the goodwill associated with our trademarks and trade names, it can be difficult to enforce these policies and procedures because of the large number of distributors and their independent status.  

Given the size and diversity of our distributor force, we experience problems with distributors from time to time, especially with respect to our distributors in foreign markets.  Distributors often desire to enter a market, before we have received approval to do business, to gain an advantage in the marketplace.  Improper distributor activity in new geographic markets could result in adverse publicity and can be particularly harmful to our ability to ultimately enter these markets.  Violations by our distributors of applicable law or of our policies and procedures in dealing with customers could reflect negatively on our products and operations, and harm our business reputation.  In addition, it is possible that a court could hold us civilly or criminally accountable based on vicarious liability because of the actions of our distributors.  If any of these events occur, our business, financial condition, or results of operations could be materially adversely affected.


Adverse publicity associated with our products, ingredients or network marketing program, or those of similar companies, could harm our financial condition and operating results.

Adverse publicity concerning any actual or claimed failure by us or our distributorsmembers to comply with applicable laws and regulations regarding product claims and advertising, good manufacturing practices, the regulation of our network marketing program, the licensing of our products for sale in our target markets or other aspects of our business, whether or not resulting in enforcement actions or the imposition of penalties, could have an adverse effect on our goodwill and could negatively affect our ability to attract, motivate and retain distributors,members, which would negatively impact our ability to generate revenue.  We cannot ensure that all distributorsmembers will comply with applicable legal requirements relating to the advertising, labeling, licensing or distribution of our products.

In addition, our distributors’members’ and consumers’ perception of the safety and quality of our products and ingredients, as well as similar products and ingredients distributed by other companies, can be significantly influenced by national media attention, publicized scientific research or findings, widespread product liability claims and other publicity concerning our products or ingredients or similar products and ingredients distributed by other companies.  Adverse publicity, whether or not accurate or resulting from consumers’ use or misuse of our products, that associates consumption of our products or ingredients or any similar products or ingredients with illness or other adverse effects, questions the benefits of our or similar products or claims that any such products are ineffective, inappropriately labeled or have inaccurate instructions as to their use, could negatively impact our reputation or the market demand for our products.


We are subject to risks relating to product concentration and lack of revenue diversification.
 

WeAlthough we have a limited product line.

We offer a limited numberin recent years expanded our line of products, under our NHT Global brand.  Our Premium Noni Juice™ product accounts for a significant portionwe derive more than 10% of our total revenue.revenue from each of our Premium Noni Juice and Enhanced Essential Probiotics® products. Further, we currently source each such product from a single supplier. If demand decreases significantly, government regulation restricts itstheir sale, we are unable to adequately source or deliver the product,products, or we cease offeringare unable to offer the productproducts for any reason without a suitable replacement,replacements, our business, financial condition and results of operations could be materially and adversely affected.

Our future success will also depend on our ability to reduce our dependence on these few products by developing and introducing new products and product or feature enhancements in a timely manner. Even if we are able to develop and commercially introduce new products and enhancements, they may not achieve market acceptance and the revenue generated from these new products and enhancements may not offset the costs, which could substantially impair our business, financial condition and results of operations.

We rely on a limited number of independent third parties to manufacture and supply our products.

All of our products are manufactured by a limited number of independent third parties.  There is no assurance that our current manufacturers will continue to reliably supply products to us at the level of quality we require.  If a key manufacturer suffers liquidity problems or experiences operational or other problems assisting with our products, our results could suffer.  In the event any of our third-party manufacturers become unable or unwilling to continue to provide the products in required volumes and quality levels at acceptable prices, we will be required to identify and obtain acceptable replacement manufacturing sources or replacement products.  There is no assurance that we will be able to obtain alternative manufacturing sources or products or be able to do so on a timely basis.  An extended interruption in the supply of certain of our products may result in a substantial loss of revenue.  In addition, any actual or perceived degradation of product quality as a result of our reliance on third party manufacturers may have an adverse effect on revenue or result in increased product returns.  

Growth may be impeded by the political and economic risks of entering and operating foreign markets.

Our ability to achieve future growth is dependent, in part, on our ability to continue our international expansion efforts.  However, there can be no assurance that we would be able to grow in our existing international markets, enter new international markets on a timely basis, or that new markets would be profitable.  We must overcome significant regulatory and legal barriers before we can begin marketing in any foreign market.


Also, it is difficult to assess the extent to which our products and sales techniques would be accepted or successful in any given country.  In addition to significant regulatory barriers, we may also encounter problems conducting operations in new markets with different cultures and legal systems from those elsewhere.  We may be required to reformulate certain of our products before commencing sales in a given country.  Once we have entered a market, we must adhere to the regulatory and legal requirements of that market.  No assurance can be given that we would be able to successfully reformulate our products in any of our current or potential international markets to meet local regulatory requirements or attract local customers.  The failure to do so could have a material adverse effect on our business, financial condition, and results of operations.  There can be no assurance that we would be able to obtain and retain necessary permits and approvals.

In many markets, other direct selling companies already have significant market penetration, the effect of which could be to desensitize the local distributormember population to a new opportunity or to make it more difficult for us to recruit qualified distributors.members. There can be no assurance that, even if we are able to commence operations in foreign countries, there would be a sufficiently large population of potential distributorsmembers inclined to participate in a direct selling system offered by us.  We believe our future success could depend in part on our ability to seamlessly integrate our business methods, including distributormember compensation plan, across all markets in which our products are sold.  There can be no assurance that we would be able to further develop and maintain a seamless compensation program.

Currency exchange rate fluctuations could lower our revenue and net income.

In 2014, approximately 98% of our revenue was recorded by subsidiaries located outside of North America.  Revenue transactions and related commission payments, as well as other incurred expenses, are typically denominated in the local currency.  Accordingly, our international subsidiaries use the local currency as their functional currency.  The results of operations of our international subsidiaries are exposed to foreign currency exchange rate fluctuations during consolidation since we translate into U.S. dollars using the average exchanges rates for the period.  As exchange rates vary, revenue and other operating results may differ materially from our expectations.  Additionally, we may record significant gains or losses related to foreign-denominated cash and cash equivalents and the re-measurement of inter-company balances.  

We believe that our foreign currency exchange rate exposure is somewhat limited since the Hong Kong dollar is pegged to the U.S. dollar.  We also purchase a significant majority of inventories in U.S. dollars.  Our foreign currency exchange rate exposure, mainly to South Korean won, Taiwan dollar, Japanese yen, Chinese yuan, Russian ruble, Kazakhstani tenge, Ukrainian hryrnia and European euro, represented approximately 18% and 9% of our revenue in 2013 and 2014, respectively.  Our foreign currency exchange rate exposure may increase in the near future as we intend to develop opportunities in Southeast Asia, Canada and Europe.  Additionally, our foreign currency exchange rate exposure would significantly increase if the Hong Kong dollar were no longer pegged to the U.S. dollar.  

 

Given our inability to predict the degree of exchange rate fluctuations, we cannot estimate the effect these fluctuations may have upon future reported results, product pricing or our overall financial condition.  Further, to date we have not attempted to reduce our exposure to short-term exchange rate fluctuations by using foreign currency exchange contracts.

Changes in tax or duty laws, and unanticipated tax or duty liabilities, could adversely affect our net income.

In the course of doing business we may be subject to various taxes, such as sales and use, value-added, and franchise. We are also subject to income taxes in the United States and numerous foreign jurisdictions. We earn a substantial portion of our income in foreign jurisdictions. If our capital or financing needs in the United States require us to repatriate earnings from foreign jurisdictions above our current levels, our effective income tax rates for the affected periods could be negatively impacted. Economic and political conditions make tax rules in any jurisdiction, including the United States, subject to significant change. There have been proposals to reform U.S. and foreign tax laws that could significantly impact how U.S. multinational corporations are taxed on foreign earnings. Although we cannot predict whether or in what form these proposals will pass, several of the proposals considered, if enacted into law, could have an adverse impact on our income tax expense and cash flows.

Our principal domicile is the United States. Under tax treaties, we are eligible to receive foreign tax credits in the United States for taxes paid abroad. Taxes paid to foreign taxing authorities may exceed the credits available to us, resulting in the payment of a higher overall effective tax rate on our worldwide operations.

Our effective income tax rate in the future could be adversely affected by a number of factors, including changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities, changes in tax laws, the outcome of income tax audits in various jurisdictions around the world, and any repatriation of non-U.S. earnings for which we have not previously provided for U.S. taxes.

We may also be subject to examinations of our tax returns and other tax matters by the Internal Revenue Service and other tax authorities and governmental bodies. We regularly assess the likelihood of an adverse outcome resulting from these examinations to determine the adequacy of our provision for taxes, which is subject to significant discretion. There can be no assurance as to the outcome of these examinations. If our effective tax rates were to increase, particularly in the U.S., or if the ultimate determination of taxes owed is for an amount in excess of amounts previously accrued, our financial results or operations could be adversely affected.

In addition, our operations are subject to regulations designed to ensure that appropriate levels of customs duties are assessed on the importation of our products. The failure to properly calculate, report and pay such duties when we are subject to them could have a material adverse effect on our financial condition and results of operations. Any change in the laws or regulations regarding such duties, or any interpretation thereof, could result in an increase in the cost of doing business.

Transfer pricing regulations affect our business and results of operations.

In many countries, including the United States, we are subject to transfer pricing and other tax regulations designed to ensure that appropriate levels of income are reported as earned by our United States or local entities and are taxed accordingly. We have adopted transfer pricing agreements with our subsidiaries to regulate inter-company transfers, which agreements are subject to transfer pricing laws that regulate the flow of funds between the subsidiaries and the parent corporation for product purchases, management services, and contractual obligations, such as the payment of distributor compensation. We believe that we operate in compliance with all applicable transfer pricing laws, and we intend to continue to operate in compliance with such laws. However, there can be no assurance that we will continue to be found to be operating in compliance with transfer pricing laws, or that those laws would not be modified, which, as a result, may require changes in our operating procedures or otherwise may have a material adverse effect on our financial results or operations.

We may be held responsible for certain taxes or assessments relating to the activities of our distributors,members, which could harm our financial condition and operating results.

Our distributorsmembers are subject to taxation, and in some instances, legislation or governmental agencies impose an obligation on us to collect the taxes, such as value added taxes, and to maintain appropriate records.  In addition, we are subject to the risk in some jurisdictions of being responsible for social security and similar taxes with respect to our distributors.

members.
 

We may face litigation that could harm our business.

We have been a party to lawsuits and other proceedings in the past.  Prosecuting and defending potential litigation and other governmental proceedings may require significant expense and attention of our management.  There can be no assurance that the significant money, time and effort spent will not adversely affect our business, financial condition and results of operations.

We may be unable to protect or use our intellectual property rights.

We rely on trade secret, copyright and trademark laws and confidentiality agreements with employees and third parties, all of which offer only limited protection of our confidential information and trademarks.  Moreover, the laws of some countries in which we market our products may afford little or no effective protection of our intellectual property rights.  The unauthorized copying, use or other misappropriation of our confidential information, trademarks and other intellectual property could enable third parties to benefit from such property without paying us for it.  This could have a material adverse effect on our business, operating results and financial condition.  If we resort to legal proceedings to enforce our intellectual property rights, the proceedings could be burdensome, expensive and result in inadequate remedies.  It is also possible that our use of our intellectual property rights could be found to infringe on prior rights of others and, in that event, we could be compelled to stop or modify the infringing use, which could be burdensome and expensive.

We do not have a comprehensive product liability insurance program and product liability claims could hurt our business.

Currently, we do not have a comprehensive product liability insurance program, although the insurance carried by our suppliers may cover certain product liability claims against us.  As a marketer of dietary supplements, cosmetics and other products that are ingested by consumers or applied to their bodies, we may become subjected to various product liability claims, including that:

our products contain contaminants or unsafe ingredients;

our products include inadequate instructions as to their uses; or

our products include inadequate warnings concerning side effects and interactions with other substances.

our products contain contaminants or unsafe ingredients;

our products include inadequate instructions as to their uses; or

our products include inadequate warnings concerning side effects and interactions with other substances.
If our suppliers’ product liability insurance fails to cover product liability claims or other product liability claims, or any product liability claims exceeds the amount of coverage provided by such policies or if we are unsuccessful in any third party claim against the manufacturer or if we are unsuccessful in collecting any judgment that may be recovered by us against the manufacturer, we could be required to pay substantial monetary damages which could materially harm our business, financial condition and results of operations. As a result, we may become required to pay high premiums and accept high deductibles in order to secure adequate insurance coverage in the future.  Especially since we do not have direct product liability insurance, it is possible that product liability claims and the resulting adverse publicity could negatively affect our business.


Our internal controls and accounting methods may require modification.

We continue to review and develop controls and procedures sufficient to accurately report our financial performance on a timely basis.  If we do not develop and implement effective controls and procedures, we may not be able to report our financial performance on a timely basis and our business and stock price would be adversely affected.

If we fail to achieve and maintain an effective system of internal controls in the future, we may not be able to accurately report our financial results or prevent fraud.  As a result, investors may lose confidence in our financial reporting.

The Sarbanes-Oxley Act of 2002 requires that we report annually on the effectiveness of our internal control over financial reporting.  Among other things, we must perform systems and processes evaluation and testing.  We must also conduct an assessment of our internal controls to allow management to report on our assessment of our internal control over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act.  We are required to provide management’s assessment of internal controls in conjunction with the filing of our Annual Report on Form 10-K.  As disclosed under Item 9A“Item 9A. Controls and Procedures” of this report, our management concludedhas delivered its report concluding that our internal control over financial reporting was effective at December 31, 2014.2016, and our independent registered public accounting firm has also delivered its attestation to the report.  In the future, our continued assessment, or the assessment by our independent registered public accounting firm, could reveal significant deficiencies or material weaknesses in our internal controls, which may need to be disclosed in future Annual Reports on Form 10-K.  We believe, at the current time, that we are taking appropriate steps to mitigate these risks.  However, disclosures of this type can cause investors to lose confidence in our financial reporting and may negatively affect the price of our common stock.  Moreover, effective internal controls are necessary to produce reliable financial reports and to prevent fraud.  Deficiencies in our internal controls over financial reporting may negatively impact our business and operations.  



We rely on and are subject to risks associated with our reliance upon information technology systems.

Our success is dependent on the accuracy, reliability, and proper use of information processing systems and management information technology.  Our information technology systems are designed and selected to facilitate order entry and customer billing, maintain distributormember records, accurately track purchases and distributormember compensation payments, manage accounting operations, generate reports, and provide customer service and technical support.  Any interruption in these systems could have a material adverse effect on our business, financial condition, and results of operations.

Although we believe that the members of our software development team have the qualifications, know-how and experience to perform the necessary software development and other information technology services, there can be no assurance that there will not be delays or interruptions in these services.  An interruption or delay in availability of these services could, if it lasted long enough, prevent us from accepting orders, cause distributorsmembers to leave our business, or otherwise materially adversely affect our business.

System failures and attacks could harm our business.

Because of our diverse geographic operations and our internationally applicable distributormember compensation plans, our business is highly dependent on the efficient functioning of our information technology systems and operations, which are vulnerable to damage or interruption from fires, earthquakes, telecommunications failures, computer viruses and worms, hacking, denial of service attacks, software defects and other events.  They are also subject to break-ins, sabotage, acts of vandalism and similar misconduct, as well as human error.  Despite precautions implemented by our information technology staff, problems could result in interruptions in services and materially and adversely affect our business, financial condition and results of operations.

Moreover, hackers could attack our system seeking to retrieve personal or confidential information of ours or of third parties, such as credit card information used to purchase our products on-line.  Although we take steps to prevent such loss of information, there can be no assurance that our system will not be successfully hacked.  Laws in the United States and other jurisdictions where we do business require prompt notice of any such loss of information.  Failure to comply with those reporting obligations could result in material penalties.  In addition, if our system were hacked, we could incur material costs in investigating the incidents and could be liable for damages.  Any such damages may or may not be covered by insurance.


Terrorist attacks, cyber-attacks, acts of war, epidemics or other communicable diseases or any other natural disasters may seriously harm our business.

Terrorist attacks, cyber-attacks, or acts of war or natural disasters may cause damage or disruption to us, our employees, our facilities and our distributorsmembers and customers, which could impact our revenues, expenses and financial condition.  The potential for future terrorist attacks, the national and international responses to terrorist attacks, and other acts of war or hostility, such as challenges to Chinese sovereignty claims in the South China Sea or Chinese objection to the Taiwan independence movement and itsthe resultant tension in the Taiwan Strait, could materially and adversely affect our business, results of operations, and financial condition in ways that we currently cannot predict.  Additionally, natural disasters less severe than the Indian Ocean tsunami that occurred in December 2004 may adversely affect our business, financial condition and results of operations.

Because our systems, software and data reside on third-party servers, our access could be temporarily or permanently interrupted.

Beginning in 2012, most of our systems, software and data reside in the “cloud” on third-party servers to which we have contractual access.  Cyber-attacks or hacking on these servers unrelated to us, or system or hardware failures experienced by the third party vendor, could result in disclosure of or damage to our systems, software and data.  Moreover, any delay or failure in payment of the third party vendors, disputes with such vendors, or business interruption or failure of the third party vendors could result in loss of or interruption in access to our systems, software or data.  It is possible that our systems, software and data could in the future be moved to servers of different third parties or to our own servers.  Any such move could result in temporary or permanent loss of access to our systems, software or data.  Any protracted loss of such access would materially and adversely affect our business, financial condition and results of operations.



We may experience substantial negative cash flows, which may have a significant adverse effect on our business and could threaten our solvency.

We experienced substantial negative cash flows during the years ended December 31, 20082009 and 2009,2008, primarily due to declines in our revenues greater than the decreases in expenditures we could manage.  If we again experience negative cash flows, any resulting decreasing cash balance could impair our ability to support our operations and, eventually, threaten our solvency, which would have a material adverse effect on our business, results of operations and financial condition, as well as our stock price.  Negative cash flows and the related adverse market perception associated therewith may have negatively affected, and may in the future negatively affect, our ability to attract new distributorsmembers and/or sell our products.  There can be no assurance that we will be successful in maintaining an adequate level of cash resources and we could be forced to act more aggressively in the area of expense reduction in order to conserve cash resources as we look for alternative solutions.

If we experience negative cash flows, we may need to seek additional debt or equity financing, which may not be available on acceptable terms or at all.  If available, it could have a highly dilutive effect on the holdings of existing stockholders.

Unless we are able to at least maintain revenues, control expenses and achieve positive cash flows, our ability to support our obligations could be impaired and our liquidity could be adversely affected and our solvency and our ability to repay our debts when they come due could be threatened.  We may need to seek additional debt or equity financing on acceptable terms in order to improve our liquidity.  However, we may not be able to obtain additional debt or equity financing on satisfactory terms, or at all, and any new financing could have a dilutive effect to our existing stockholders.

Disappointing quarterly revenue or operating results could cause the price of our common stock to fall.

Our quarterly revenue and operating results are difficult to predict and may fluctuate significantly from quarter to quarter.  If our quarterly revenue or operating results fall below the expectations of investors or securities analysts, the price of our common stock could fall substantially.

Our common stock is particularly subject to volatility because of the industry in which we operate.

The market prices of securities of direct selling companies have been extremely volatile, and have experienced fluctuations that have often been unrelated or disproportionate to the operating performance of such companies.  These broad market fluctuations could adversely affect the market price of our common stock.

The historic price of our


Our common stock has been volatilecontinues to experience wide fluctuations in trading volumes and the future market price of our common stock is likely to continue to be volatile. Further, the limited trading volume in our common stock has, and in the future may, contribute significantly to the high volatility in the market price of our common stock.prices. This may make it more difficult for holders of our common stock to sell shares when they want and at prices they find attractive.

The public market for our common stock has historically been very volatile. Prior to February 17, 2015,Notwithstanding the transition in trading of our common stock was quoted on the OTCQB tier offrom the OTC Market and, like many other stocks quoted onto the OTCQB, tradingNASDAQ Capital Market in February 2015, our common stock was often thin and characterized bycontinues to experience wide fluctuations in trading volumes and prices. Although we are hopeful that the transition to trading our common stock on the NASDAQ Capital Market will reduce the historical volatility in our common stock, it is likely that our common stock will continue to experience volatility for some time. There are a number of factors that may contribute to this volatility, butincluding the limited trading volumefollowing:

active participation of speculative traders in our common stock has,(including short sellers);

market rumors regarding our business operations;

government scrutiny of our business;

adverse publicity related to our business or industry; and

fluctuations in the future may, contribute significantly to volatility. our operating results.

This market volatility for our stock may make it more difficult for holders of our common stock to sell shares when they want and at prices they find attractive. There can be no assurance that a larger or more liquid market will be developed or maintained for our common stock.

Future sales by us or our existing stockholders could depress the market price of our common stock.

If we or our existing stockholders sell a large number of shares of our common stock, the market price of our common stock could decline significantly.  Further, even the perception in the public market that we or our existing stockholders might sell shares of common stock could depress the market price of theour common stock.

Item 1B.

Item 1B. UNRESOLVED STAFF COMMENTS

Not applicable.



None.


Item 2.

PROPERTIES

Item 2. PROPERTIES
We lease 3,800 square feet of office space in Dallas, Texas for our corporate headquarters. In January 2015, we entered into a lease for 3,7004,900 square feet of office space in Rolling Hills Estates, California for our corporate headquarters with the intention of relocating some Dallas-based employees and hiring additional staff.  The California location will make traveling to and communicating with Asia easier.terms expiring in September 2025. In addition, we are intending to execute a lease for 2,400 and 1,600 square footfeet of retail space in MonterreyMonterey Park, California and Vancouver, British Columbia, respectively, to help further develop the Chinese-American market for our products in Southern California. North America. The Monterey Park and Vancouver locations have terms expiring in August 2020 and February 2021, respectively. We also maintain an office in Dallas, Texas.

Outside the United States,of North America, we lease 7,300 square feet of office space in Hong Kong with terms expiring in February 2018, nine branch offices throughout China, and additional office space in Japan, Taiwan, South Korea, Singapore, Malaysia, Vietnam and Singapore.the Cayman Islands. We also lease a multi-purposedmulti-purpose facility and factory in Zhongshan, China and 11 service stations throughout the city of Guangzhou, China that servesserve or will in the future serve the needs of our Chinese consumers. We contract with third parties for fulfillment and distribution operations in mostall of our international markets. Through a local service provider, we maintain marketing and distributormember centers in Almaty, Kazakhstan and Odessa, Ukraine.Moscow, Russia. We believe that our existing office space is in good condition, and is suitable and adequate for the conduct of our business.


Item 3.

LEGAL PROCEEDINGS

None.

Item 3. LEGAL PROCEEDINGS

Securities Class Action

In January 2016, two putative securities class action complaints were filed against us and our top executives in the United States District Court for the Central District of California: Ford v. Natural Health Trends Corp. and Li v. Natural Health Trends Corp. On March 29, 2016, the court consolidated these actions, appointed two Lead Plaintiffs, Messrs. Dao and Juan, and appointed the Rosen Law Firm and Levi & Korsinsky LLP as co-Lead Counsel for the purported class. Plaintiffs filed a consolidated complaint on April 29, 2016. The consolidated complaint purports to assert claims on behalf of all persons who purchased or otherwise acquired our common stock between March 6, 2015 and March 15, 2016 under (i) Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder against Natural Health Trends Corp., Chris T. Sharng, and Timothy S. Davidson, and (ii) Section 20(a) of the Securities Exchange Act of 1934 against Chris T. Sharng, Timothy S. Davidson, and George K. Broady. The consolidated complaint alleges, inter alia, that we made materially false and misleading statements regarding the legality of our business operations in China, including running an allegedly illegal multi-level marketing business. The consolidated complaint seeks an indeterminate amount of damages, plus interest and costs. We filed a motion to dismiss the consolidated complaint on June 15, 2016 and a reply in support of our motion to dismiss on August 22 2016. On December 5, 2016, the Court denied our motion to dismiss. On February 17, 2017, we filed an answer to the consolidated complaint. We believe that these claims are without merit and intend to vigorously defend against them.

Shareholder Derivative Claims

In February 2016, a purported shareholder derivative complaint was filed in the Superior Court of the State of California, County of Los Angeles: Zhou v. Sharng. In March 2016, a purported shareholder derivative complaint was filed in the United States District Court for the Central District of California: Kleinfeldt v. Sharng (collectively the “Derivative Complaints”). The Derivative Complaints purport to assert claims for breach of fiduciary duties, unjust enrichment, abuse of control, gross mismanagement and corporate waste against certain of our officers and directors. The Derivative Complaints also purport to assert fiduciary duty claims based on alleged insider selling and conspiring to enter into several stock repurchase agreements, which allegedly harmed us and our assets. The Derivative Complaints allege, inter alia, that we made materially false and misleading statements regarding the legality of our business operations in China, including running an allegedly illegal multi-level marketing business, and that certain officers and directors sold common stock on the basis of this allegedly material, adverse non-public information. The Derivative Complaints seek an indeterminate amount of damages, plus interest and costs, as well as various equitable remedies. On February 1, 2017, pursuant to a stipulation among the parties, the Los Angeles Superior Court entered a stay of the Zhou action pending conclusion of the related federal class action in the United States District Court for the Central District of California: Ford v. Natural Health Trends Corp. and Li v. Natural Health Trends Corp. A nearly identical stipulated stay was entered in the Kleinfeldt case on February 28, 2017. We believe that these claims are without merit and intend to vigorously defend against them.

Item 4.

MINE SAFETY DISCLOSURES

Item 4. MINE SAFETY DISCLOSURES

Not applicable.




Part II
 

Part II

Item 5.

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Item 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

Our common stock is currently traded on the NASDAQ Capital Market (“Nasdaq”) under the symbol “NHTC.” Prior to February 17, 2015, our common stock was quoted under the trading symbol “NHTC” on the OTCQB tier of the OTC Market. The following table sets forth the range of the high and low bid quotations of our common stock as reported by Nasdaq and the OTC Markets Group, Inc. The bid quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent actual transactions.

  

2013

  

2014

 
  

High

  

Low

  

High

  

Low

 
                 

First quarter

 $1.44  $1.01  $4.95  $2.81 

Second quarter

  1.30   0.80   7.50   4.80 

Third quarter

  2.20   0.93   19.85   6.76 

Fourth quarter

  3.40   1.86   13.80   8.05 

 2016 2015
 High Low High Low
First quarter$36.19
 $17.75
 $18.29
 $10.49
Second quarter38.25
 26.24
 44.18
 17.78
Third quarter34.30
 25.89
 43.33
 21.91
Fourth quarter29.95
 21.44
 53.72
 32.96
On February 27, 2015,March 7, 2017, the closing price of our common stock as reported by Nasdaq was $13.05$27.95 per share.

Holders of Record

At February 27, 2015,March 7, 2017, there were approximately 160125 record holders of our common stock (although we believe that the number of beneficial owners of our common stock is substantially greater).


Dividends

No dividends

The following tables summarize all cash dividend activity during 2016 and 2015 (in thousands, except per share data), all of which dividend payments were ever declared or paid onmade to holders of our common stock prior to 2014. At December 31, 2013, we had accrued unpaid dividends of $98,000 with respect to outstanding shares of Series A preferred stock, but such dividends had not been declared and we were under no obligation to pay such accrued dividends except in certain extraordinary circumstances. On March 7, 2014,stock:
Declaration Date Per Share Amount Payment Date
October 23, 2016 (special) $0.35
 $3,941
 November 25, 2016
October 23, 2016 0.08
 901
 November 25, 2016
July 19, 2016 0.07
 787
 August 26, 2016
April 21, 2016 0.06
 686
 May 20, 2016
March 1, 2016 0.05
 576
 March 24, 2016
Total $0.61
 $6,891
  

Declaration Date Per Share Amount Payment Date
October 21, 2015 $0.05
 $598
 November 20, 2015
July 28, 2015 0.04
 489
 August 28, 2015
May 4, 2015 0.03
 372
 May 29, 2015
February 27, 2015 0.02
 250
 March 27, 2015
Total $0.14
 $1,709
  

Additionally, on January 24, 2017, the Board of Directors declared a dividend on each share of outstanding Series A preferred stock in the amount of $0.81507 per share representing the accrued unpaid dividends from May 4, 2007 through March 7, 2014. All outstanding shares of Series A preferred stock were converted into common stock during 2014. The following table summarizes all cash dividend activity during 2014 (in thousands, except per share data):

  

Dividends Per Share

      

Declaration Date

 

Preferred

  

Common

  

Amount

 

Date Payable

              

March 7, 2014

 $0.815  $0.005  $159 

April 8, 2014

May 6, 2014

  0.020   0.005   62 

June 4, 2014

July 29, 2014

  0.027   0.010   127 

August 27, 2014

November 4, 2014

  0.032   0.010   128 

December 3, 2014

Total

 $0.894  $0.030  $476  

Additionally, on February 27, 2015, the Board of Directors declared$0.09 and a special cash dividend of $0.02$0.35 on each share of common stock outstanding. Such dividends are payable in cashwere paid on March 27, 20153, 2017 to stockholders of record on March 17, 2015.February 21, 2017. Payment of any future dividends on shares of common stock will be at the discretion of the Company’sour Board of Directors.




Stock Performance Graph

Set forth below is a line graph and table comparing the performance of our common stock to the S&P 500 Index and to a market-weighted index of publicly traded peers from the period from December 31, 2011 through December 31, 2016. The graph assumes $100 was invested in our common stock, the S&P 500 Index and the index of publicly traded peers on December 31, 2011 and that all dividends were reinvested. The publicly traded companies in the peer group consist of Nature's Sunshine Products, Nu Skin Enterprises Inc., USANA Health Sciences Inc., and Herbalife Ltd. The graph represents past performance and should not be considered to be an indication of future performance.

 Period NHTC S&P 500 Peer Group
December 31, 2011 $100
 $100
 $100
December 31, 2012 155
 116
 74
December 31, 2013 492
 154
 224
December 31, 2014 1,766
 175
 135
December 31, 2015 5,194
 177
 167
December 31, 2016 3,944
 198
 161

 

Equity Compensation Plan Information

The following table sets forth information regarding all compensation plans under which Company equity securities are authorized for issuance as of December 31, 2014:

Plan Category

 

Number of securities to be issued upon exercise of outstanding options, warrants and rights

(a)

  

Weighted-average exercise price of outstanding options, warrants and rights

(b)

  

Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))

(c)

 
             

Equity compensation plans approved by security holders

    $   1,083 

Equity compensation plans not approved by security holders

    $  

 

Total

    $   1,083 

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

A summary of the Company’s purchases of shares of its common stock during the quarter ended December 31, 2014 is as follows:

Period

 

Total Number of Shares Purchased(a)

  

Average Price Paid Per Share

  

Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(b)

  

Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs(c)

 
                 

October 1–31, 2014

  2,100  $9.98   53,835  $262,015 

November 1—30, 2014

  216,737  $12.26   270,572  $2,148,200 

December 1—31, 2014

  146,927  $12.82   417,499  $235,100 

(a)

The shares were purchased in open market transactions as described in footnote (b) below, except for those shares purchased under the Stock Repurchase Agreement also described in footnote (b) below.

(b)

On August 13, 2012, the Company disclosed in its Quarterly Report on Form 10-Q that its Board of Directors had, on that day, authorized the Company, acting as trustee for certain of its employees, to execute a Rule 10b5-1 plan to purchase 100,000 shares of its common stock in accordance with guidelines specified under Rule 10b5-1 of the Exchange Act and the Company's policies regarding stock transactions (the “Employee Plan”).  The Company may terminate the plan at any time.  The employees for whom the Company will purchase stock as trustee under the plan will receive the stock as incentive compensation in quarterly increments over three years beginning March 15, 2013, provided that they are employees of the Company on the date of the distribution. Any stock that is purchased under the plan that is forfeited by an employee whose employment terminates will be delivered to the Company and held by it as treasury stock.

On November 4, 2014, the Board of Directors approved a special, stock repurchase program of up to $5 million of the Company’s outstanding shares of common stock (the “Repurchase Plan”). In connection therewith, the Company was advised by George K. Broady, a director of the Company and owner of more than 5% of its outstanding common stock, that Mr. Broady desired to participate in the Repurchase Plan on a basis roughly proportional to his ownership interest, with an estimate of generating approximately $1.5 million through the sale of a portion of the shares of the Company’s common stock held by him. After noting Mr. Broady’s participation interest, the Company authorized its broker to proceed with the purchase of shares of the Company’s common stock in the open market for a total purchase price of $3.0 million in accordance with Rules 10b5-1 and 10b-18 under the Exchange Act.

On November 14, 2014, the Company entered into a Stock Repurchase Agreement (the “Stock Repurchase Agreement”) with Mr. Broady in accordance with Rule 10b5-1 under the Exchange Act. The Stock Repurchase Agreement provided for the Company’s purchase from Mr. Broady of one-half of the number of shares of common stock purchased by the Company’s broker in the open market under the Repurchase Plan approved by the Company’s Board of Directors on November 4, 2014. The Stock Repurchase Agreement with Mr. Broady required that the Company report to Mr. Broady on a weekly basis information regarding the broker’s open market purchases, and that the Company purchase from Mr. Broady on a weekly basis at a per share purchase price equal to the weighted average price per share paid by the Company’s broker to purchase shares in the open market.



(c)

The Company, as Trustee, began purchasing under the Employee Plan in December 2012. Under the initial 10b5-1 plan executed by the Company, as Trustee, with the Board’s authorization, the Company would not purchase more than 2,800 shares per month. That 10b5-1 plan was replaced by a new 10b5-1 plan effective November 11, 2013, which was amended on May 13, 2014 and again on October 23, 2014. The latest 10b5-1 plan terminated in November 2014, and the Company, as Trustee, has not entered into a new 10b5-1 plan.

The Repurchase Plan was completed on December 17, 2014, and resulted in the Company purchasing an aggregate of 359,840 shares of its common stock for a purchase price of $4.5 million, plus transaction costs. Of that total, the Company purchased 119,947 shares from Mr. Broady under the Stock Repurchase Agreement for an aggregate purchase price of $1.5 million.

Item 6.

SELECTED FINANCIAL DATA

Not applicable under smaller reporting company disclosure rules.

Item 6. SELECTED FINANCIAL DATA

The following selected consolidated financial data, which have been derived from our audited consolidated financial statements, are not necessarily indicative of the results of future operations and should be read in conjunction with “Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations”, and the consolidated financial statements and accompanying notes included elsewhere in this Annual Report on Form 10-K (in thousands, except per share data).
 Year Ended December 31
 2016 2015 2014 2013 2012
Consolidated Statements of Operations Data:         
Net sales$287,728
 $264,860
 $124,590
 $52,527
 $37,514
Cost of sales54,903
 54,098
 26,981
 12,551
 9,685
Gross profit232,825
 210,762
 97,609
 39,976
 27,829
Operating expenses:         
Commissions expense125,050
 126,598
 56,997
 24,053
 15,724
Selling, general and administrative expenses43,245
 36,024
 19,687
 11,634
 9,415
Depreciation and amortization394
 263
 105
 66
 45
Total operating expenses168,689
 162,885
 76,789
 35,753
 25,184
Income from operations64,136
 47,877
 20,820
 4,223
 2,645
Other expense, net(59) (84) (184) (32) (39)
Income before income taxes64,077
 47,793
 20,636
 4,191
 2,606
Income tax provision (benefit)8,991
 552
 266
 102
 (24)
Net income55,086
 47,241
 20,370
 4,089
 2,630
Preferred stock dividends
 
 (10) (15) (17)
Net income available to common stockholders$55,086
 $47,241
 $20,360
 $4,074
 $2,613
Income per common share:         
Basic$4.84
 $3.84
 $1.67
 $0.36
 $0.24
Diluted$4.83
 $3.82
 $1.61
 $0.36
 $0.23
Weighted-average number of common shares outstanding:         
Basic11,382
 12,302
 12,131
 11,154
 10,944
Diluted11,407
 12,372
 12,600
 11,331
 11,234
Cash dividends declared per common share$0.61
 $0.14
 $0.03
 $
 $
          
Consolidated Balance Sheets Data:         
Cash and cash equivalents$125,921
 $104,914
 $44,816
 $14,550
 $4,207
Inventories, net11,257
 10,455
 3,760
 1,828
 867
Working capital84,090
 56,199
 25,253
 3,598
 (325)
Long-term incentive8,190
 5,770
 1,665
 
 
Total assets148,051
 124,152
 52,540
 19,827
 8,219
Total stockholders’ equity82,439
 56,809
 26,450
 6,077
 1,909
          
Consolidated Statements of Cash Flows Data:         
Net cash provided by (used in):         
Operating activities$53,174
 $81,326
 $30,613
 $10,686
 $2,214
Investing activities(905) (3,738) (339) (292) 397
Financing activities(30,595) (17,471) (189) (52) (3)
Repurchase of common stock(23,704) (16,071) (4,661) (52) (3)
Income taxes paid, net of refunds8,791
 707
 60
 71
 34

Item 7.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Item 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Business Overview

We are an international direct-selling and e-commerce company. Subsidiaries controlled by us sell personal care, wellness, and “quality of life” products under the “NHT Global” brand. In most markets, we sell our products to an independent distributor network that either uses the products themselves or resells them to consumers. Our wholly-owned subsidiaries have an active physical presence in the following markets: North America; Greater China, which consists of Hong Kong, Taiwan and China; Commonwealth of Independent States, which consists ofRussia, Kazakhstan and Ukraine; South Korea; Singapore; Malaysia; Japan; and Europe, which consists of ItalyEurope. We also operate in Russia and Slovenia.

Our distributor network operates inKazakhstan through our engagement with a seamless manner from market to market, except for the Chinese market, where we sell to consumers through an e-commerce platform. We believe that all of our operating segments should be aggregated into a single reportable segment as they have similar economic characteristics. Additionally, we believe that alllocal service provider. See Note 10 of the operating segments are similarNotes to Consolidated Financial Statements in the nature“Item 8. Financial Statements and Supplementary Data” of the products sold, the product acquisition process, the types of customers products are sold to, the methods used to distribute the products, and the nature of the regulatory environment. Our e-commerce retail business in China does not require a direct selling license and allowsthis report for discounts on volume purchases. There is no separate segment manager who is held accountablefurther information about our net sales by our chief operating decision-makers, or anyone else, for operations, operating results and planning for the Chinese market on a stand-alone basis. Accordingly, we consider ourselves to be in a single reporting segment and operating unit structure. 

geographic area.

As of December 31, 2014,2016, we were conducting business through 118,960 active members, compared to 109,360 in 2015 and 54,360 active distributors.in 2014. We consider a distributormember “active” if they have placed at least one product order with us during the preceding year. Our priority is to focus our resources in our most promising markets, which we consider to be Greater China and countries where our existing members have the connections to recruit prospects and sell our products, such as Southeast Asia. Up to $10.0 million of our available cash may be investedWe have also begun investing some resources in our Mainland China entity within the next 18 months for such purposes as establishing China-based manufacturing capabilities, opening additional Healthy Lifestyle Centers or branch offices,Central and ultimately, funding the mandated deposit and other requirements for a China direct selling license application. We also may evaluate product or distribution opportunities to diversify from our current Greater China concentration.

South America.

We generate approximately 98% of our net sales from subsidiaries located outside North America, with sales inof our Hong Kong subsidiary representing 89%92% of net sales in the latest fiscal year. Because of the size of our foreign operations, operating results can be impacted negatively or positively by factors such as foreign currency fluctuations, and economic, political and business conditions around the world. In addition, our business is subject to various laws and regulations, in particular, regulations related to direct selling activities that create certainuncertain risks for our business, including improper claims or activities by our distributorsmembers and potential inability to obtain necessary product registrations.

For further information regarding some of the risks associated with the conduct of our business in China, see “Item 1A. Risk Factors,” and more specifically under the captions “Risk Factors - Because our Hong Kong operations account for a substantial portion of our overall business...” and “Risk Factors - Our operations in China are subject to compliance with a myriad of applicable laws and regulations...”.

China has been and continues to be our most important business development project. In June 2004, we obtained a general business licenseWe operate an e-commerce direct selling model in Hong Kong that generates revenue derived from the sale of products to members in Hong Kong and elsewhere, including China. Substantially all of our Hong Kong revenues are derived from the sale of products that are delivered to members in China. Direct selling is prohibitedThrough a separate Chinese entity, we operate an e-commerce retail platform in China withoutChina. We believe that neither of these activities require a direct selling license in China, which we do not have. In December 2005, we submittedcurrently hold. We have previously sought to obtain a direct selling license, and in August 2015 initiated the process for submitting a new preliminary application for a direct selling license. In June 2006,license in China. If we submittedare able to obtain a revised application packagedirect selling license in accordance with new requirements issued byChina, we believe that the Chinese government. In June 2007, we launched a new e-commerce retail platformincentives inherent in the direct selling model in China would incrementally benefit our existing business. Increased sales in China that does not requirecould be derived from obtaining a direct selling license. We believe this model, which offers discounts based on volume purchases, will encourage repeat purchases of our products for personal consumption in the Chinese market. The platform is designed tolicense may be in compliance with our understanding of current laws and regulations in China. In November 2007, we filed a new, revised direct selling application incorporating a name change, our new e-commerce model and other developments. These direct selling applications were not approved or rejectedpartially offset by the pertinent authorities, but did not appear to materially progress. By 2009, the information contained in the most recent application was stale. The Company applied to temporarily withdraw the license application in February 2009 to furnish new information and intends to amend its applicationhigher fixed costs associated with the goal to re-apply in the future.establishment and maintenance of required service centers and branch offices. We are unable to predict whether and when we will be successful in obtaining a direct selling license to operate in China, and if we are successful, when we will be permitted to enhance our e-commerce retail platform withconduct direct selling operations.

Most of our Hong Kong revenue is derived from the sale of products that are delivered to members in China. After consulting with outside professionals, we believe that our Hong Kong e-commerce business does not violate any applicable laws in China even though it is used for the internet purchase of our products by buyers in China. But the government in China could, in the future, officially interpret its lawsoperations and regulations – or adopt new laws and regulations – to prohibit some or all of our e-commerce activities with China and, if our members engage in illegal activities in China, those actions couldwhether such operations would be attributed to us. In addition, other Chinese laws regarding how and when members may assemble and the activities that they may conduct, or the conditions under which the activities may be conducted, in China are subject to interpretations and enforcement attitudes that sometimes vary from province to province, among different levels of government, and from time to time. Members sometimes violate one or more of the laws regulating these activities, notwithstanding training that we attempt to provide. Enforcement measures regarding these violations, which can include arrests, raise the uncertainty and perceived risk associated with conducting this business, especially among those who are aware of the enforcement actions but not the specific activities leading to the enforcement action. We believe that this has led some existing members in China – who are signed up as distributors in Hong Kong – to leave the business or curtail their selling activities and has led some potential members to choose not to participate. Among other things, we are combating this with more training and public relations efforts that are designed, among other things, to distinguish the Company from businesses that make no attempt to comply with the law. This environment creates uncertainty about the future of doing this type of business in China generally and under our business model, specifically.See “Item 1A. Risk Factors—Because our Hong Kong operations account for a majority of our overall business….”

profitable.


Income Statement Presentation

We mainly derive revenue from sales of products, enrollment packages, and shipping charges.products. Substantially all of our product sales are to independent distributorsmembers at published wholesale prices. Product sales are recorded when the products are shipped and title passes to independent distributors,members, which generally is upon our delivery to the carrier that completes delivery to the distributors.members. We estimate and accrue a reserve for product returns based on our return policies and historical experience. Enrollment package revenue, including any nonrefundable set-up fees, is deferred and recognized over the term of the arrangement, generally twelve months.

We bill members for shipping charges and recognize the freight revenue in net sales. Event and training revenue is deferred and recognized as the event or training occurs.

Cost of sales consists primarily of products purchased from third-party manufacturers, freight cost for transporting products to our foreign subsidiaries and shipping products to distributors,members, import duties, packing materials, product royalties, costs of promotional materials sold to the Company’s distributorsour members at or near cost, and provisions for slow moving or obsolete inventories. Cost of sales also includes purchasing costs, receiving costs, inspection costs and warehousing costs.

Distributor


Member commissionsare typically our most significant expense and are classified as an operating expense. Under our compensation plan, distributorsmembers are paid weekly commissions by our subsidiary in which they are enrolled, generally in their home country currency, for product purchases by their down-line distributormember network across all geographic markets, exceptmarkets. Our China where we launchedsubsidiary maintains an e-commerce retail platform and dodoes not pay any commissions. This "seamless"“seamless” compensation plan enables a distributormember located in one country to sponsorenroll other distributorsmembers located in other countries where we are authorized to conduct our business. Currently, there are basically two ways in which our distributorsmembers can earn income:

Through retail markups on sales of products purchased by distributors at wholesale prices (in some markets, sales are for personal consumption only and income may not be earned through retail mark-ups on sales in that market); and

Through commissions paid on product purchases made by their down-line distributors.


through commissions paid on product purchases made by their down-line members; and

through retail markups on sales of products purchased by members at wholesale prices (in some markets, sales are for personal consumption only and income may not be earned through retail mark-ups on sales in that market).
Each of our products is designated a specified number of bonus volume points. Commissions are based on total personal and group bonus volume points per weekly sales period. Bonus volume points are essentially a percentage of a product’s wholesale cost.price. As the distributor’smember’s business expands from successfully sponsoringenrolling other distributorsmembers who in turn expand their own businesses by sponsoringselling product to other distributors,members, the distributormember receives higher commissions from purchases made by an expanding down-line network. ToIn some of our markets, to be eligible to receive commissions, a distributormember may be required to make nominal monthly or other periodic purchases of our products. Certain of our subsidiaries do not require these nominal purchases for a distributormember to be eligible to receive commissions. In determining commissions, the number of levels of down-line distributorsmembers included within the distributor'smember’s commissionable group increases as the number of distributorshipsmemberships directly below the distributormember increases. Under our current compensation plan, certain of our commission payouts may be limited to a hard cap dollar amount per week or a specific percentage of total product sales. In some markets, commissions may be further limited. In some markets, we also pay certain bonuses on purchases by up to three generations of personally sponsored distributors,enrolled members, as well as bonuses on commissions earned by up to three generations of personally sponsored distributors. Distributorsenrolled members. Members can also earn income, trips and other prizes in specific time-limited promotions and contests we hold from time to time. DistributorMember commissions are dependent on the sales mix and, for each of fiscal 20132016, 2015 and 2014 represented 44%, 48% and 46%, respectively, of net sales. From time to timeOccasionally, we make modifications and enhancements to our compensation plan to help motivate distributors,members, which can have an impact on distributormember commissions. From time to time weWe may also enter into agreements for business or market development, which maycould result in additional compensation to specific distributors.

members.

Selling, general and administrative expenses consist of administrative compensation and benefits, (including stock-based compensation), travel, credit card fees and assessments, professional fees, certain occupancy costs, and other corporate administrative expenses.expenses (including stock-based compensation). In addition, this category includes selling, marketing, and promotion expenses including(including the costs of distributormember training events and conventions whichthat are designed to increase both product awareness and distributor recruitment.member recruitment). Because our various distributormember conventions are not always held at the same time each year, interim period comparisons will be impacted accordingly. 



The functional currency of our international subsidiaries is generally their local currency. Local currency assets and liabilities are translated at the rates of exchange on the balance sheet date, and local currency revenues and expenses are translated at average rates of exchange during the period. Equity accounts are translated at historical rates.  The resulting translation adjustments are recorded directly into a separate component of stockholders’ equity and represent the only component of accumulated other comprehensive income.

Sales by our foreign subsidiaries are transacted in the respective local currencies and are translated into U.S. dollars using average rates of exchange for each monthly accounting period to which they relate.  Most of our product purchases from third-party manufacturers are transacted in U.S. dollars.  Consequently, our sales and net earnings are affected by changes in currency exchange rates, with sales and earnings generally increasing with a weakening U.S. dollar and decreasing with a strengthening U.S. dollar. 

dollar, see “Item 7A. Quantitative and Qualitative Disclosures About Market Risk” and more specifically under the caption “Foreign Currency Exchange Risk” for further information. 



Results of Operations

The following table sets forth our operating results as a percentage of net sales for the periods indicated.

  

Year Ended December 31,

 
  

2013

  

2014

 
         

Net sales

  100.0%  100.0%

Cost of sales

  23.9   21.7 

Gross profit

  76.1   78.3 

Operating expenses:

        

Distributor commissions

  45.8   45.7 

Selling, general and administrative expenses

  22.2   15.8 

Depreciation and amortization

  0.1   0.1 

Total operating expenses

  68.1   61.6 

Income from operations

  8.0   16.7 

Other expense, net

     (0.2)

Income before income taxes

  8.0   16.5 

Income tax provision

  0.2   0.2 

Net income

  7.8%  16.3%

Net Sales

indicated:

 Year Ended December 31,
 2016 2015 2014
Net sales100.0% 100.0% 100.0 %
Cost of sales19.1
 20.4
 21.7
Gross profit80.9
 79.6
 78.3
Operating expenses:     
Commissions expense43.5
 47.8
 45.7
Selling, general and administrative expenses15.0
 13.6
 15.8
Depreciation and amortization0.1
 0.1
 0.1
Total operating expenses58.6
 61.5
 61.6
Income from operations22.3
 18.1
 16.7
Other expense, net
 
 (0.2)
Income before income taxes22.3
 18.1
 16.5
Income tax provision3.1
 0.2
 0.2
Net income19.2% 17.9% 16.3 %
The following table sets forth revenue by market for the periods indicated (in thousands):

  

Year Ended December 31,

 
  

2013

  

2014

 
                 

North America

 $2,361   4.5% $2,812   2.3%

Hong Kong

  40,585   77.3   111,028   89.1 

China

  791   1.5   1,538   1.2 

Taiwan

  3,387   6.4   4,628   3.7 

South Korea

  702   1.3   1,009   0.8 

Japan

  106   0.2   89   0.1 

Russia, Kazakhstan and Ukraine

  4,354   8.3   3,113   2.5 

Europe

  241   0.5   373   0.3 

Total

 $52,527   100.0% $124,590   100.0%

 Year Ended December 31,
 2016 2015 2014
North America$5,909
 2.0% $5,992
 2.3% $2,812
 2.3%
Hong Kong1
263,482
 91.6
 245,737
 92.8
 111,028
 89.1
China9,086
 3.2
 4,425
 1.7
 1,538
 1.2
Taiwan6,213
 2.2
 5,965
 2.3
 4,628
 3.7
South Korea691
 0.2
 1,128
 0.4
 1,009
 0.8
Japan86
 
 92
 
 89
 0.1
Singapore169
 0.1
 
 
 
 
Russia, Kazakhstan and Ukraine2
858
 0.3
 1,139
 0.4
 3,113
 2.5
Europe1,234
 0.4
 382
 0.1
 373
 0.3
Total$287,728
 100.0% $264,860
 100.0% $124,590
 100.0%
1Substantially all of our Hong Kong revenues are derived from the sale of products that are delivered to members in China. See “Item 1A. Risk Factors”.
2We discontinued our Ukraine operations during the second quarter of 2015.

Financial Results of 2016 Compared to 2015

Net Sales
Net sales were $124.6$287.7 million for the year ended December 31, 20142016 compared with $52.5$264.9 million a year ago, an increase of $72.1$22.8 million, or 137%9%.  Hong Kong net sales, substantially all of which were shipped to members residing in China, increased $70.4$17.7 million, or 174%7%, over the prior year. Hong Kong experienced an increase of 7,800 active members, or 8%, during 2016, which contributed to the increase in product sales volume. We also launched new Wellness products during 2016, which contributed approximately $11.2 million to our top-line growth. However, we believe our net sales increase was adversely impacted by the following:

A primary factor was the special measures the Chinese government implemented in preparation of the G20 Summit in Hangzhou, one of our top markets, in which they relocated city residents, emptied entire districts, blocked urban traffic and shut down businesses in July, August and early September 2016.

Also, we did not offer a comparable incentive trip promotion in 2016 as the 2015 supplemental incentive trip promotion to the U.S., which proved to be appealing and contributed to increased sales in 2015.

Finally, the devaluation of the Chinese yuan, which depreciated 7% against the Hong Kong dollar during 2016, indirectly affected our financial results by increasing the product pricing in the currency of our Chinese members.
Outside of our Hong Kong business, net sales increased $5.1 million, or 27%, compared with the prior year, driven by a 105% increase in our China e-commerce business and a 223% increase in Europe, offset by the performance of South Korea, which decreased 39% and our Commonwealth of Independent States (“CIS”) market, which decreased 25%. The $4.7 million net sales increase in our China e-commerce business was primarily driven by increased sales in our Home product line, which was introduced during the fourth quarter of 2015. The $852,000 net sales increase in Europe was primarily driven by our Wellness product line.
As of December 31, 2016, deferred revenue was $4.9 million, which primarily consisted of $2.2 million in unshipped product orders, and $2.3 million and $430,000 pertaining to auto ship advances and unamortized enrollment package revenue, respectively.
Gross Profit
Gross profit was 80.9% of net sales for the year ended December 31, 2016 compared with 79.6% of net sales for the year ended December 31, 2015. The gross profit margin percentage increase is due to higher event and training revenue, higher product margins and lower logistics costs.
Commissions
Commissions were 43.5% of net sales for the year ended December 31, 2016 compared with 47.8% of net sales for the year ended December 31, 2015.  The decrease as a percentage of net sales resulted primarily from the reduction in our on-going cash and other incentive programs which cost 3.0% of net sales for the year ended December 31, 2016 compared with 6.4% of net sales for the year ended December 31, 2015.
Selling, General and Administrative Expenses
Selling, general and administrative expenses were $43.2 million for the year ended December 31, 2016 compared with $36.0 million for the year ended December 31, 2015. Selling, general and administrative expenses increased by $7.2 million, or 20%, mainly due to an increase in event costs, member training costs, professional fees, and an increase in credit card fees and assessments due to higher net sales, offset by a decrease in our employee-related expenses, as compared to the year ended December 31, 2015.
Income Taxes
An income tax provision of $9.0 million was recognized for the year ended December 31, 2016 compared with $552,000 for the year ended December 31, 2015. The increase is due to greater profitability of our international operations, as well as the repatriation of foreign earnings back to the U.S. during the year. As a result of capital return activities approved by the Board of Directors during the first quarter of 2016 and anticipated future capital return activities, we then determined that a portion of our undistributed foreign earnings were no longer deemed reinvested indefinitely by our non-U.S. subsidiaries. We repatriated $19.8 million to the U.S. during the three months ended March 31, 2016, part of which was offset by U.S. net operating losses. Accordingly, the deferred tax liability previously established for undistributed foreign earnings up to existing U.S. net operating losses was reduced. The excess amount repatriated during the year ended December 31, 2016 was generated from current foreign earnings. In addition, during the three months ended December 31, 2016, we released our remaining valuation allowance against U.S. deferred tax assets as it was determined that it is more likely than not that we will realize the tax benefits of our deferred assets in future periods. We will continue to periodically reassess the needs of our foreign subsidiaries and update our indefinite reinvestment assertion as necessary. To the extent that additional foreign earnings are not deemed permanently reinvested, we expect to recognize additional income tax provision at the applicable U.S. corporate tax rate.


Financial Results of 2015 Compared to 2014

Net Sales

Net sales were $264.9 million for the year ended December 31, 2015 compared with $124.6 million a year ago, an increase of $140.3 million, or 113%.  Hong Kong net sales, substantially all of which were shipped to members residing in China, increased $134.7 million, or 121%, over the prior year.  Hong Kong experienced an increase of 54,100 active members, or 116%, during 2015, which is comparable to the increase in net sales. The sales increase in Hong Kong was primarily due to a substantial increase in product sale volumes attributable to the increase in new active members and effectiveness of the Company’sour leadership development, promotional programs, incentives, events, new products, training, commission plans and services.

During 2015, our on-going member cash and incentive programs, including a supplemental incentive trip promotion to the U.S. offered during part of 2015, were more appealing to our members than those offered during the prior year and contributed to increased sales. Additionally, we hosted the largest event in our company’s history in Hong Kong during August 2015, and launched new Wellness products that resulted in additional sales of approximately $7.0 million.

Outside of our Hong Kong business, net sales increased $5.6 million, or 41%, compared with the prior year. Double or triple digit percentage sales increases occurred in North America, Taiwan, South Korea and the China e-commerce business. These increases were offset by the performance of our Commonwealth of Independent States (“CIS”)CIS market, werewhich continued to be negatively impacted in 2014 by the political unrest in the region, as well as the devaluation of the Russian ruble, and decreased $1.2$2.0 million, or 29%63%, overcompared with the prior year. Elsewhere, net sales increased $2.9 million, or 38%, over the prior year, resulting in a total net sales increase in 2014 outside of our Hong Kong business of $1.7 million, or 14%, over the prior year.

 

As of December 31, 2014, our operating subsidiaries had 54,360 active distributors, compared with 27,520 active distributors at December 31, 2013. Hong Kong experienced an increase of 26,520 active distributors, or 131%, from December 31, 2013 to December 31, 2014. This substantial increase in the number of active distributors is attributable to the same factors that contributed to the increase in net sales and product sale volumes on a year-over-year basis.

As of December 31, 2014,2015, deferred revenue was $2.7$4.0 million, which primarily consisted of $1.2$1.8 million pertaining toin unshipped product orders, $815,000and $1.6 million and $331,000 pertaining to auto ship advances and $222,000 pertaining to unamortized enrollment package revenue.

revenue, respectively.

Gross Profit

Gross profit was 79.6% of net sales for the year ended December 31, 2015 compared with 78.3% of net sales for the year ended December 31, 2014 compared with 76.1%2014. The gross profit margin percentage increase was primarily attributable to higher product margins, lower third party service provider fees in Russia and lower logistics costs in Hong Kong.
Commissions
Commissions were 47.8% of net sales for the year ended December 31, 2013. The gross profit margin percentage increase is primarily attributable to lower fees paid to our third-party service provider in the CIS market and less importation costs as a percentage of overall net sales, which occurs when sales from the CIS market comprise a lower percentage of our overall net sales. Additionally, the increase is attributable to higher product margins in Hong Kong due to a more favorable product mix. The margin increase is somewhat offset by a cost increase assessed by one of our Hong Kong third-party logistics service providers effective in the fourth quarter of 2013.

Distributor Commissions

Distributor commissions were2015 compared with 45.7% of net sales for the year ended December 31, 2014 compared with 45.8%2014.  The increase as a percentage of net sales for the year ended December 31, 2013.  Though overall commissions as a percentage of net sales were flat year over year, there was a change2015 primarily resulted from an increase in the composition.  During 2014, commissions earned on a weekly basis increased 1%, mainly in Hong Kong; but that increase was offset by a comparable decrease incost of our on-going member cash and other incentive program costs during 2014, primarily the Supreme Bonus Plan, which is tied to our international recognition program.

programs.

Selling, General and Administrative Expenses

Selling, general and administrative expenses were $36.0 million for the year ended December 31, 2015 compared with $19.7 million for the year ended December 31, 2014 compared with $11.6 million for the year ended December 31, 2013.2014. Selling, general and administrative expenses increased by $8.1$16.3 million, or 69%83%, mainly due to an increase in employee-related costs and incentive program accruals, professional fees, director costs, and facility costs, as well as an increase in credit card fees and assessments due to higher net sales as compared to the same period in the prior year.

Other Expense, Net

Loss on foreign exchange was $202,000 for the year ended December 31, 2014 primarily due to the impact2014.

Income Taxes
An income tax provision of CIS market currency devaluation (against the U.S. dollar) on inter-company balances, namely the Ukrainian hryvnia, the Russian ruble and the Kazakhstani tenge. A loss on foreign exchange totaling $32,000$552,000 was recognized for the year ended December 31, 2013.

Income Taxes

An income tax provision of2015 compared with $266,000 was recognized for the year ended December 31, 2014 compared with $102,0002014. The increase was due to greater profitability of our international operations, as well as the repatriation of foreign earnings back to the U.S. during the year. As a result of capital return activities approved by the Board of Directors during the three months ended September 30, 2015, and anticipated future capital return activities intended to take full advantage of existing U.S. net operating losses, we determined that a portion of our undistributed foreign earnings were no longer deemed reinvested indefinitely by our non-U.S. subsidiaries beginning in the quarter ended September 30, 2015. As such, an accumulated deferred tax liability of $9.3 million was recorded against these undistributed earnings, which included the impact of utilization of foreign tax credits. However, because it was anticipated that these earnings would be offset by U.S. net operating losses that had previously been fully offset by a valuation allowance, we also released a similar amount of valuation allowance. Accordingly, there was no significant impact on the income tax provision for the year ended December 31, 2013. The increase is due to increased profitability2015.



During 2015, $18.4 million in foreign earnings were repatriated back into the U.S. which were offset by U.S. net operating losses. As of our operations both domestically and internationally. The Company did not recognizeDecember 31, 2015 there was a remaining deferred tax benefit forliability of $2.8 million, which was offset by an equivalent amount of net operating loss deferred tax assets. This represented the remaining balance of the U.S. tax purposesimpact of undistributed foreign earnings that was planned to be repatriated to the U.S. as of December 31, 2015. All other undistributed foreign earnings were intended to be permanently reinvested in 2013 duenon-U.S. operations to uncertainty thatfund and expand the benefit will be realized.

non-U.S. subsidiaries as of December 31, 2015.


Liquidity and Capital Resources

At December 31, 2014, the Company’s2016, our cash and cash equivalents totaled $44.8$125.9 million. Total cash and cash equivalents increased by $10.3$21.0 million and $30.3$60.1 million during 20132016 and 2014,2015, respectively.

We consider all highly liquid investments with original maturities of three months or less, when purchased, to be cash equivalents. As of December 31, 2016, we had $73.5 million in available-for-sale investments classified as cash equivalents. In addition, cash and cash equivalents included $120.0 million held in bank accounts overseas, which included $6.8 million held in banks located in China subject to foreign currency controls.

At December 31, 2014,2016, the ratio of current assets to current liabilities was 2.032.47 to 1.00 and the Companywe had $25.2$84.1 million of working capital. Current liabilities included deferred revenue of $2.7 million that consisted primarily of unshipped product orders, auto ship advances and unamortized enrollment package revenues. The ratio of current assets to current liabilities excluding deferred revenue was 2.28 to 1.00. Working capital as of December 31, 20142016 increased $21.8$27.9 million compared to the Company’sour working capital as of December 31, 2013,2015, primarily due to cash generated from operations.



Cash provided by operations during 20142016 was $30.6$53.2 million compared to $10.7$81.3 million during 2013.2015. The increasedecrease in operating cash flows resultsresulted primarily from the net sales increase year over year. Additionally, the timing difference of cash outlays associated with both distributor and employee incentive programs contributed toincreased commission-related payments, the increase asof our members' utilization of our eWallet functionality and U.S. income tax payments resulting from the current year expenses were greater than those recognizedrepatriation of overseas profits of $7.4 million, offset by a reduction in the prior year.

our inventory purchases and increased net income during 2016.


Cash flows used in investing activities totaled $339,000$905,000 during 2014, primarily2016. Software development costs of $666,800 were incurred during the resultyear ended December 31, 2016 for our Oracle ERP upgrade and enhancement of buildout costs incurred at the multi-purposed facility in Zhongshan, China and renovations in the Taipei, Taiwan office.our back office software platform. Cash flows used in investing activities totaled $292,000$3.7 million during 2013,the year ended December 31, 2015 and consisted primarily of which $210,000 were purchasesour June 2015 funding of property and equipment. The buildouta bank deposit amount in the amount of the multi-purposed facility in Zhongshan, China began in November 2013 and such costs totaled $102,000 during 2013. Also, asCNY 20 million (USD $3.3 million at June 30, 2015) for our direct selling license application. Such deposit is required by Chinese laws to establish a result of increased sales in South Korea during 2013, additionalconsumer protection fund. In August 2015, cash deposits in the amount of $82,000$218,000 were required to be held by areceived from certain South Korean credit card processing company.

companies. Additionally, buildout costs of $608,000 were incurred during 2015 for new offices located in California, Hong Kong and Singapore, at the multi-purpose facility in Zhongshan, China and at the new Healthy Lifestyle Center in Monterey Park, California.


Cash flows used in financing activities during 20142016 totaled $189,000. Warrants$30.6 million. We used $23.7 million to purchase 1,407,855repurchase shares of our common stock were exercised during 2014 at exercise prices ranging from $3.5108 to $3.52 per share for total proceeds of $4.9 million. Offsetting this amount, on November 4, 2014,stock. On January 12, 2016, the Board of Directors approved a specialauthorized an increase to our stock repurchase program of upfirst approved on July 28, 2015 from $15.0 million to $5.0 million$70.0 million. Repurchases are expected to be executed to the extent that our earnings and cash-on-hand allow, and will be made in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Company’s outstanding sharesExchange Act. For all or a portion of common stock.the authorized repurchase amount, we may enter into one or more plans that are compliant with Rule 10b5-1 of the Exchange Act that are designed to facilitate these purchases. The stock repurchase program was completed ondoes not require us to acquire a specific number of shares, and may be suspended from time to time or discontinued. During February 2016, pursuant to the stock repurchase program, we authorized our broker to proceed with the purchase of shares of our common stock in the open market. During the year ended December 17, 2014 and31, 2016, the stock repurchase program resulted in our purchasing a total of 903,031 shares of our common stock repurchases totaling $4.5for an aggregate purchase price of $23.7 million, plus transaction costs. George K. Broady, a director and an ownerAs of more than 5% of the Company’s outstanding common stock, participated in the Company’s repurchase program on a basis roughly proportional to his ownership interest, selling approximately $1.5December 31, 2016, $32.0 million of the Company’s$70.0 million stock repurchase program approved on July 28, 2015 and increased on January 12, 2016 remained available for future purchases, inclusive of related estimated income tax. Cash flows used in financing activities during 2015 totaled $17.5 million, and consisted primarily of $16.1 million used to repurchase a total of 547,042 shares of our common stock held by him (see Note 8 of the Notes to Consolidated Financial Statementsand $1.7 million in Item 8 of this report). Additionally, othercash dividends.


Other financing cash outflowsflows during 2016 included the following cash dividend payments of $476,000 and the repurchase of shares of common stock pursuant to Rule 10b5-1 under a program authorized by the Board of Directors for the Company to purchase 100,000 shares, acting as Trustee for certain of its non-officer, overseas employees. Such repurchases totaled $159,000 and $52,000 during 2014 and 2013, respectively. No additional financing activities occurred during 2013.

The following table summarizes the Company’s cash dividend activity during 2014 (in thousands, except per share data):

  

Dividends Per Share

      

Declaration Date

 

Preferred

  

Common

  

Amount

 

Date Payable

              

March 7, 2014

 $0.815  $0.005  $159 

April 8, 2014

May 6, 2014

  0.020   0.005   62 

June 4, 2014

July 29, 2014

  0.027   0.010   127 

August 27, 2014

November 4, 2014

  0.032   0.010   128 

December 3, 2014

Total

 $0.894  $0.030  $476  

On February 27, 2015,amounts) to holders of our common stock:

Declaration Date Per Share Amount Record Date Payment Date
October 23, 2016 (special) $0.35
 $3,941
 November 15, 2016 November 25, 2016
October 23, 2016 0.08
 901
 November 15, 2016 November 25, 2016
July 19, 2016 0.07
 787
 August 16, 2016 August 26, 2016
April 21, 2016 0.06
 686
 May 10, 2016 May 20, 2016
March 1, 2016 0.05
 576
 March 16, 2016 March 24, 2016
Total $0.61
 $6,891
    

Subsequent to December 31, 2016, on January 24, 2017, the Board of Directors declared a cash dividend of $0.02$0.09 and a special cash dividend of $0.35 on each share of common stock outstanding. Such dividends are payablewere paid on March 27, 20153, 2017 to stockholders of record on March 17, 2015.February 21, 2017. Payment of any future dividends on shares of common stock will be at the discretion of the Company’sour Board of Directors.

The Company believes

We believe that itsour existing internal liquidity, supported by cash on hand and cash flows from operations should be adequate to fund normal business operations and address itsour financial commitments for at least the next 12 months, assuming no significant unforeseen expense or revenue decline. If the Company’s foregoing beliefs or assumptions prove to be incorrect, however, the Company’s business, results of operations and financial condition could be materially adversely affected. See “Item 1A. Risk Factors.”

The Company doesforeseeable future.

We do not have any significant unused sources of liquid assets. If necessary, the Companywe may attempt to generate more funding from the capital markets, but currently doesdo not believe that will be necessary.

On October 19, 2007, the Company issued warrants to purchase 3,141,499 shares of common stock in connection with a convertible debentures financing. The warrants consisted of seven-year warrants to purchase 1,495,952 shares of common stock, one-year warrants to purchase 1,495,952 shares of common stock, and five-year warrants to purchase 149,595 shares of common stock. The term for each of the warrants began six months and one day after their respective issuance and each had an exercise price of $3.52 per share.  Such one-year warrants expired unexercised on April 21, 2009 and such five-year warrants expired unexercised on April 21, 2013. Of the seven-year warrants to purchase 1,495,952 shares of common stock, as of February 27, 2015, warrants to purchase 88,097 shares of common stock remain outstanding with an exercise price of $3.5082 per share. Such exercise price was adjusted as a result of cash dividends declared during 2014 on each share of outstanding common stock in accordance with the terms of the related warrant agreement. The exercise price per share may be further adjusted on March 17, 2015, the record date for the dividends declared on February 27, 2015. The unexercised warrants expire April 21, 2015 if not previously exercised.



Our priority is to focus our resources on investing in our most important markets, which we consider to be Greater China and countries where our existing members may have the connections to recruit prospects and sell our products, such as Southeast Asia. UpWe will continue to $10.0 million of our available cash may be investedinvest in our Mainland China entity within the next 18 months for such purposes as establishing China-based manufacturing capabilities, increasing public awareness of our brand and our products, sourcing more Chinese-made products, building a chain of service stations, opening additional Healthy Lifestyle Centers or branch offices, adding local staffing and ultimately, funding the required depositother requirements for a China direct selling license application. We have also may evaluate product or distribution opportunitiesbegun to diversify frominvest some resources in Central and South America.

Quarterly Results of Operations (Unaudited)

The following table sets forth unaudited quarterly operating results for each of the last eight fiscal quarters. The information for each of these quarters has been prepared on the same basis as the audited annual financial statements included elsewhere in this annual report and, in the opinion of management, includes all adjustments, which includes only normal recurring adjustments, necessary for the fair statement of the results of operations for these periods. This data should be read in conjunction with our current Greater China concentration.

audited consolidated financial statements and related notes included in “Item 8. Financial Statements and Supplementary Data” of this annual report. These quarterly operating results are not necessarily indicative of our operating results for any future period.

 2016 2015
 
4th
Quarter
 
3rd
Quarter
 
2nd
Quarter
 
1st
Quarter
 4th
Quarter
 3rd
Quarter
 2nd
Quarter
 1st
Quarter
                
 (In Thousands, Except Per Share Data)
Net sales$62,312
 $70,679
 $80,391
 $74,346
 $73,656
 $80,779
 $69,716
 $40,709
Gross profit50,375
 57,052
 65,332
 60,066
 58,583
 64,778
 55,622
 31,779
Income from operations20,014
 15,208
 14,927
 13,987
 13,893
 14,803
 12,263
 6,918
Net income19,048
 12,557
 12,201
 11,280
 13,699
 14,531
 12,273
 6,738
Income per common share:               
Basic1.70
 1.12
 1.08
 0.96
 1.13
 1.19
 0.99
 0.54
Diluted1.70
 1.12
 1.07
 0.95
 1.13
 1.18
 0.98
 0.54


Contractual Obligations

The Company hasfollowing table summarizes our contractual obligations as of December 31, 2016 and the expected effect on our cash flow and liquidity in future periods (in thousands):
  Total 2017 2018-2019 2020-2021 Thereafter
Operating leases $3,923
 $1,559
 $1,154
 $510
 $700
Purchase obligations 20,745
 9,725
 11,020
 
 
Long-term incentive 10,064
 1,874
 2,390
 1,963
 3,837
Other commitments 357
 107
 163
 87
 
Total $35,089
 $13,265
 $14,727
 $2,560
 $4,537

We have entered into non-cancelable operating lease agreements for locations within the United States and for itsour international subsidiaries, with expirations through March 2018.

September 2025 totaling $3.9 million.

In May 2013, the Companywe entered into an exclusive distribution agreement with one of itsour suppliers to purchase itstheir product through July 2016.2016 which automatically renews annually unless terminated 90 days prior to the termination date. To maintain exclusivity, the Company iswe are required to purchase a minimum of $40,000 of product per month until the termination date. As of December 31, 2014, the Company was2016, we were in compliance with the exclusivity provision.

In December 2014, the CompanyFebruary 2016, we amended a supply agreement with one of itsour suppliers to obtainmaintain worldwide exclusivity in return for purchasing a minimum of $3.3$9.4 million of product annually.annually on average over the next three years, plus certain raw material guarantees. If the Company doeswe do not purchase the minimum product as required, then a Cure Payment, as defined, will be due to the supplier. The term of the agreement is three years commencing on January 1, 2015February 2016 and shall automatically renew for successive three year terms unless notice of termination is provided by either party.

The Company has


In recognition of the achievement of specified performance goals, financial rewards are awarded under our 2014 Long-Term Incentive Plan with cash payments through December 2023. See Note 1 of the Notes to Consolidated Financial Statements in “Item 8. Financial Statements and Supplementary Data” of this report for additional information.

We have evaluated our tax positions and have determined that there are no uncertain tax positions for the current year or years prior.
We have employment agreements with certain members of itsour management team that can be terminated by either the employee or the Companyus upon four weeks’ notice.  The employment agreements entered into with the management team contain provisions that guarantee the payments of specified amounts in the event of a change in control, as defined, or if the employee is terminated without cause, as defined, or terminates employment for good reason, as defined. In addition, the Company has an employment agreement with another employee that can be terminated at will by either the employee or the Company, provided that the Company must pay a specified amount if it terminates the agreement without cause, as defined, or the employee terminates the agreement with good reason, as defined. Accrued severance totaling $12,000 as of December 31, 2014 was paid in January 2015.


Critical Accounting Policies and Estimates

A summary of our significant accounting policies is provided in Note 1 of the Notes to Consolidated Financial Statements in Item 8“Item 8. Financial Statements and Supplementary Data” of this report. The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reported period. The process of determining significant estimates is fact specific and takes into account historical experience and current and expected economic conditions. To the extent that there are material differences between the estimates and actual results, future results of operations will be affected.

Critical accounting policies and estimates are defined as both those that are material to the portrayal of our financial condition and results of operations and as those that require management’s most subjective judgments.  Management believes the Company’sour critical accounting policies and estimates are those related to obsolete inventory and the fair value of acquired intangible assets, including goodwill, revenue recognition, as well as those used in the determination of liabilities related to sales returns, distributormember commissions and income taxes.

Inventory Valuation.The Company reviews its inventory carrying value and compares it to the net realizable value of its inventory and any inventory value in excess of net realizable value is written down. In addition, the Company reviews its inventory for obsolescence and any inventory identified as obsolete is reserved or written off. The Company’s determination of obsolescence is based on assumptions about the demand for its products, product expiration dates, estimated future sales, and management’s future plans. Also, if actual sales or management plans are less favorable than those originally projected by management, additional inventory reserves or write-downs may be required. At December 31, 2013 and 2014, the Company’s inventory value was $1.8 million and $3.8 million, respectively, net of reserves of zero and $18,000, respectively. No significant provision was recorded during the periods presented.

Valuation of Goodwill.The Company assesses qualitative factors in order to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, through this qualitative assessment, the conclusion is made that it is more likely than not that a reporting unit’s fair value is less than its carrying amount, a two-step impairment test is performed. The Company’s policy is to test for impairment annually during the fourth quarter. At December 31, 2013 and 2014, goodwill of $1.8 million was reflected on the Company’s balance sheet. No impairment of goodwill was recognized during the periods presented.



Allowance for Sales Returns.An allowance for sales returns is provided during the period the product is shipped.  The allowance is based upon the return policy of each country, which varies from 14 days to one year, and their historical return rates, which range from 1% to 7% of sales.  Sales returns were 1% and 2% of sales for the years ended December 31, 2013 and 2014, respectively.  The allowance for sales returns was $504,000 and $654,000 at December 31, 2013 and 2014, respectively.  No material changes in estimates have been recognized during the periods presented.

Revenue Recognition.Product sales are recorded when the products are shipped and title passes to independent distributors.members. Product sales to distributorsmembers are made pursuant to a distributormember agreement that provides for transfer of both title and risk of loss upon our delivery to the carrier that completes delivery to the distributors,members, which is commonly referred to as “F.O.B. Shipping Point.” The CompanyWe primarily receivesreceive payment by credit card at the time distributorsmembers place orders. The Company’sOur sales arrangements do not contain right of inspection or customer acceptance provisions other than general rights of return. Amounts received for unshipped product are recorded as deferred revenue. Such amounts totaled $1.9$2.2 million and $1.2$1.8 million at December 31, 20132016 and 2014,2015, respectively. Shipping charges billed to distributorsmembers are included in net sales. Costs associated with shipments are included in cost of sales.

Event and training revenue is deferred and recognized as the event or training occurs.

Enrollment package revenue, including any nonrefundable set-up fees, is deferred and recognized over the term of the arrangement, generally twelve months. Enrollment packages provide distributorsmembers access to both a personalized marketing website and a business management system. No upfront costs are deferred as the amount is nominal. At December 31, 20132016 and 2014,2015, enrollment package revenue totaling $182,000$430,000 and $222,000$331,000 was deferred, respectively. Although the Company haswe have no immediate plans to significantly change the terms or conditions of enrollment packages, any changes in the future could result in additional revenue deferrals or could cause us to recognize the deferred revenue over a longer period of time. Additionally, deferred revenue includes advances for auto ship orders. In certain markets, when a distributor’smember’s cumulative commission income reaches a certain threshold, a percentage of the distributor’smember’s weekly commission is held back as an advance and applied to an auto ship order once the accumulated amount of the advances is sufficient to pay for the pre-selected auto ship package of the distributor.member.  Such advances were $449,000$2.3 million and $815,000$1.6 million at December 31, 20132016 and 2014,2015, respectively.

Distributor

Allowance for Sales Returns. An allowance for sales returns is provided during the period the product is shipped.  The allowance is based upon the return policy of each country, which varies from 14 days to one year, and their historical return rates, which range from 1% to 7% of sales.  Sales returns were 2% and 1% of sales for the years ended December 31, 2016 and 2015, respectively.  The allowance for sales returns was $1.6 million at December 31, 2016 and 2015.  No material changes in estimates have been recognized during the periods presented.
Commissions.Independent distributorsmembers earn commissions based on total personal and group bonus volume points per weekly sales period.  Each of our products are designated a specified number of bonus volume points, which is essentially a percentage of the product’s wholesale price.  The Company accruesWe accrue commissions when earned and paysas the related revenue is recognized and pay commissions on product sales generally two weeks following the end of the weekly sales period.

In some markets, we also pay certain bonuses on purchases by up to three generations of personally sponsored distributors, as well as bonuses on commissions earned by up to three generations of personally sponsored distributors.

Independent distributorsmembers may also earn incentives based on meeting certain qualifications during a designated incentive period, which may range from several weeks to up to a year.  These incentives may be both monetary and non-monetary in nature.  The Company estimatesFor each individual incentive, we estimate the total number of qualifiers as well as the expected per qualifier cost and accrues theaccrue all costs associated with incentives throughout the qualification period. We regularly review and update, if necessary, the estimates of both qualifiers and cost as more information is obtained during the qualification period. Any resulting change in total cost is recognized over the duration of theremaining qualification period based on distributor achievement of the qualification requirements.period. Accrued commissions, including the estimated cost of our international recognition incentive program and other supplemental programs,totaled $4.0$13.6 million and $8.9$19.6 million at December 31, 20132016 and 2014,2015, respectively.

Tax Valuation Allowance.The Company evaluates

Income Taxes. Deferred income taxes are recognized for differences between the financial reporting and tax bases of assets and liabilities at enacted statutory rates for the years in which the temporary differences are expected to be recovered or settled. We evaluate the probability of realizing the future benefits of any of itsour deferred tax assets and recordsrecord a valuation allowance when it believeswe believe a portion or all of itsour deferred tax assets may not be realized. The Company increased the valuation allowance to equal its netDeferred tax expense or benefit is a result of changes in deferred tax assets during 2005 dueand liabilities. Based on the technical merits of our tax position, tax benefits may be recognized if we determine it is more likely than not that our position will be sustained on examination by tax authorities. The complex nature of these estimates requires us to anticipate the likely application of tax law and make judgments on the largest benefit that has a greater than fifty percent likelihood of being realized prior to the uncertaintycompletion and filing of future operating results.tax returns for such periods. As of December 31, 2016, we no longer have a valuation allowance against our U.S. deferred tax assets. We maintain a valuation allowance in certain foreign jurisdictions with an overall tax loss. The valuation allowance will be reduced at such time as management believes it is more likely than not that the deferred tax assets will be realized. During 2013 and 2014, no such reduction in the valuation allowance occurred. Any reductions in the valuation allowance will reduce future income tax provisions.

provision.



Provision for income taxes depends on the statutory tax rates in each of the jurisdictions in which we operate. We believeAs a result of capital return activities, we determined that we operate in compliance with all applicable transfer pricing laws and we intend to continue to operate in compliance with such laws. However, there can bea portion of our current undistributed foreign earnings are no assurance that welonger deemed reinvested indefinitely by our non-U.S. subsidiaries. We will continue to be foundperiodically reassess the needs of our foreign subsidiaries and update our indefinite reinvestment assertion as necessary. To the extent that additional foreign earnings are not deemed permanently reinvested, we expect to recognize additional income tax provision at the applicable U.S. corporate tax rate. As of December 31, 2016, we recorded a deferred tax liability for earnings that we plans to repatriate out of accumulated earnings in future periods. All undistributed earnings in excess of 50% of current earnings on an annual basis are intended to be operatingreinvested indefinitely as of December 31, 2016.

We estimate what our effective tax rate will be for the full fiscal year at each interim reporting period and record a quarterly tax provision based on that estimated effective tax rate. Throughout the year that estimated rate may change based on variations in compliance with transfer pricing laws, or that those laws would not be modified, which, as a result, may requireour business, changes in our operating procedures. If the United States Internal Revenue Service or the taxing authorities of any other jurisdiction were to successfully challenge these agreements, plans, or arrangements, or requirecorporate structure, changes in the geographic mix and amount of income, applicable tax laws and regulations, communications with tax authorities, as well as our transfer pricing practices, we could be required to pay higher taxes, interestestimated and penalties, andactual level of annual pre-tax income. We adjust our earnings would be adversely affected. 

income tax provision in the reporting period in which the change in our estimated rate occurs so that the year-to-date provision is consistent with the anticipated annual tax rate. 


Item 7A.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable under smaller reporting company disclosure rules.

Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We have operations both internationally and within the United States, and we are exposed to market risks in the ordinary course of our business. These risks include primarily interest rate, foreign exchange and inflation risks.

Interest Rate Fluctuation Risk

Our cash and cash equivalents consist of cash, available-for-sale securities, comprising municipal notes, bonds and corporate debt, money market funds and time deposits. The primary objective of our investment in available-for-sale securities is to preserve principal while maximizing income without significantly increasing risk. Because our cash and cash equivalents have a relatively short maturity, our portfolio's fair value is relatively insensitive to interest rate changes. In future periods, we will continue to evaluate our investment policy relative to our overall objectives.

Foreign Currency Exchange Risk

We have foreign currency risks related to our revenue and expenses denominated in currencies other than the U.S. dollar. Our most significant foreign exchange exposure, the Hong Kong dollar, is for now pegged to the U.S. dollar. Our foreign currency exchange rate exposure to South Korean won, Taiwan dollar, Japanese yen, Chinese yuan, Russian ruble, Kazakhstani tenge, Singaporean dollar, Malaysian ringgit, Canadian dollar, and European euro represented approximately 7%, 6% and 10% of our revenue during the years ended December 31, 2016, 2015 and 2014, respectively. We have experienced and will continue to experience fluctuations in our net income as a result of transaction gains and losses related to translating certain balances denominated in currencies other than the U.S. dollar.

Our foreign currency exchange rate exposure may increase in the near future as we further develop opportunities in Southeast Asia, Canada, Central America, South America and Europe. Additionally, our foreign currency exchange rate exposure would significantly increase if the Hong Kong dollar were no longer pegged to the U.S. dollar. We also experience indirect exchange rate exposure due to the recent devaluation of the Chinese yuan, which has depreciated 7% against the Hong Kong dollar and has eroded our Chinese memberspurchasing power. Given our inability to predict the degree of exchange rate fluctuations, we cannot estimate the effect these fluctuations may have upon future reported results, product pricing or our overall financial condition. Further, to date we have not attempted to reduce our exposure to short-term exchange rate fluctuations by using foreign currency exchange contracts.

Inflation Risk

We do not believe that inflation has had a material effect on our business, financial condition or results of operations. If our costs were to become subject to significant inflationary pressures, we might not be able to fully offset such higher costs through price increases. Our inability or failure to do so could harm our business, financial condition and results of operations.



Item 8.

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

NATURAL HEALTH TRENDS CORP.

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

Page
  

33

34

35

36

37

38

39


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors and Stockholders

Natural Health Trends Corp.

Dallas, Texas

Rolling Hills Estates, California
We have audited the accompanying consolidated balance sheets of Natural Health Trends Corp. (the “Company”) as of December 31, 20142016 and 2013,2015, and the related consolidated statements of operations, comprehensive income, stockholders’ equity, and cash flows for each of the years in the two-yearthree-year period ended December 31, 2014.2016. We also have audited the Company’s internal control over financial reporting as of December 31, 2016, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). The Company’s management is responsible for these financial statements.statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying “Management's Annual Report on Internal Control over Financial Reporting”. Our responsibility is to express an opinion on these financial statements and an opinion on the Company’s internal control over financial reporting based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration ofmisstatement and whether effective internal control over financial reporting as a basis for designing audit procedures that are appropriatewas maintained in the circumstances, but not for the purpose of expressing an opinion on the effectivenessall material respects. Our audits of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includesstatements included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well asand evaluating the overall financial statement presentation. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinion.

opinions.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of Natural Health Trends Corp. as of December 31, 20142016 and 2013,2015, and the results of its operations and its cash flows for each of the years in the two-yearthree-year period ended December 31, 2014,2016, in conformity with accounting principles generally accepted in the United States of America.

Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2016, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

/s/ Lane Gorman Trubitt, PLLC

Dallas, Texas

March 6, 2015

LLC
 
Dallas, Texas
March 10, 2017


NATURAL HEALTH TRENDS CORP.

CONSOLIDATED BALANCE SHEETS

(In Thousands, Except Share Data)

  

December 31,

 
  

2013

  

2014

 
         

ASSETS

        

Current assets:

        

Cash and cash equivalents

 $14,550  $44,816 

Accounts receivable

  134   107 

Inventories, net

  1,828   3,760 

Other current assets

  658   930 

Total current assets

  17,170   49,613 

Property and equipment, net

  265   476 

Goodwill

  1,764   1,764 

Restricted cash

  328   315 

Other assets

  300   372 

Total assets

 $19,827  $52,540 
         

LIABILITIES AND STOCKHOLDERS’ EQUITY

        
         

Current liabilities:

        

Accounts payable

 $3,058  $2,232 

Income taxes payable

  25   268 

Accrued distributor commissions

  3,962   8,853 

Other accrued expenses

  3,146   6,743 

Deferred revenue

  2,569   2,687 

Deferred tax liability

  108   65 

Amounts held in distributor eWallets

     2,064 

Other current liabilities

  882   1,513 

Total current liabilities

  13,750   24,425 
Long-term incentive     1,665 
Total liabilities  13,750   26,090 

Commitments and contingencies

        

Stockholders’ equity:

        

Preferred stock, $0.001 par value; 5,000,000 shares authorized; 1,761,900 shares designated Series A convertible preferred stock at December 31, 2013, 123,693 shares issued and outstanding at December 31, 2013

  111    

Common stock, $0.001 par value; 50,000,000 shares authorized; 11,359,769 and 12,891,317 shares issued at December 31, 2013 and 2014, respectively

  11   13 

Additional paid-in capital

  80,690   85,750 

Accumulated deficit

  (74,619)  (54,799)

Accumulated other comprehensive income (loss):

        

Foreign currency translation adjustments

  (81)  62 

Treasury stock, at cost; 26,998 and 384,220 shares at December 31, 2013 and 2014, respectively

  (35)  (4,576)

Total stockholders’ equity

  6,077   26,450 

Total liabilities and stockholders’ equity

 $19,827  $52,540 

 December 31,
 2016 2015
ASSETS   
Current assets:   
Cash and cash equivalents$125,921
 $104,914
Inventories, net11,257
 10,455
Other current assets4,066
 2,343
Total current assets141,244
 117,712
Property and equipment, net1,388
 894
Goodwill1,764
 1,764
Restricted cash2,963
 3,166
Other assets692
 616
Total assets$148,051
 $124,152
LIABILITIES AND STOCKHOLDERS’ EQUITY   
Current liabilities:   
Accounts payable$2,145
 $2,862
Income taxes payable663
 379
Accrued commissions13,611
 19,634
Other accrued expenses14,989
 16,703
Deferred revenue4,948
 4,011
Amounts held in eWallets19,165
 16,414
Other current liabilities1,633
 1,510
Total current liabilities57,154
 61,513
Deferred tax liability268
 60
Long-term incentive8,190
 5,770
Total liabilities65,612
 67,343
Commitments and contingencies

 

Stockholders’ equity:   
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding at December 31, 2016 and 2015
 
Common stock, $0.001 par value; 50,000,000 shares authorized; 12,979,414 shares issued at December 31, 2016 and 201513
 13
Additional paid-in capital86,574
 85,963
Retained earnings (accumulated deficit)38,548
 (9,647)
Accumulated other comprehensive loss(807) (101)
Treasury stock, at cost; 1,692,218 and 840,202 shares at December 31, 2016 and 2015, respectively(41,889) (19,419)
Total stockholders’ equity82,439
 56,809
Total liabilities and stockholders’ equity$148,051

$124,152
See accompanying notes to consolidated financial statements.


NATURAL HEALTH TRENDS CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In Thousands, Except Per Share Data)

  

Year Ended December 31,

 
  

2013

  

2014

 
         

Net sales

 $52,527  $124,590 

Cost of sales

  12,551   26,981 

Gross profit

  39,976   97,609 

Operating expenses:

        

Distributor commissions

  24,053   56,997 

Selling, general and administrative expenses (including stock-based compensation expense of $110 and $49 during 2013 and 2014, respectively)

  11,634   19,687 

Depreciation and amortization

  66   105 

Total operating expenses

  35,753   76,789 

Income from operations

  4,223   20,820 

Other expense, net

  (32)  (184)

Income before income taxes

  4,191   20,636 

Income tax provision

  102   266 

Net income

  4,089   20,370 

Preferred stock dividends

  (15)  (10)

Net income available to common stockholders

 $4,074  $20,360 
         
Income per common share:        

Basic

 $0.36  $1.67 

Diluted

 $0.36  $1.61 
         
Weighted-average number of common shares outstanding:        

Basic

  11,154   12,131 

Diluted

  11,331   12,600 

 Year Ended December 31,
 2016 2015 2014
Net sales$287,728
 $264,860
 $124,590
Cost of sales54,903
 54,098
 26,981
Gross profit232,825

210,762
 97,609
Operating expenses:     
Commissions expense125,050
 126,598
 56,997
Selling, general and administrative expenses43,245
 36,024
 19,687
Depreciation and amortization394
 263
 105
Total operating expenses168,689
 162,885
 76,789
Income from operations64,136
 47,877
 20,820
Other expense, net(59) (84) (184)
Income before income taxes64,077
 47,793
 20,636
Income tax provision8,991
 552
 266
Net income55,086

47,241
 20,370
Preferred stock dividends
 
 (10)
Net income available to common stockholders$55,086
 $47,241
 $20,360
Income per common share:     
Basic$4.84
 $3.84
 $1.67
Diluted$4.83
 $3.82
 $1.61
Weighted-average number of common shares outstanding:     
Basic11,382
 12,302
 12,131
Diluted11,407
 12,372
 12,600
Cash dividends declared per common share$0.61
 $0.14
 $0.03
See accompanying notes to consolidated financial statements.



NATURAL HEALTH TRENDS CORP.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In Thousands)

  

Year Ended December 31,

 
  

2013

  

2014

 
         

Net income

 $4,089  $20,370 

Other comprehensive income, net of tax:

        

Foreign currency translation adjustments

  21   143 

Comprehensive income

 $4,110  $20,513 

 Year Ended December 31,
 2016 2015 2014
Net income$55,086
 $47,241
 $20,370
Other comprehensive income (loss), net of tax:     
Foreign currency translation adjustments(838) (79) 143
Release of cumulative translation adjustment132
 (82) 
Net change in foreign currency translation adjustment(706) (161) 143
Unrealized losses on available-for-sale securities
 (2) 
Comprehensive income$54,380
 $47,078
 $20,513
See accompanying notes to consolidated financial statements.



NATURAL HEALTH TRENDS CORP.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In Thousands, Except Share Data)

                          Accumulated             
                  Additional      Other             
  Preferred Stock  Common Stock  Paid-In  Accumulated  Comprehensive  Treasury Stock     
  

Shares

  

Amount

  

Shares

  

Amount

  Capital  Deficit  Loss  

Shares

  

Amount

  

Total

 
                                         

BALANCE, December 31, 2012

  138,400  $124   11,345,062  $11  $80,591  $(78,708) $(102)  (21,014) $(7) $1,909 

Net income

                 4,089            4,089 

Conversion of Series A preferred stock

  (14,707)  (13)  14,707      13                

Repurchase of common stock

                       (32,660)  (52)  (52)

Shares issued for stock-based compensation awards

              (24)        26,676   24    

Foreign currency translation adjustments

                    21         21 

Stock-based compensation

              110               110 

BALANCE, December 31, 2013

  123,693   111   11,359,769   11   80,690   (74,619)  (81)  (26,998)  (35)  6,077 

Net income

                 20,370            20,370 

Conversion of Series A preferred stock

  (123,693)  (111)  123,693      111                

Exercise of warrants

        1,407,855   2   4,946               4,948 

Repurchase of common stock

                       (382,564)  (4,661)  (4,661)

Shares issued for stock-based compensation awards

              (46)  (74)     25,342   120    

Dividends declared

                 (476)           (476)

Foreign currency translation adjustments

                    143         143 

Stock-based compensation

              49               49 

BALANCE, December 31, 2014

    $   12,891,317  $13  $85,750  $(54,799) $62   (384,220) $(4,576) $26,450 

 Preferred Stock Common Stock 
Additional
Paid-In
Capital
 
Retained Earnings
(Accumulated Deficit)
 
Accumulated
Other
Comprehensive
(Loss) Income
 Treasury Stock  
 Shares Amount Shares Amount    Shares Amount Total
BALANCE, December 31, 2013123,693
 $111
 11,359,769
 $11
 $80,690
 $(74,619) $(81) (26,998) $(35) $6,077
Net income
 
 
 
 
 20,370
 
 
 
 20,370
Conversion of Series A preferred stock(123,693) 
(111
) 123,693
 
 111
 
 
 
 
 
Exercise of warrants
 
 1,407,855
 2
 4,946
 
 
 
 
 4,948
Repurchase of common stock
 
 
 
 
 
 
 (382,564) (4,661) (4,661)
Common stock issued
 
 
 
 (46) (74) 
 25,342
 120
 
Dividends declared
 
 
 
 
 (476) 
 
 
 (476)
Foreign currency translation adjustments
 
 
 
 
 
 143
 
 
 143
Stock-based compensation
 
 
 
 49
 
 
 
 
 49
BALANCE, December 31, 2014
 
 12,891,317
 13
 85,750
 (54,799) 62
 (384,220) (4,576) 26,450
Net income
 
 
 
 
 47,241
 
 
 
 47,241
Exercise of warrants
 
 88,097
 
 309
 
 
 
 
 309
Repurchase of common stock
 
 
 
 
 
 
 (547,042) (16,071) (16,071)
Common stock issued
 
 
 
 (182) (380) 
 91,060
 1,228
 666
Dividends declared
 
 
 
 
 (1,709) 
 
 
 (1,709)
Elimination of CTA upon dissolution
 
 
 
 
 
 (82) 
 
 (82)
Foreign currency translation adjustments
 
 
 
 
 
 (79) 
 
 (79)
Unrealized loss on available-for-sale securities
 
 
 
 
 
 (2) 
 
 (2)
Stock-based compensation
 
 
 
 86
 
 
 
 
 86
BALANCE, December 31, 2015
 
 12,979,414
 13
 85,963
 (9,647) (101) (840,202) (19,419) 56,809
Net income
 
 
 
 
 55,086
 
 
 
 55,086
Repurchase of common stock
 
 
 
 
 
 
 (903,031) (23,704) (23,704)
Common stock issued
 
 
 
 507
 
 
 51,015
 1,234
 1,741
Dividends declared
 
 
 
 
 (6,891) 
 
 
 (6,891)
Elimination of CTA upon dissolution
 
 
 
 
 
 132
 
 
 132
Foreign currency translation adjustments
 
 
 
 
 
 (838) 
 
 (838)
Stock-based compensation
 
 
 
 104
 
 
 
 
 104
BALANCE, December 31, 2016
 $
 12,979,414
 $13
 $86,574
 $38,548
 $(807) (1,692,218) $(41,889) $82,439
See accompanying notes to consolidated financial statements. 


NATURAL HEALTH TRENDS CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Thousands)

  

Year Ended December 31,

 
  

2013

  

2014

 
         

CASH FLOWS FROM OPERATING ACTIVITIES:

        

Net income

 $4,089  $20,370 

Adjustments to reconcile net income to net cash provided by operating activities:

        

Depreciation and amortization

  66   105 

Stock-based compensation

  110   49 

Deferred income taxes

  16   (43)

Changes in assets and liabilities:

        

Accounts receivable

  (17)   

Inventories, net

  (974)  (2,029)

Other current assets

  (35)  (501)

Other assets

  (38)  (85)

Accounts payable

  1,673   (822)

Income taxes payable

  16   243 

Accrued distributor commissions

  2,679   5,077 

Other accrued expenses

  1,467   3,706 

Deferred revenue

  1,738   147 

Amounts held in distributor eWallets

     2,065 

Other current liabilities

  (104)  666 
Long-term incentive     1,665 

Net cash provided by operating activities

  10,686   30,613 
         

CASH FLOWS FROM INVESTING ACTIVITIES:

        

Purchases of property and equipment

  (210)  (339)

Increase in restricted cash

  (82)   

Net cash used in investing activities

  (292)  (339)
         

CASH FLOWS FROM FINANCING ACTIVITIES:

        

Proceeds from exercise of warrants

     4,948 

Repurchase of common stock

  (52)  (4,661)

Dividends paid

     (476)

Net cash used in financing activities

  (52)  (189)
         

Effect of exchange rates on cash and cash equivalents

  1   181 

Net increase in cash and cash equivalents

  10,343   30,266 

CASH AND CASH EQUIVALENTS, beginning of period

  4,207   14,550 

CASH AND CASH EQUIVALENTS, end of period

 $14,550  $44,816 

 Year Ended December 31,
 2016 2015 2014
CASH FLOWS FROM OPERATING ACTIVITIES:     
Net income$55,086
 $47,241
 $20,370
Adjustments to reconcile net income to net cash provided by operating activities:     
Depreciation and amortization394
 263
 105
Stock-based compensation104
 86
 49
Cumulative translation adjustment realized in net income132
 (82) 
Deferred income taxes217
 (15) (43)
Changes in assets and liabilities:     
Inventories, net(851) (6,762) (2,029)
Other current assets(1,681) (1,025) (501)
Other assets(90) (267) (85)
Accounts payable(714) 637
 (822)
Income taxes payable303
 (115) 243
Accrued commissions(6,031) 10,840
 5,077
Other accrued expenses51
 10,714
 3,706
Deferred revenue947
 1,331
 147
Amounts held in eWallets2,752
 14,350
 2,065
Other current liabilities135
 25
 666
Long-term incentive2,420
 4,105
 1,665
Net cash provided by operating activities53,174
 81,326
 30,613
CASH FLOWS FROM INVESTING ACTIVITIES:     
Purchases of property and equipment(905) (710) (339)
Increase in restricted cash
 (3,028) 
Net cash used in investing activities(905) (3,738) (339)
CASH FLOWS FROM FINANCING ACTIVITIES:     
Proceeds from exercise of warrants
 309
 4,948
Repurchase of common stock(23,704) (16,071) (4,661)
Dividends paid(6,891) (1,709) (476)
Net cash used in financing activities(30,595) (17,471) (189)
Effect of exchange rates on cash and cash equivalents(667) (19) 181
Net increase in cash and cash equivalents21,007

60,098
 30,266
CASH AND CASH EQUIVALENTS, beginning of period104,914
 44,816
 14,550
CASH AND CASH EQUIVALENTS, end of period$125,921
 $104,914
 $44,816
See accompanying notes to consolidated financial statements.



NATURAL HEALTH TRENDS CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1.     NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

Natural Health Trends Corp. (the “Company”), a Delaware corporation (whether or not including its subsidiaries, the “Company”), is an international direct-selling and e-commerce company headquartered in Dallas, Texas.company. Subsidiaries controlled by the Company sell personal care, wellness, and “quality of life” products under the “NHT Global” brand. In most markets, we sell our products to an independent member network that either uses the products themselves or resells them to consumers.

Our

The Company’s wholly-owned subsidiaries have an active physical presence in the following markets: North America; Greater China, which consists of Hong Kong, Taiwan and China; South Korea; Singapore; Malaysia; Japan; and Europe, which consists of ItalyEurope. The Company also operates in Russia and Slovenia. We also operate within certain Commonwealth of Independent States (Russia, Kazakhstan and Ukraine) through ourits engagement with a local service provider.


 In September 2015, the Company relocated its corporate headquarters from Dallas, Texas to Rolling Hills Estates, California.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and all of its wholly-owned subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reported period.


The most significant accounting estimates inherent in the preparation of the Company’s financial statements include estimates associated with obsolete inventory and the fair value of acquired intangible assets, including goodwill, revenue recognition, as well as those used in the determination of liabilities related to sales returns, distributor commissions and income taxes. Various assumptions and other factors prompt the determination of these significant estimates. The process of determining significant estimates is fact specific and takes into account historical experience and current and expected economic conditions. The actual results may differ materially and adversely from the Company’s estimates. To the extent that there are material differences between the estimates and actual results, future results of operations will be affected.

Reclassification

Certain equityaccounts receivable balances have been reclassified in the prior year consolidated financial statements to conform to current year presentation of treasury stock.presentation. No change in total stockholders’ equitycurrent assets occurred.

Additionally, deferred tax liability balances have been reclassified from current to long-term in the prior year consolidated financial statements to conform to the early adoption of ASU No. 2015-17, Balance Sheet Classification of Deferred Taxes.


Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities

As of three months or less, when purchased,December 31, 2016, cash and cash equivalents include $6.8 million held in banks located within China subject to be cash equivalents.foreign currency controls. The Company includes credit card receivables due from certain of its credit card processors in its cash and cash equivalents as the cash proceeds are received within two to five days.



Additionally, as of December 31, 2016, cash and cash equivalents include the Company's investments in debt securities, comprising municipal notes, bonds and corporate debt, money market funds and time deposits. The Company considers all highly liquid investments with original maturities of three months or less, when purchased, to be cash equivalents. Debt securities classified as cash equivalents are required to be accounted for in accordance with ASC 320, Investments - Debt and Equity Securities. As such, the Company determined its investments in debt securities held at December 31, 2016 should be classified as available-for-sale and are carried at fair value with unrealized gains and losses reported in accumulated other comprehensive income in stockholders' equity. The cost of debt securities is adjusted for amortization of premiums and discounts to maturity. This amortization is included in other income. Realized gains and losses, as well as interest income, are also included in other income. The fair values of securities are based on quoted market prices.
Cash and cash equivalents at the end of each period were as follows (in thousands):
 December 31,
 2016 2015
Cash$52,453
 $47,431
Cash equivalents73,468
 57,483
Total cash and cash equivalents$125,921
 $104,914

The Company maintains certain cash balances at several institutions located in the United States, Hong Kong and Malaysia which at times may exceed insured limits.  The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk.


Restricted Cash
 

In June 2015, the Company funded a bank deposit account in the amount of CNY 20 million (USD 2.9 million at December 31, 2016) in anticipation of submitting a direct selling license application in China. Such deposit is required by Chinese laws to establish a consumer protection fund.

Restricted Cash

The Company periodically maintains a cash reserve with certain credit card processing companies to provide for potential uncollectible amounts and chargebacks. Those cash reserves held by credit card processing companies located in South Korea are reflected in noncurrent assets since they require the Company to provide 100% collateral before processing transactions, which must be maintained indefinitely.

Inventories

Inventories consist primarily of finished goods and are stated at the lower of cost or market, using the first-in, first-out method. The Company reviews its inventory for obsolescence and any inventory identified as obsolete is reserved or written off. The Company’s determination of obsolescence is based on assumptions about the demand for its products, product expiration dates, estimated future sales, and management’s future plans. At December 31, 2014,2016 and 2015, the reserve for obsolescence totaled $18,000. No such reserve existed at December 31, 2013.

$82,000, and $29,000, respectively.

Property and Equipment

Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, generally three to five years for office equipment and office software and five to seven years for furniture and fixtures. Leasehold improvements are amortized over the shorter of the lease term or the estimated useful life of the assets. Expenditures for maintenance and repairs are charged to expense as incurred.

The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Recoverability of these assets is measured by comparison of its carrying amounts to future undiscounted cash flows the assets are expected to generate. If property and equipment are considered to be impaired, the impairment to be recognized equals the amount by which the carrying value of the asset exceeds its fair value.


Goodwill

The Company assesses qualitative factors in order to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, through this qualitative assessment, the conclusion is made that it is more likely than not that a reporting unit’s fair value is less than its carrying amount, a two-step impairment test is performed. The Company’s policy is to test for impairment annually during the fourth quarter. Considerable management judgment is necessary to measure fair value. WeThe Company did not recognize any impairment charges for goodwill during the periods presented.

Income Taxes

The Company recognizes income taxes under the liability method of accounting for income taxes. Deferred income taxes are recognized for differences between the financial reporting and tax bases of assets and liabilities at enacted statutory tax rates in effect for the years in which the temporary differences are expected to reverse.be recovered or settled. Deferred tax expense or benefit is a result of changes in deferred tax assets and liabilities. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized.realized based on the more likely than not recognition criteria. The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The Company has evaluated its tax positions and determined that there are no uncertain tax positions for the current year or years prior. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution.  The Company recognizes interest and penalties related to unrecognized tax benefits as a component of income tax expense.  Deferred taxes are not provided on the portion of undistributed earnings of subsidiaries outside of the United States when these earnings are considered permanently reinvested.

The Company and its subsidiaries file income tax returns in the United States, various states, and foreign jurisdictions. The Company is no longer subject to U.S. federal income tax examinations for years prior to 2011, and is no longer subject to state income tax examinations for years prior to 2010. No jurisdictions are currently examining any income tax returns of the Company or its subsidiaries.


Amounts Held in Distributor eWallets

Commencing in October 2014, the Company requires commission payments of certain distributorsmembers in Hong Kong to be first deposited into an electronic wallet (eWallet) account in lieu of being paid out directly to distributors.members. The eWallet functionality allows distributorsmembers to place new product orders utilizing eWallet available funds and/or request commission payout via multiple payment methods. Amounts held in eWallets are reflected on the balance sheet as a current liability.


Long-Term Incentive
 

Long-Term Incentive

Financial rewards earned under the 2014 Long-Term Incentive Plan (the “LTI Plan”) are recognized over the performance period as specified performance or other goals are achieved or exceeded. In accordance with the LTI Plan, fifty percent of any cash payment earned is payable in cash in thirty-five equal consecutive monthly installments commencing in February of the calendar year immediately following the conclusion of the performance period and the remaining fifty percent of the payment earned is payable in cash in thirty-five equal consecutive monthly installments commencing in February 2021 and ending in December 2023. As such, certain installments to be paid are reflected on the balance sheet as a non-current liability, and the current portion of the installments is reflected in other accrued expenses.


At the sole discretion of the Compensation Committee of the Company’s Board of Directors, distributions under the LTI Plan are made in cash, or alternatively awarded in the form of common stock or other common stock rights having an equivalent cash value under the terms of the Natural Health Trends Corp. 2016 Equity Incentive Plan. A determination of the form of distribution, if any, is made by the Compensation Committee subsequent to the end of each calendar year. As such, amounts earned are considered non-equity awards. See Note 5 for grant information of distributions settled in common stock.
Foreign Currency

The functional currency of the Company’s international subsidiaries is generally their local currency. Local currency assets and liabilities are translated at the rates of exchange on the balance sheet date, and local currency revenues and expenses are translated at average rates of exchange during the period. Equity accounts are translated at historical rates.  The resulting translation adjustments are recorded directly into a separate component of stockholders’ equity and represents the only component of accumulated other comprehensive income.

Aggregate transaction gains or losses, including gains or losses related to foreign-denominated cash and cash equivalents and the re-measurement of certain inter-company balances, are included in the statement of operations as other income and expense. Loss on foreign exchange totaling $32,000$333,000, $204,000 and $202,000 was recognized during 20132016, 2015 and 2014, respectively.


Revenue Recognition

Product sales are recorded when the products are shipped and title passes to independent distributors.members. Product sales to distributorsmembers are made pursuant to a distributormember agreement that provides for transfer of both title and risk of loss upon ourthe Company’s delivery to the carrier that completes delivery to the distributors,members, which is commonly referred to as “F.O.B. Shipping Point.” The Company primarily receives payment by credit card at the time distributorsmembers place orders. Amounts received for unshipped product are recorded as deferred revenue. The Company’s sales arrangements do not contain right of inspection or customer acceptance provisions other than general rights of return.

Actual product returns are recorded as a reduction to net sales. The Company estimates and accrues a reserve for product returns based on its return policies and historical experience.

Enrollment package revenue, including any nonrefundable set-up fees, is deferred and recognized over the term of the arrangement, generally twelve months. Enrollment packages provide distributorsmembers access to both a personalized marketing website and a business management system. No upfront costs are deferred as theamountthe amount is nominal.

Shipping charges billed to distributorsmembers are included in net sales. Costs associated with shipments are included in cost of sales.

Event and training revenue is deferred and recognized as the event or training occurs. Costs of events and member training are included within selling, general and administrative expenses.

Various taxes on the sale of products and enrollment packages to distributorsmembers are collected by the Company as an agent and remitted to the respective taxing authority. These taxes are presented on a net basis and recorded as a liability until remitted to the respective taxing authority.

Distributor

Commissions

Independent distributorsmembers earn commissions based on total personal and group bonus volume points per weekly sales period.  Each of ourthe Company’s products are designated a specified number of bonus volume points, which is essentially a percentage of the product’s wholesale price.  The Company accrues commissions when earned and pays commissions on product sales generally two weeks following the end of the weekly sales period.

In some markets, wethe Company also paypays certain bonuses on purchases by up to three generations of personally sponsored distributors,enrolled members, as well as bonuses on commissions earned by up to three generations of personally sponsored distributors.enrolled members. Independent distributorsmembers may also earn incentives based on meeting certain qualifications during a designated incentive period, which may range from several weeks to up to a year.  These incentives may be both monetary and non-monetary in nature.  The Company estimates and accrues all costs associated with the incentives as the distributorsmembers meet the qualification requirements.

From time to time we makethe Company makes modifications and enhancements to ourthe Company’s compensation plan to help motivate distributors,members, which can have an impact on distributormember commissions. From time to time wethe Company also enterenters into agreements for business or market development, which may result in additional compensation to specific distributors.

members.

Operating Leases

The Company leases its physical properties under operating leases. Certain lease agreements include rent holidays. The Company recognizes rent holiday periods on a straight-line basis over the lease term beginning when the Company has the right to the leased space.

Stock-Based Compensation
 

Stock-Based Compensation

Stock-based compensation expense is determined based on the grant date fair value of each award, net of estimated forfeitures which are derived from historical experience, and is recognized on a straight-line basis over the requisite service period for the award.


Income Per Share

Basic income per share isfor 2014 was computed via the “two-class” method by dividing net income allocated to common stockholders by the weighted-average number of common shares outstanding during the period. Net income available to common stockholders is allocated to both common stock and participating securities as if all of the income for the period had been distributed. The Company’s Series A convertible preferred stock was a participating security due to its participation rights related to dividends declared by the Company. If dividends were distributed to common stockholders, the Company was also required to pay dividends to the holders of the preferred stock in an amount equal to the greater of (1) the amount of dividends then accrued and not previously paid on such shares of preferred stock or (2) the amount payable if dividends were distributed to the common stockholders on an as-converted basis.

Diluted income per share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. The dilutive effect of non-vested restricted stock and warrants is reflected by application of the treasury stock method. Under the treasury stock method, the amount of compensation cost for future service that the Company has not yet recognized and the amount of tax benefit that would be recorded in additional paid-in capital when the award becomes deductible are assumed to be used to repurchase shares. TheFor 2014, the dilutive effect of the Company’s Series A convertible preferred stock was calculated using the more dilutive of the “two-class” method and the “if-converted” method, which assumes that the preferred stock was converted into common stock at the beginning of each period presented.


 All shares of the Company’s Series A convertible preferred stock were converted into shares of common stock in December 2014. Warrants to purchase 88,097 shares of common stock were still outstanding at December 31, 2014. Such warrants were exercised during April 2015.

The following table illustrates the computation of basic and diluted income per share for the periods indicated (in thousands, except per share data):

 

Year Ended December 31,

 Year Ended December 31,
 

2013

  

2014

 2016 2015 2014
 

Income

(Numerator)

  

Shares

(Denominator)

  

Per Share Amount

  

Income

(Numerator)

  

Shares

(Denominator)

  

Per Share Amount

 Income Shares Per Share Income Shares Per Share Income Shares Per Share

Basic EPS:

                                         

Net income available to common stockholders

 $4,074          $20,360         $55,086
  
  
 $47,241
  
  
 $20,360
  
  

Less: undistributed earnings to participating securities

  (31)          (127)        
  
  
 
  
  
 (127)  
  

Net income allocated to common stockholders

 $4,043   11,154  $0.36  $20,233   12,131  $1.67 $55,086

11,382
 $4.84
 $47,241
 12,302
 $3.84
 $20,233
 12,131
 $1.67
                        

Effect of dilutive securities:

                                         

Warrants to purchase common stock

               421     
 
  
 
 21
  
 
 421
  

Non-vested restricted stock

     177          48     
 25
  
 
 49
  
 
 48
  

Plus: reallocation of undistributed earnings to participating securities

             5         
  
  
 
  
  
 5
  
  
                        

Diluted EPS:

                                         

Net income allocated to common stockholders plus assumed conversions

 $4,043   11,331  $0.36  $20,238   12,600  $1.61 $55,086
 11,407
 $4.83
 $47,241
 12,372
 $3.82
 $20,238
 12,600
 $1.61

Warrants

Certain non-vested restricted stock is anti-dilutive upon applying the treasury stock method since the amount of compensation cost for future service results in the hypothetical repurchase of shares exceeding the actual number of shares to purchase 2,234,994be vested. For the year ended December 31, 2016, 345 shares of commonnon-vested restricted stock were not included in the computation of diluted income per share for 2013 as their effect is anti-dilutive since the applicable exercise price exceeds the average market price of the related common stock for the period.  Warrants to purchase 88,097 shares of common stock were still outstanding at December 31, 2014. Such warrants expire April 21, 2015.

would have been anti-dilutive.



Certain Risks and Concentrations

A substantial portion of the Company’s sales are generated in Hong Kong (see Note 10). MostSubstantially all of the Company’s Hong Kong revenues are derived from the sale of products that are delivered to members in China. In contrast to the Company’s operations in other parts of the world, the Company has not implemented a direct sales model in China. The Chinese government permits direct selling only by organizations that have a license, thatwhich the Company does not have,has applied for, and has also adopted anti-multilevel marketing legislation. The Company operates an e-commerce direct selling model in Hong Kong and recognizes the revenue derived from sales to both Hong Kong and Chinese members as being generated in Hong Kong. Products purchased by members in China are delivered by the Company to one or more third parties that act as the importers of record under agreements to pay applicable duties. In addition, through a Chinese entity, the Company sells products in China using an e-commerce retail model. The Chinese entity operates separately from the Hong Kong entity, althoughand a Chinese member may elect to participate separately or in both.



The Company believes that theits e-commerce direct selling model in Hong Kong does not violate any applicable laws and regulations in China, regarding direct selling and multi-level marketing are not specifically applicable toeven though it is used for the Company’s Hong Kong basedinternet purchase of the Company's products by members in China. The Company also believes that its Chinese entity, including its e-commerce activity, and that the Company’s Chinese entityretail platform, is operating in compliance with applicable Chinese laws. However, there can be no assurance that the Chinese authorities will agree with the Company’s interpretations of applicable laws and regulations or that China will not adopt new laws or regulations. Should the Chinese government determine that the Company’s e-commerce activity violatesactivities violate China’s direct selling or anti-multilevel marketing legislation, or should new laws or regulations be adopted, there could be a material adverse effect on the Company’s business, financial condition and results of operations.

Although the Company attempts to work closely with both national and local Chinese governmental agencies in conducting the Company’sits business, the Company’s efforts to comply with national and local laws may be harmed by a rapidly evolving regulatory climate, concerns about activities resembling violations of direct selling or anti-multi-level marketing legislation, subjective interpretations of laws and regulations, Chinese nationals collaborating with short traders to damage the Company's business and activities by individual distributorsmembers that may violate laws notwithstanding the Company’s strict policies prohibiting such activities. Any determination that the Company’s operations or activities, or the activities of the Company’sits individual distributorsmembers or employee sales representatives, or importers of record are not in compliance with applicable laws and regulations could result in the imposition of substantial fines, extended interruptions of business, restrictions on the Company’s future ability to obtain business licenses or expand into new locations, changes to the Company’sits business model, the termination of required licenses to conduct business, or other actions, any of which could materially harm the Company’s business, financial condition and results of operations.

The Company’sPremium Noni Juice product accounts and Enhanced Essential Probiotics®products each account for a significant portionmore than 10% of the Company’s total revenue. The Company currently sources iteach such product from a single supplier. If demand decreases significantly, government regulation restricts itstheir sale, the Company is unable to adequately source or deliver the product,products, or the Company ceases offering the productproducts for any reason without a suitable replacement,replacements, the Company’s business, financial condition and results of operations could be materially and adversely affected.

Fair


Sales are made to the Company’s members and no single customer accounted for 10% or more of its net sales. However, the Company’s business model can result in a concentration of sales to several different members and their network of members. Although no single member accounted for 10% or more of net sales, the loss of a key member or that member’s network could have an adverse effect on the Company’s net sales and financial results.
Fair Value of Financial Instruments

The carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximate fair value because of their short maturities. The carrying amount of the noncurrent restricted cash approximates fair value since, absent the restrictions, the underlying assets would be included in cash and cash equivalents.

The Company’s cash equivalents are valued based on level 1 inputs which consist of quoted prices in active markets.

Accounting standards permit companies, at their option, to choose to measure many financial instruments and certain other items at fair value.  The Company has elected to not fair value existing eligible items.



Available-for-sale investments included in cash equivalents at the end of each period were as follows (in thousands):
 December 31, 2016 December 31, 2015
 Adjusted Cost Gross Unrealized Gains/Losses Fair Value Adjusted Cost Gross Unrealized Gains/Losses Fair Value
Municipal bonds and notes$43,490
 $
 $43,490
 $35,222
 $2
 $35,224
Corporate debt securities1,673
 (2) 1,671
 5,029
 (5) 5,024
Financial institution instruments28,307
 
 28,307
 17,235
 
 17,235
Total available-for-sale investments$73,470
 $(2) $73,468
 $57,486
 $(3) $57,483

Financial institution instruments include instruments issued or managed by financial institutions such as money market fund deposits and time deposits.

Recently Issued and Adopted Accounting Pronouncements


In March 2013,November 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2013-05, Foreign Currency Matters (Topic 830) —Parent’s2016-18, Statement of Cash Flows - Restricted Cash, that requires amounts generally described as restricted cash or restricted cash equivalents be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The new standard will be effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years, and early adoption is permitted. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements.

In March 2016, the FASB issued ASU No. 2016-09, Compensation - Stock Compensation: Improvements to Employee Share-Based Payment Accounting, that simplifies several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. The new standard will be effective for fiscal years beginning after December 15, 2016, including interim periods within those annual years, and early adoption is permitted. The Company is currently assessing the impact that this standard will have on its consolidated financial statements.

In February 2016, the FASB issued ASU No. 2016-02, Leases, that requires organizations that lease assets, referred to as “lessees”, to recognize on the balance sheet the assets and liabilities for the Cumulative Translation Adjustment upon Derecognitionrights and obligations created by those leases with lease terms of Certain Subsidiaries or Groupsmore than 12 months. ASU 2016-02 will also require disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of Assetscash flows arising from leases and will include qualitative and quantitative requirements. The new standard will be effective for fiscal years beginning after December 15, 2018, including interim periods within a Foreign Entity orthose annual years, and early application is permitted. The Company is currently assessing the impact that this standard will have on its consolidated financial statements.
In November 2015, the FASB issued ASU No. 2015-17, Balance Sheet Classification of an InvestmentDeferred Taxes. Under this guidance, entities are required to present deferred tax tax assets and deferred tax liabilities as noncurrent in a Foreign Entity, to clarify theclassified balance sheet. This guidance is effective for entities that cease to hold a controlling financial interest in a subsidiary or group of assets within a foreign entity when (1) the subsidiary or group of assets is a nonprofit activity or a business (other than a sale of in substance real estate or conveyance of oilannual and gas mineral rights) and (2) there is a cumulative translation adjustment balance associated with that foreign entity.  ASU 2013-05 was effective prospectively for reporting periods, including interim periods beginning after December 15, 2013.2016, with early adoption permitted. Entities are permitted to adopt this guidance either prospectively or retrospectively. The Company’s adoptionCompany elected to early adopt this guidance prospectively as of the standard on January 1, 2014 did not have a material impact on its consolidated financial statements.

quarter ended December 31, 2016.


In July 2013,2015, the FASB issued ASU No. 2013-11, Income Taxes (Topic 740) — Presentation2015-11, Inventory: Simplifying the Measurement of an Unrecognized Tax Benefit When AInventory. Under this guidance, inventory not measured using either the last in, first out (LIFO) or the retail inventory method to be measured at the lower of cost and net realizable value.  Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists, to provide explicit guidance onrealizable value is the financial statement presentationestimated selling price in the ordinary course of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists.business, less reasonably predictable cost of completion, disposal, and transportation.  The amendments in this update werenew standard will be effective for fiscal years, and interim periods within those years beginning after December 15, 20132016, including interim periods within those fiscal years, and shouldwill be applied prospectively to all tax benefits that exist at the effective date. Retrospective application wasprospectively.  Early adoption is permitted. The Company’s adoption of the standard on January 1, 2014 didthis guidance is not expected to have a material impacteffect on itsthe Company’s consolidated financial statements.



In May 2014, the FASB issued ASU No. 2014-09, Revenue From Contracts With Customers, that outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. ASU 2014-09 is based on the principle that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.  It also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to fulfill a contract.  Entities have the option of using either a full retrospective or a modified retrospective approach for the adoption of the new standard.  ASU 2014-09 becomesIn July 2015, the FASB approved the deferral of the effective date for annual reporting periods including interim periods, beginningthat begin after December 15, 2016.2017, including interim reporting periods. Early adoption is not permitted.permitted to the original effective date of December 15, 2016, including interim reporting periods. The companyCompany is currently assessing the impact that this standard will have on its consolidated financial statements.


Other recently issued accounting pronouncements did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

2.     BALANCE SHEET COMPONENTS

The components of certain balance sheet amounts are as follows (in thousands):

  

December 31,

 
  

2013

  

2014

 
         

Property and equipment:

        

Office equipment

 $354  $391 

Office software

  533   537 

Furniture and fixtures

  62   59 
Leasehold improvements  256   345 

Construction in progress

  102   75 

Property and equipment, at cost

  1,307   1,407 

Accumulated depreciation and amortization

  (1,042)  (931)
  $265  $476 
         

Other accrued expenses:

        

Sales returns

 $504  $654 

Employee-related expense

  1,860   4,620 

Warehousing and inventory-related expense

  595   987 

Other

  187   482 
  $3,146  $6,743 
December 31,
2016 2015
Property and equipment:   
Office equipment$517
 $495
Office software672
 536
Machinery28
 24
Furniture and fixtures241
 222
Leasehold improvements840
 730
Construction in progress (including internal use software development costs)157
 10
Property and equipment, at cost2,455
 2,017
Accumulated depreciation and amortization(1,067) (1,123)
$1,388
 $894
Other accrued expenses:   
Sales returns$1,632
 $1,552
Employee-related expense10,541
 11,064
Warehousing, inventory-related and other2,816
 4,087
$14,989
 $16,703

Deferred revenue:

         
  

Unshipped product

 $1,938  $1,150 $2,191
 $1,783

Auto ship advances

  449   815 2,327
 1,597

Enrollment package revenue

  182   222 430
 331

Market development fees

     500 
 300
 $2,569  $2,687 $4,948
 $4,011

Other current liabilities:

        

Unclaimed checks

 $674  $1,266 

Other

  208   247 
 $882  $1,513 




3.     COMMITMENTS AND CONTINGENCIES

Operating Leases

The Company has entered into non-cancelable operating lease agreements for locations within the United States and for its international subsidiaries, with expirations through March 2018.September 2025. Rent expense in connection with operating leases was $787,000$1.8 million, $1.5 million and $777,000 during 20132016, 2015 and 2014, respectively.


Future minimum lease obligations as of December 31, 20142016 are as follows (in thousands):

2015

 $466 
2016  178 
2017  71 $1,559
2018  18 752
2019   402
2020314
2021196
Thereafter700

Total minimum lease obligations

 $733 $3,923



Purchase Commitments


In May 2013, the Company entered into an exclusive distribution agreement with one of its suppliers to purchase its product through July 2016.2016 which automatically renews annually unless terminated 90 days prior to the termination date. To maintain exclusivity, the Company is required to purchase a minimum of $40,000 of product per month until the termination date. As of December 31, 2014,2016, the Company was in compliance with the exclusivity provision.

In December 2014,February 2016, the Company amended a supply agreement with one of its suppliers to obtainmaintain worldwide exclusivity in return for purchasing a minimum of $3.3$9.4 million of product annually.annually on average over the next three years, plus certain raw material guarantees. If the Company does not purchase the minimum product as required, then a Cure Payment, as defined, will be due to the supplier. The term of the agreement is three years commencing on January 1, 2015February 2016 and shall automatically renew for successive three year terms unless notice of termination is provided by either party.


Employment Agreements

The Company has employment agreements with certain members of its management team that can be terminated by either the employee or the Company upon four weeks’ notice.  The employment agreements entered into with the management team contain provisions that guarantee the payments of specified amounts in the event of a change in control, as defined, or if the employee is terminated without cause, as defined, or terminates employment for good reason, as defined. In addition, the Company has an employment agreement with another employee that can be terminated at will by either the employee or the Company, provided that the Company must pay a specified amount if it terminates the agreement without cause, as defined, or the employee terminates the agreement with good reason, as defined. Accrued severance totaling $12,000 as of December 31, 2014 was paid in January 2015.

Consumer Indemnity

As required by the Door-to-Door Sales Act in South Korea, the Company maintains insurance for consumer indemnity claims with a mutual aid cooperative by possessing a mutual aid contract with Mutual Aid Cooperative & Consumer (the “Cooperative”). The contract secures payment to distributorsmembers in the event that the Company is unable to provide refunds to distributors.members. Typically, requests for refunds are paid directly by the Company according to the Company’s normal Korean refund policy, which requires that refund requests be submitted within three months. Accordingly, the Company estimates and accrues a reserve for product returns based on this policy and its historical experience. Depending on the sales volume, the Company may be required to increase or decrease the amount of the contract. The maximum potential amount of future payments the Company could be required to make to address actual distributormember claims under the contract is equivalent to three months of rolling sales. At December 31, 2014,2016, non-current other assets include KRW 197223 million (USD $180,000)$185,000) underlying the contract, which can be utilized by the Cooperative to fund any outstanding distributormember claims. The Company believes that the likelihood of utilizing these funds to provide for distributorsmembers claims is remote.

Registration Payment Arrangements

Pursuant



Securities Class Action

In January 2016, two putative securities class action complaints were filed against the Company and its top executives. On March 29, 2016, the court consolidated these actions, appointed two Lead Plaintiffs, Messrs. Dao and Juan, and appointed the Rosen Law Firm and Levi & Korsinsky LLP as co-Lead Counsel for the purported class. Plaintiffs filed a consolidated complaint on April 29, 2016. The consolidated complaint purports to a Registration Rights Agreement withassert claims on behalf of all persons who purchased or otherwise acquired our common stock between March 6, 2015 and March 15, 2016 under (i) Section 10(b) of the investorsSecurities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder against Natural Health Trends Corp., Chris T. Sharng, and Timothy S. Davidson, and (ii) Section 20(a) of the Securities Exchange Act of 1934 against Chris T. Sharng, Timothy S. Davidson, and George K. Broady. The consolidated complaint alleges, inter alia, that the Company made materially false and misleading statements regarding the legality of its business operations in the Company’s October 2007 financing of variable rate convertible debentures havingChina, including running an aggregate faceallegedly illegal multi-level marketing business. The consolidated complaint seeks an indeterminate amount of $4,250,000, seven-year warrants to purchase 1,495,952 shares of the Company’s common stock,damages, plus interest and one-year warrants to purchase 1,495,952 shares of the Company’s common stock, the Company was obligated to (i) file a registration statement covering the resale of the maximum number of Registrable Securities (as defined) that is permitted by SEC Guidance (as defined) prior to November 18, 2007, (ii) cause the registration statement to be declared effective within certain specified periods of time and (iii) maintain the effectiveness of the registration statement until all Registrable Securities have been sold, or may be sold without volume restrictions pursuant to Rule 144(k) under the Securities Act.  The Company timely filed that registration statement covering the shares of common stock underlying the debentures, which have been redeemed, and the one-year warrants, which have expired. At the time, the 1,495,952 shares of common stock underlying the seven-year warrants were not deemed Registrable Securities and were not included in the Registration Statement. If they are subsequently deemed Registrable Securities at a time when a registration statement covering them is required to be effective under the Registration Rights Agreement, and such registration statement is not then effective, then the warrants may be exercised by means of a cashless exercise. The maximum number of shares that could be required to be issued upon exercise of the warrants (whether on a cashless basis or otherwise) is limited to the number of shares indicated on the face of the warrants.costs. The Company filed a registration statementmotion to dismiss the consolidated complaint on NovemberJune 15, 2016 and a reply in support of its motion to dismiss on August 22, 2013 covering2016. On December 5, 2016, the maximum number of sharesCourt denied the Company’s motion to dismiss. On February 17, 2017, the Company filed an answer to the consolidated complaint. The Company believes that could be requiredthese claims are without merit and intends to be issued upon exercisevigorously defend against them.

Shareholder Derivative Claims

In February 2016, a purported shareholder derivative complaint was filed in the Superior Court of the warrants,State of California, County of Los Angeles: Zhou v. Sharng. In March 2016, a purported shareholder derivative complaint was filed in the United States District Court for the Central District of California: Kleinfeldt v. Sharng (collectively the “Derivative Complaints”). The Derivative Complaints purport to assert claims for breach of fiduciary duties, unjust enrichment, abuse of control, gross mismanagement and such registration statementcorporate waste against certain of the Company’s officers and directors. The Derivative Complaints also purport to assert fiduciary duty claims based on alleged insider selling and conspiring to enter into several stock repurchase agreements, which allegedly harmed the Company and its assets. The Derivative Complaints allege, inter alia, that the Company made materially false and misleading statements regarding the legality of its business operations in China, including running an allegedly illegal multi-level marketing business, and that certain officers and directors sold common stock on the basis of this allegedly material, adverse non-public information. The Derivative Complaints seek an indeterminate amount of damages, plus interest and costs, as well as various equitable remedies. On February 1, 2017, pursuant to a stipulation among the parties, the Los Angeles Superior Court entered a stay of the Zhou action pending conclusion of the related federal class action in the United States District Court for the Central District of California: Ford v. Natural Health Trends Corp. and Li v. Natural Health Trends Corp. A nearly identical stipulated stay was declared effectiveentered in the Kleinfeldt case on December 5, 2013.February 8, 2017. The Company believes that these claims are without merit and intend to vigorously defend against them.

The consolidated class action and the Derivative Complaints, or others filed alleging similar facts, could result in monetary or other penalties that may materially affect the Company’s operating results and financial condition.

Other Claims

The Company is currently involved in a post-effective amendmentlegal matter with one of its vendors and an outside party. Per the royalty agreement with the vendor, the Company believes that it is fully indemnified in the event of an unfavorable outcome and any potential settlement costs related to that registration statement on June 9, 2014, which was declared effective on June 16, 2014. As of December 31, 2014, no contingent obligations have been recognized under registration payment arrangements.

the matter would be fully covered by the Company’s vendor.


4.     STOCKHOLDERS’ EQUITY

Authorized Shares

The Company is authorized to issue two classes of capital stock consisting of up to 5,000,000 shares of preferred stock, $0.001$0.001 par value, and 50,000,000 shares of common stock, $0.001$0.001 par value. On May 4, 2007, the Board of Directors designated up to 1,761,900 shares of preferred stock as Series A preferred stock with the following rights and preferences:


Priority – the Series A preferred stock shall rank, in all respects, including the payment of dividends and upon liquidation, senior and prior to the common stock and other equity of the Company not expressly made senior or pari passu with the Series A preferred stock (collectively, “Junior Securities”).



Dividends –dividends at the rate per annum of $0.119$0.119 per share shall accrue from the date of issuance of any shares of Series A preferred stock, payable upon declaration by the Board of Directors. Accruing dividends shall be cumulative; provided, however, that except as set forth below for the liquidation preference, the Company shall be under no obligation to pay such dividends. No dividends shall be declared on Junior Securities (other than dividends on shares of common stock payable in shares of common stock) unless the holders of the Series A preferred stock then outstanding shall first receive, or simultaneously receive, a dividend on each outstanding share of Series A preferred stock in an amount at least equal to the greater of (i) the amount of the aggregate accrued dividends on such share of Series A preferred stock and not previously paid and (ii) in the case of a dividend on common stock or any class or series of Junior Securities that is convertible into common stock, that dividend per share of Series A preferred stock as would equal the product of (1) the dividend payable on each share as if all shares of such class or series had been converted into common stock and (2) the number of shares of common stock issuable upon conversion of a share of Series A preferred stock.


Liquidation preference – in the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, then, before any distribution or payment shall be made to the holders of any Junior Securities, the holders of the Series A preferred stock then outstanding shall be entitled to be paid in cash out of the assets of the Company available for distribution to its stockholders (on a pari passu basis with the holders of any series of preferred stock ranking on liquidation on a parity with the Series A preferred stock) an amount per share equal to the sum of the Series A Original Issue Price plus any dividends accrued but unpaid thereon, whether or not declared, together with any other dividends declared but unpaid thereon. If the assets of the Company are insufficient to pay the aggregate liquidation preference and the liquidation preference of any series of preferred stock ranking on liquidation on a parity with the Series A preferred stock, the holders of the Series A preferred stock and the holders of any series of preferred stock ranking on liquidation on a parity with the Series A preferred stock shall share ratably with one another in any such distribution or payment in proportion to the full amounts to which they would otherwise be respectively entitled before any distribution shall be made to the holders of the Junior Securities. The “Series A Original Issue Price” shall mean $1.70$1.70 per share, subject to adjustment.


Voting rights – the holders of shares of Series A preferred stock shall be entitled to vote with the holders of the common stock, and with the holders of any other series of preferred stock, voting together as a single class, upon all matters submitted to a vote of stockholders of the Company. Each holder of shares of Series A preferred stock shall be entitled to the number of votes equal to the product (rounded down to the nearest number of whole shares) of 0.729 times the largest number of shares of common stock into which all shares of Series A preferred stock held of record by such holder could then be converted.



Conversion – each share of Series A preferred stock shall be convertible, subject to adjustment only in the event of stock splits, stock dividends, recapitalizations and similar events that would affect all of stockholders,, at the option of the holder thereof, at any time and from time to time, into such number of fully paid and nonassessable shares of common stock as determined by dividing the Series A Original Issue Price by the Series A Conversion Price (as defined) in effect at the time of conversion. The “Series A Conversion Price” shall initially be equal to $1.70.$1.70. Each share of Series A preferred stock shall automatically be converted into shares of common stock at the then effective conversion price immediately upon such date as the average closing price of the common stock over a consecutive, trailing 6-month period equals or exceeds $10.00$10.00 per share.


On December 3, 2014, the Company filed a Certificate of Elimination of the Series A Convertible Preferred Stock (the “Certificate”) with the Secretary of State of the State of Delaware. The Certificate, which was effective upon filing, canceled the Company’s Series A preferred stock. At the time of filing the Certificate, no shares of Series A preferred stock remained outstanding as a result of the automatic conversion of all outstanding shares into the Company’s common stock due to the fact that the average closing price of the Company’s common stock equaled or exceeded $10.00 per share over a consecutive, trailing 6-month period that ended November 18, 2014.


Common Stock Purchase Warrants

On October 19, 2007, the Company issued warrants to purchase 3,141,499 shares of common stock in connection with a convertible debentures financing. The warrants consisted of seven-year warrants to purchase 1,495,952 shares of common stock, one-year warrants to purchase 1,495,952 shares of common stock, and five-year warrants to purchase 149,595 shares of common stock. The term for each of the warrants began six months and one day after their respective issuance and each have an exercise price of $3.52 per share. The exercise price and the number of shares underlying the warrants are subject to adjustment for stock dividends and splits, combinations, and reclassifications, certain rights offerings and distributions to common stockholders, and mergers, consolidations, sales of all or substantially all assets, tender offers, exchange offers, reclassifications or compulsory share exchanges. In addition, subject to certain exceptions, the exercise price and number of shares underlying the warrants are subject to anti-dilution adjustments from time to time if the Company issues its common stock or equivalent securities at below the exercise price for the warrants. If, at any time after the earlier of October 19, 2008 and the completion of the then applicable holding period under Rule 144, there is no effective registration statement for the underlying shares of common stock that are then required to be registered, the warrants may be exercised by means of a cashless exercise. Such one-year warrants expired unexercised on April 21, 2009 and such five-year warrants expired unexercised on April 21, 2013. Seven-year warrants to purchase 1,407,855 shares of common stock were exercised during 2014 at exercise prices ranging from $3.5108 to $3.52$3.52 per share for total proceeds of $4.9 million.$4.9 million. As a result of the cash dividends declared on each share of outstanding common stock and in accordance with the terms of the related warrant agreement, the exercise price per share for each warrant was adjusted from $3.52 per share to $3.5082 per share. TheIn April 2015, the remaining warrants to purchase 88,097 shares of common stock expire April 21, 2015 if not previously exercised.

were exercised at $3.5043 per share for total proceeds of $309,000.

Dividends

The following table summarizestables summarize the Company’s cash dividend activity during 2016, 2015 and 2014 (in thousands, except per share data):

  

Dividends Per Share

      

Declaration Date

 

Preferred

  

Common

  

Amount

 

Date Payable

              

March 7, 2014

 $0.815  $0.005  $159 

April 8, 2014

May 6, 2014

  0.020   0.005   62 

June 4, 2014

July 29, 2014

  0.027   0.010   127 

August 27, 2014

November 4, 2014

  0.032   0.010   128 

December 3, 2014

Total

 $0.894  $0.030  $476  

Declaration Date Per Common Share Amount Payment Date
October 23, 2016 (special) $0.35
 $3,941
 
November 25, 2016
October 23, 2016 0.08
 901
 
November 25, 2016
July 19, 2016 0.07
 787
 
August 26, 2016
April 21, 2016 0.06
 686
 
May 20, 2016
March 1, 2016 0.05
 576
 
March 24, 2016
Total $0.61
 $6,891
  
Declaration Date Per Common Share Amount Payment Date
October 21, 2015 $0.05
 $598
 
November 20, 2015
July 28, 2015 0.04
 489
 
August 28, 2015
May 4, 2015 0.03
 372
 
May 29, 2015
February 27, 2015 0.02
 250
 
March 27, 2015
Total $0.14
 $1,709
  

  Dividends Per Share    
Declaration Date Preferred Common Amount Payment Date
November 4, 2014 $0.032
 $0.010
 $128
 
December 3, 2014
July 29, 2014 0.027
 0.010
 127
 
August 27, 2014
May 6, 2014 0.020
 0.005
 62
 
June 4, 2014
March 7, 2014 0.815
 0.005
 159
 
April 8, 2014
Total $0.894
 $0.030
 $476
  

Payment of any future dividends on shares of common stock will be at the discretion of the Company’s Board of Directors.



Treasury Stock


On August 13, 2012,January 12, 2016, the Board of Directors authorized an increase to the Company’s stock repurchase program first approved on July 28, 2015 from $15.0 million to $70.0 million. Repurchases are expected to be executed to the extent that the Company’s earnings and cash-on-hand allow, and will be made in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Exchange Act. For all or a portion of the authorized repurchase amount, the Company acting as trustee for certain of its non-officer, overseas employees, to execute amay enter into one or more plans that are compliant with Rule 10b5-1 planof the Exchange Act that are designed to facilitate these purchases. The stock repurchase program does not require the Company to acquire a specific number of shares, and may be suspended from time to time or discontinued.

During February 2016, pursuant to the stock repurchase program, the Company authorized its broker to proceed with the purchase 100,000of shares of the Company’s common stock in the open market. During the year ended December 31, 2016, the Company purchased a total of 903,031 shares of its common stock for an aggregate purchase price of $23.7 million, plus transaction costs. As of December 31, 2016, $32.0 million of the $70.0 million stock repurchase program approved on July 28, 2015 and increased on January 12, 2016 remained available for future purchases, inclusive of related estimated income tax.

On July 28, 2015, the Board of Directors approved a stock repurchase program of up to $15.0 million of the Company’s outstanding shares of common stock. Repurchases are expected to be executed to the extent that the Company’s earnings and cash-on-hand allow, are anticipated to be conducted through December 2016, and will be made in accordance with guidelines specified underall applicable securities laws and regulations, including Rule 10b-18 of the Exchange Act.  For all or a portion of the authorized repurchase amount, the Company may enter into one or more plans that are compliant with Rule 10b5-1 of the Securities Exchange Act that are designed to facilitate these purchases.  The repurchase program does not require the Company to acquire a specific number of 1934 (the “Exchange Act”)shares, and may be suspended from time to time or discontinued. In connection therewith, the Company was advised that George K. Broady, a director of the Company and owner of more than 5% of its outstanding shares of common stock, would participate in the stock repurchase program on a basis roughly proportional to his family’s ownership interest. See Note 8.

During August 2015, pursuant to the foregoing stock repurchase program, the Company authorized its broker to proceed with the purchase of shares of the Company’s common stock in the open market for a total purchase price of $3.5 million. The open market repurchases were completed on August 4, 2015. The stock repurchase program, which included both open market purchases and the Company's policies regarding stock transactions. Pursuant to this authority,purchase of shares from Mr. Broady, resulted in the Company as Trustee,purchasing a total of 162,442 shares of its common stock for an aggregate purchase price of $5.0 million, plus transaction costs. During October 2015, the Company authorized its broker to proceed with the purchase of shares of the Company’s common stock in the open market for a total purchase price of $3.6 million. The open market repurchases were completed on October 30, 2015. The stock repurchase program, which included both open market purchases and the purchase of shares from Mr. Broady, resulted in the Company purchasing a total of 106,264 shares of its common stock for an aggregate purchase price of $5.0 million, plus transaction costs.

On May 4, 2015, the Board of Directors approved a separate, prior stock repurchase program of up to $5.0 million of the Company’s outstanding shares of common stock.  In connection therewith, the Company was advised by Mr. Broady that he would participate in the stock repurchase program on a basis roughly proportional to his family’s ownership interest (see Note 8). As such, the Company authorized its broker to proceed with the purchase of shares of the Company’s common stock in the open market for a total purchase price of $3.5 million in accordance with Rules 10b5-1 and 10b-18 under the Exchange Act. The stock repurchase program, which included both open market purchases and the purchase of shares from Mr. Broady, was completed on May 13, 2015, and resulted in the Company purchasing a total of 186,519 shares of its common stock for an aggregate purchase price of $5.0 million, plus transaction costs. 

On January 22, 2015, the Company entered into a 10b5-1 planstock repurchase agreement with Mr. Broady that provided for the Company’s purchase from Mr. Broady in off-the-market, private transactions of a total of 91,817 shares of the Company’s common stock, which would be purchased at the rate of 5,000 shares each trading day following the date of the agreement until all of such shares were purchased (see Note 8). The shares were purchased at a per share price equal to the closing price per share of the Company’s common stock on the preceding trading day, as reported on the primary market in which the Company’s common stock is publicly traded. The Company’s purchases concluded on February 19, 2015, and began purchasing sharesresulted in December 2012. The latest 10b5-1 plan terminated in November 2014 and the Company, as Trustee, has not entered into a new 10b5-1 plan. See Note 5.

an aggregate purchase price of $1.1 million.


On November 4, 2014, the Board of Directors approved a special stock repurchase program of up to $5$5.0 million of the Company’s outstanding shares of common stock (the “Repurchase Plan”). In connection therewith, the Company was advised by George K. Broady, a director of the Company and owner of more than 5% of its outstanding common stock, that Mr. Broady desired to participate in the Repurchase Plan on a basis roughly proportional to his family’s ownership interest, with an estimate of generating approximately $1.5 million through the sale of a portion of the shares of the Company’s common stock held by him (see Note 8). After noting Mr. Broady’s participation interest, the Company authorized its broker to proceed with the purchase of shares of the Company’s common stock in the open market for a total purchase price of $3.0 million in accordance with Rules 10b5-1 and 10b-18 under the Exchange Act. The Repurchase Plan was completed on December 17, 2014. The Repurchase Plan, which included both open market purchases and the purchase of shares from Mr. Broady, resulted in the Company purchasing a total of 359,840 shares of its common stock for an aggregate purchase price of $4.5 million, plus transaction costs. 

5.     STOCK-BASED COMPENSATION

On August 18, 2006, the Compensation Committee of Company’s Board of Directors approved, subject to stockholder approval, the Natural Health Trends Corp. 2007 Equity Incentive Plan (the “2007 Plan”). Under the 2007 Plan, the Company may grant (i) incentive stock options, (ii) nonqualified stock options, (iii) restricted stock, (iv) restricted stock units, (v) stock appreciation rights either in tandem with an option or alone and unrelated to an option, or SARs, (vi) performance shares, (vii) award shares, or (viii) stock awards. The 2007 Plan was approved by the Company’s stockholders on November 17, 2006.

The purpose of the 2007 Plan is to enable the Company to attract and retain employees, officers, directors, consultants and advisors; to provide an incentive for them to assist in achieving long-range performance goals; and to enable them to participate in the long-term growth of the Company. The terms of any particular grant are determined by the Board of Directors or a committee appointed by the Board of Directors. Generally, the grants of restricted stock vest quarterly on a pro rata basis over a three-year period. The maximum number of shares available for issuance under the 2007 Plan was 1,550,000 shares. At the Company’s Annual Meeting of Stockholders held on December 30, 2008, the Company’s stockholders approved an increase in the maximum number of shares available for issuance under the 2007 Plan by 500,000 shares. As such, the maximum aggregate number of shares available for issuance under the 2007 Plan totals 2,050,000 shares.As of December 31, 2014, 1,083 shares remain available to be granted under the 2007 Plan.

Valuation and Expense Information under FASB ASC Topic 718

Stock-based compensation expense totaled approximately $110,000 and $49,000 for 2013 and 2014, respectively. No tax benefits were attributed to the stock-based compensation because a valuation allowance was maintained for substantially all net deferred tax assets.     

A following table summarizes the Company’s restricted stock activity under the 2007 Plan:

  

Shares

  

Wtd. Avg. Price at Date of Issuance

 
         

Nonvested at December 31, 2012

  261,658  $0.37 

Vested

  (206,672)  0.37 

Nonvested at December 31, 2013

  54,986   0.37 

Vested

  (54,986)  0.37 

Nonvested at December 31, 2014

      

 

On August 13, 2012, the Board of Directors authorized the Company, acting as trustee for certain of its non-officer, overseas employees, to execute a Rule 10b5-1 plan to purchase 100,000 shares of its common stock in accordance with guidelines specified under Rule 10b5-1 of the Exchange Act and the Company'sCompany’s policies regarding stock transactions.  Pursuant to this authority, the Company, as Trustee, entered into a 10b5-1 plan and began purchasing shares in December 2012. The latest 10b5-1 plan terminated in November 2014 and the Company, as Trustee, has not entered into a new 10b5-1 plan. See Note 5.


5.     STOCK-BASED COMPENSATION
Stock-based compensation expense totaled approximately $104,000, $86,000 and $49,000 for 2016, 2015 and 2014, respectively. No tax benefits were attributed to the stock-based compensation because a valuation allowance was maintained for substantially all net deferred tax assets. During March 2016, the Company modified the vesting feature of an award granted to a director who decided to not stand for re-election at the Company’s 2016 annual meeting of stockholders. The modification of the award resulted in an additional $64,000 in stock-based compensation expense for the three months ended March 31, 2016.

At the Company’s annual meeting of stockholders held on April 7, 2016, the Company’s stockholders approved the Natural Health Trends Corp. 2016 Equity Incentive Plan (the “2016 Plan”) to replace its 2007 Equity Incentive Plan. The 2016 Plan allows for the grant of various equity awards including incentive stock options, non-statutory options, stock, stock units stock appreciation rights and other similar equity-based awards to the Company’s employees, officers, non-employee directors, contractors, consultants and advisors of the Company. Up to 2,500,000 shares of the Company’s common stock (subject to adjustment under certain circumstances) may be issued pursuant to awards granted.

On April 8, 2016, the Company initially granted 51,015 shares of restricted common stock under the 2016 Plan to certain employees for the purpose of further aligning their interest with those of its stockholders and settling fiscal 2015 performance incentives. The shares vest on a quarterly basis over three years and are subject to forfeiture in the event of the employee’s termination of service to the Company under specified circumstances.

The following table summarizes the Company’s restricted stock activity under the 2016 Plan:
 Shares Wtd. Avg. Price at Date of Issuance
Nonvested at December 31, 2015
 $
Granted51,015
 34.13
Vested(12,759) 34.13
Nonvested at December 31, 201638,256
 34.13

On January 20, 2015, the Company’s Board of Directors granted 60,960 shares of restricted common stock to certain employees and its then-existing outside directors for the purpose of further aligning their interest with those of its stockholders and as to the employee shares, settling fiscal 2014 performance incentives. The shares vest on a quarterly basis over the next three years and are subject to forfeiture in the event of their termination of service to the Company under specified circumstances. On February 11, 2015, the Board of Directors granted an additional 6,116 shares of restricted common stock to its newly-elected outside directors subject to the same conditions.


The following table summarizes the Company’s other restricted stock activity:
 Shares Wtd. Avg. Price at Date of Issuance
Nonvested at December 31, 2014
 $
Granted67,076
 12.15
Vested(22,364) 12.15
Nonvested at December 31, 201544,712
 12.15
Granted
 
Vested(22,364) 12.15
Nonvested at December 31, 201622,348
 12.15

As of December 31, 2016, total unrecognized stock-based compensation expense related to non-vested restricted stock was $38,000, which is expected to be recognized over a weighted-average period of one year.

On August 13, 2012, the Board of Directors authorized the Company, acting as trustee for certain of its non-officer, overseas employees, to execute a Rule 10b5-1 plan to purchase 100,000 shares of its common stock in accordance with guidelines specified under Rule 10b5-1 of the Exchange Act and the Company’s policies regarding stock transactions.  Pursuant to this authority, the Company, as Trustee, entered into a 10b5-1 plan and began purchasing in December 2012. The latest 10b5-1 plan terminated in November 2014, and the Company, as Trustee, hasdid not enteredenter into a new 10b5-1 plan. The employees will receivereceived the stock as incentive compensation in quarterly increments over three years beginning March 15, 2013, provided that they arewere employees of the Company on the date of the distribution. Any common stock that iswas forfeited by an employee whose employment terminates will beterminated was delivered to the Company and held as treasury stock.

 

Shares

  

Wtd. Avg. Grant-Date Fair Value

 
        

Nonvested at December 31, 2012

  100,000  $1.37 

Vested

  (26,676)  1.37 

Forfeited

  (20,000)  1.37 
Shares Wtd. Avg. Grant-Date Fair Value

Nonvested at December 31, 2013

  53,324   1.37 53,324
 $1.37

Vested

  (25,342)  1.37 (25,342) 1.37

Forfeited

  (3,998)  1.37 (3,998) 1.37

Nonvested at December 31, 2014

  23,984   1.37 23,984
 1.37
Vested(23,984) 1.37
Forfeited
 
Nonvested at December 31, 2015
 

As of December 31, 2014, total unrecognized stock-based compensation expense related to these stock awards was $31,000, which is expected to be recognized over a weighted-average period of one year.



6.     INCOME TAXES

The components of income before income taxes consist of the following (in thousands):

 

Year Ended December 31,

 
 

2013

  

2014

 Year Ended December 31,
        2016 2015 2014

Domestic

 $194  $4,502 $(3,106) $(7,820) $4,502

Foreign

  3,997   16,134 67,183
 55,613
 16,134

Income before income taxes

 $4,191  $20,636 $64,077
 $47,793
 $20,636



The components of the income tax provision consist of the following (in thousands):

  

Year Ended December 31,

 
  

2013

  

2014

 
         

Current:

        

Federal

 $10  $104 

State

     11 

Foreign

  76   194 

Total current taxes

  86   309 

Deferred foreign taxes

  16   (43)

Income tax provision

 $102  $266 

 Year Ended December 31,
 2016 2015 2014
Current:     
Federal$7,151
 $12
 $104
State(81) 100
 11
Foreign1,648
 456
 194
Total current taxes8,718
 568
 309
Deferred taxes273
 (16) (43)
Income tax provision$8,991
 $552
 $266



A reconciliation of the reported income tax provision to the provision that would result from applying the domestic federal statutory tax rate to pretax income is as follows (in thousands):

 

Year Ended December 31,

 
 

2013

  

2014

 Year Ended December 31,
        2016 2015 2014

Income tax at federal statutory rate

 $1,425  $7,016 $22,427
 $16,250
 $7,016

Effect of permanent differences

  7   9 12,496
 370
 9

Change in valuation allowance

  430   (2,070)(3,877) 2,017
 (2,070)

Foreign rate differential

  (1,218)  (5,240)(21,713) (18,099) (5,240)

Change in enacted tax rates

  (597)  38 

Expiration of net operating loss carryforward

     519 

Other reconciling items

  55   (6)(342) 14
 551

Income tax provision

 $102  $266 $8,991
 $552
 $266


Income before income taxes and the statutory tax rate for each country that materially contributed to the foreign rate differential presented above is as follows (in thousands):
   Year Ended December 31,
 Statutory Tax Rate 2016 2015 2014
Cayman Islands% $58,169
 $50,993
 $16,267
Hong Kong16.5% 3,992
 2,645
 1,129
China25.0% 3,855
 1,493
 153



Deferred income taxes consist of the following (in thousands):

 

December 31,

 
 

2013

  

2014

 December 31,
        2016 2015

Deferred tax assets:

           

Net operating losses

 $13,115  $10,083 $235
 $3,197
Stock-based compensation623
 

Accrued expenses

  268   837 3,174
 3,367

Tax credits

  512   519 
 418

Impairment of long-lived assets

  88   69 

Other

  1    
 32

Total deferred tax assets

  13,984   11,508 4,032
 7,014

Valuation allowance

  (13,927)  (11,440)(235) (4,112)
  57   68 
        
Net deferred tax assets3,797
 2,902

Deferred tax liabilities:

           

Intangible assets

  (43)   

Accrued expenses

  (107)  (64)

Prepaids

  (11)  (32)
Foreign earnings(3,650) (2,789)

Other

  (4)  (37)(415) (173)

Total deferred tax liabilities

  (165)  (133)(4,065) (2,962)

Net deferred tax liability

 $(108) $(65)$(268) $(60)

The


As of December 31, 2016, the Company has recordedreleased its valuation allowance against its U.S. deferred tax assets. In addition to having a net deferred tax liability and no indefinite lived intangibles, the Company analyzed all sources of available income and determined that they are more likely than not to realize the tax benefits of their deferred assets in future periods or carryback years.

As of December 31, 2016, the Company has a valuation allowance equal its netagainst certain foreign deferred tax assetsassets. The Company is recording a valuation allowance in the U.S. and certain of its foreign jurisdictions due to the uncertainty of future operating results.with an overall deferred tax loss. The valuation allowance will be reduced at such time as management believes it is more likely than not that the deferred tax assets will be realized. Any reductions in the valuation allowance will reduce future income tax provisions.

Atprovision. As of December 31, 2014,2016, the Company has no U.S. federal net operating loss or credit carryforwards of $27.2 million that beginas any remaining attributes are expected to expirebe fully utilized to offset tax in 2021, if not utilized. Thethe current year.


At December 31, 2016, the Company also has foreign net operating loss carryforwards totaling $3.4of approximately $1.3 million in various jurisdictions with various expirations, including $2.0 million in China with expirations from 2015 to 2017.expirations.

As a result of capital return activities approved by the Board of Directors during the first quarter of 2016 and anticipated future capital return activities, the Company determined that a portion of its current undistributed foreign earnings are no longer deemed reinvested indefinitely by its non-U.S. subsidiaries. The Company has not providedrepatriated $19.8 million to the U.S. during the three months ended March 31, 2016, part of which was offset by U.S. net operating losses. Accordingly, the deferred tax liability previously established for undistributed foreign earnings up to its existing U.S. federal andnet operating losses was reduced. The excess amount repatriated during the year ended December 31, 2016 was generated from current foreign withholding taxes onearnings. The Company will continue to periodically reassess the undistributed earningsneeds of its foreign subsidiaries and update its indefinite reinvestment assertion as necessary. To the extent that additional foreign earnings are not deemed permanently reinvested, the Company expects to recognize additional income tax provision at the applicable U.S. corporate tax rate. As of December 31, 2014. Such2016, the Company has recorded a deferred tax liability for earnings that the Company plans to repatriate out of accumulated earnings in future periods. All undistributed earnings in excess of 50% of current earnings on an annual basis are intended to be reinvested indefinitely. Generally, such earnings becomeindefinitely as of December 31, 2016.

The Company and its subsidiaries file tax returns in the United States, California and Texas and various foreign jurisdictions. For federal income tax purposes, fiscal years 2007 through 2015 remain open for examination by tax authorities as a result of net operating loss carryovers from older years being used to offset income in recent tax years. The Company is no longer subject to U.S.state income tax uponexaminations for years prior to 2011. No jurisdictions are currently examining any income tax returns of the remittance of dividends and under certain other circumstances. At December 31, 2014, it is not practicable to estimate the amount of deferred tax liability on such undistributed earnings.

Company or its subsidiaries.



7.     SUPPLEMENTAL CASH FLOW INFORMATION

 

Year Ended December 31,

 Year Ended December 31,
 

2013

  

2014

 2016 2015 2014
 

(In Thousands)

      

Cash paid during the year for:

        (In Thousands)

Income taxes, net of refunds

 $71  $60 $8,791
 $707
 $60

Interest

     1 9
 
 1
        
Non-cash financing activity:         
  
  
Conversion of preferred stock  13   111 
 
 111
Issuance of treasury stock1,741
 666
 


8.     RELATED PARTY TRANSACTIONS

Product Royalties

In February 2013,

On April 29, 2015, the Company entered into a Royalty Agreement and License with Broady Health Sciences, L.L.C., a Texas limited liability company, (“BHS”) regarding the manufacture and sale of a product called ReStor™Soothe. The Company began selling this product in the fourth quarter of 2012 with the permission of BHS. Mr. Broady is owner of BHS. Under thisthe agreement, the Company agreed to pay BHS a royalty of 2.5% of sales revenue in return for the right to manufacture (or have manufactured), market, import, export and sell this product worldwide, with certain rights being exclusive outside the United States. George K. Broady, a director ofworldwide. Further, the Company and owneragreed to pay BHS $11,700 as royalties for the period it began selling the product in the fourth quarter of more than 5% of its outstanding common stock, is owner of BHS.2012 through 2014. The Company recognized royalties of $48,000$3,400, $7,000 and $144,000$6,400 during 20132016, 2015 and 2014, respectively. The Company is not required to purchase any product under the agreement, and the agreement may be terminated at any time on 120 days’ notice or, under certain circumstances, with no notice.

The Otherwise, the agreement terminates March 31, 2020.


In February 2013, the Company is considering enteringentered into another royalty agreementa Royalty Agreement and licenseLicense with BHS regarding the manufacture and sale of a product called Soothe™, whichReStor™.  Under this agreement, the Company began sellingagreed to pay BHS a royalty of 2.5% of sales revenue in return for the fourth quarter of 2012 with the permission of BHS. To continue sellingright to manufacture (or have manufactured), market, import, export and sell this product BHS has requested thatworldwide, with certain rights being exclusive outside the United States. On April 29, 2015, the Company payand BHS amended the Royalty and Agreement and License to change the royalty to a royaltyprice per unit instead of 2.5% of sales revenue for this product for 2012revenue. This provision was effective retroactive to January 1, 2015.  The Company recognized royalties of $475,000, $555,000 and subsequent years.$144,000 during 2016, 2015 and 2014, respectively.  The Company is consideringnot required to purchase any product under the agreement, and the agreement may be terminated at any time on 120 days’ notice or, under certain circumstances, with no notice. Otherwise, the agreement terminates March 31, 2020.
Stock RepurchaseAgreements
On October 28, 2015, the Company entered into a Stock Repurchase Agreement with Mr. Broady that proposalprovided for the Company’s purchase of common stock from Mr. Broady in off-the-market, private transactions at a rate equal to 0.4066 times the number of shares purchased by the Company’s broker in conjunction with the stock repurchase program authorized by the Company’s Board of Directors on July 28, 2015. The Company’s purchases from Mr. Broady concluded on November 2, 2015, were completed at a per share purchase price equal to the weighted average price per share paid by the Company’s broker in its open-market purchases, and discussingresulted in an aggregate purchase price of $1.4 million. See Note 4.

On July 31, 2015, the termsCompany entered into a Stock Repurchase Agreement with Mr. Broady that provided for the Company’s purchase of common stock from Mr. Broady in off-the-market, private transactions at a rate equal to 0.4085 times the number of shares purchased by the Company’s broker in conjunction with the stock repurchase program authorized by the Company’s Board of Directors on July 28, 2015. The Company’s purchases from Mr. Broady concluded on August 6, 2015, were completed at a per share purchase price equal to the weighted average price per share paid by the Company’s broker in its open-market purchases, and resulted in an aggregate purchase price of $1.5 million. See Note 4.


On May 7, 2015, the Company entered into a Stock Repurchase Agreement with Mr. Broady that provided for the Company’s purchase of common stock from Mr. Broady in off-the-market, private transactions at a rate equal to 0.4286 times the number of shares purchased by the Company’s broker in conjunction with the stock repurchase program authorized by the Company’s Board of Directors on May 4, 2015. The Company’s purchases from Mr. Broady concluded on May 13, 2015, were completed at a per share purchase price equal to the weighted average price per share paid by the Company's broker in its open-market purchases, and resulted in an aggregate purchase price of $1.5 million. See Note 4.

On January 22, 2015, the Company entered into a Stock Repurchase Agreement with Mr. Broady that provided for the Company’s purchase from Mr. Broady in off-the-market, private transactions of a definitive agreement.  Attotal of 91,817 shares of the Company’s common stock, which would be purchased at the rate of 5,000 shares each trading day following the date of the agreement until all of such shares were purchased. The shares were purchased at a royaltyper share price equal to the closing price per share of 2.5%the Company’s common stock on the preceding trading day, as reported on the primary market in which the Company’s common stock was publicly traded. The Company’s purchases concluded on February 19, 2015, and resulted in an aggregate purchase price of net sales, the Company calculates that royalties through the end of December 2014 would total $11,700.

Stock Repurchase Agreement

$1.1 million. See Note 4.


On November 14, 2014, the Company entered into a Stock Repurchase Agreement (the “Stock Repurchase Agreement”) with George K.Mr. Broady a director of the Company and owner of more than 5% of its outstanding common stock, in accordance with Rule 10b5-1 under the Exchange Act. The Stock Repurchase Agreementthat provided for the Company’s purchase from Mr. Broady of one-half of the number of shares of common stock purchased by the Company’s broker in the open market under the Repurchase Plan approved by the Company’s Board of Directors on November 4, 2014 (see Note 4).2014. The Stock Repurchase Agreement with Mr. Broady required that the Company report to Mr. Broady on a weekly basis information regarding the broker’s open market purchases, and that the Company purchase from Mr. Broady on a weekly basis at a per share purchase price equal to the weighted average price per share paid by the Company’s broker to purchase shares in the open market. The Company’s purchases from Mr. Broady under the Stock Repurchase Agreement, which concluded on December 17, 2014, totaled 119,947 shares of its common stock forand resulted in an aggregate purchase price of $1.5 million.

$1.5 million. See Note 4.

9.     EMPLOYEE BENEFIT PLANS

     The Company has a 401(k) defined contribution plan which permits participating employees in the United States to defer up to a maximum of 90% of their compensation, subject to limitations established by the Internal Revenue Service. Employees age 21 and older are eligible to contribute to the plan starting the first day of the following month of employment.  Participating employees are eligible to receive discretionary matching contributions and profit sharing, subject to certain conditions, from the Company.  In 20132016, 2015 and 2014, the Company matched employee deferral contributions up to 4.5% of salary, which vested 100% immediately. No profit sharing has been paid under the plan. The Company recorded compensation expense of $62,000$134,000, $115,000 and $60,000 for 20132016, 2015 and 2014, respectively, related to its matching contributions to the plan. Certain of the Company’s employees located outside the United States participate in employee benefit plans that are statutory in nature.



10.    SEGMENT INFORMATION

The Company sells products to a distributormember network that operates in a seamless manner from market to market, except for the Chinese market. Themarket where it sells to consumers through an e-commerce retail platform. Outside of the China e-commerce retail platform, the Company believes that all of its other operating segments should be aggregated into a single reportable segment as they have similar economic characteristics.characteristics, except for its operations located within the Commonwealth of Independent States (“CIS”). In making this determination, the Company believes that all of theits operating segments are similar in the nature of the products sold, the product acquisition process, the types of customers products are sold to, the methods used to distribute the products, and the nature of the regulatory environment.

The Company’s e-commerce retail business launchedengagement of a third-party service provider in China during June 2007 does not requirethe CIS market results in a direct selling license and allows for discounts on volume purchases. Theredifferent economic structure than its other markets.


However, there is no separate segment manager who is held accountable by ourthe Company’s chief operating decision-makers, or anyone else, for operations, operating results and planning for the either Chinese marketor the CIS markets on a stand-alone basis. Accordingly, we consider ourselves tobasis, and neither market is material for the two years presented. As such, the Company believes that all operating segments should be inaggregated into a single reportingreportable segment and operating unit structure.

for disclosure purposes.


The Company’s net sales by geographic area are as follows (in thousands):

 

Year Ended December 31,

 Year Ended December 31,
 

2013

  

2014

 2016 2015 2014

Net sales from external customers:

             

United States

 $2,289  $1,438 $4,100
 $3,246
 $1,438

Canada

  72   1,374 1,809
 2,746
 1,374

Hong Kong

  40,585   111,028 263,482
 245,737
 111,028

China

  791   1,538 9,086
 4,425
 1,538

Taiwan

  3,387   4,628 6,213
 5,965
 4,628

South Korea

  702   1,009 691
 1,129
 1,009

Russia, Kazakhstan and Ukraine

  4,354   3,113 
Commonwealth of Independent States (Russia, Kazakhstan and Ukraine)1
858
 1,139
 3,113
Europe1,234
 382
 373

Other foreign countries

  347   462 255
 91
 89

Total net sales

 $52,527  $124,590 $287,728
 $264,860
 $124,590


1The Companydiscontinued its Ukraine operations during the second quarter of 2015.
The Company’s net sales by product and service are as follows (in thousands):

 

December 31,

 Year Ended December 31,
 

2013

  

2014

 2016 2015 2014

Net sales by product and service:

             

Product sales

 $50,385  $118,843 $269,731
 $253,041
 $118,843

Enrollment package revenue, freight and other

  2,955   7,927 25,616
 17,623
 7,927

Less: sales returns

  (813)  (2,180)(7,619) (5,804) (2,180)

Total net sales

 $52,527  $124,590 $287,728
 $264,860
 $124,590


Due to system constraints, it is impracticable for the Company to separately disclose sales by product category for the years presented.

The Company’s long-lived assets by geographic area are as follows (in thousands):

 

December 31,

 December 31,
 

2013

  

2014

 2016 2015

Long-lived assets:

           

United States

 $35  $31 $763
 $283
Hong Kong140
 204
China  137   241 199
 252

Other foreign countries

  93   204 286
 155

Total long-lived assets

 $265  $476 $1,388
 $894


11.     SUBSEQUENT EVENTS


On January 20, 2015,24, 2017, the Board of Directors declared a cash dividend of $0.09 and a special cash dividend of $0.35 on each share of common stock outstanding. Such dividends were paid on March 3, 2017 to stockholders of record on February 21, 2017. Payment of any future dividends on shares of common stock will be at the discretion of the Company’s Board of DirectorsDirectors.

On January 24, 2017, the Company granted 60,96056,260 shares of restricted common stock under the 2016 Plan to certain employees and its outside directors for the purpose of further aligning their interest with those of its stockholders and, as to the employee shares, settling fiscal 20142016 performance incentives. The shares vest on a quarterly basis over the next three years and are subject to forfeiture in the event of their termination of service to the Company under specified circumstances.



On January 22, 2015, the Company entered into a Stock Repurchase Agreement with George K. Broady, a director of the Company and owner of more than 5% of its outstanding common stock. The agreement provided for the Company’s purchase from Mr. Broady in off-the-market, private transactions of a total of 91,817 shares of the Company’s common stock, which would be purchased at the rate of 5,000 shares each trading day following the date of the agreement until all of such shares were purchased. The shares would be purchased at a per share price equal to the closing price per share of the Company’s common stock on the preceding trading day, as reported on the primary market in which the Company’s common stock is publicly traded. The Company’s purchases concluded on February 19, 2015, and resulted in an aggregate purchase price of $1.1 million.

On February 11, 2015, the Board of Directors voted to expand its size to provide for five directors and, in accordance with the Company’s bylaws, elected Christopher R. O’Brien and Kin Y. Chung to fill the newly-created directorships. At the time of their election, Messrs. O’Brien and Chung, together with Randall A. Mason (an existing director), were also appointed to the Board’s Audit Committee, and Messrs. O’Brien and Mason were also appointed to the Board’s Compensation Committee and Nominating and Corporate Governance Committee. The Board determined that each of Messrs. O’Brien and Chung is an “independent director,” as such term is defined in Rule 5605 of The Nasdaq Stock Market Rules; in addition, each such newly-elected director qualifies as an “independent director,” as defined in Rule 10A-3(b), as promulgated under the Exchange Act.

Upon their election and in their capacity as non-employee directors of the Company, each of Messrs. O’Brien and Chung received $25,000 cash and 3,058 shares of restricted common stock, which shares vest on a quarterly basis over the next three years and are subject to forfeiture in the event of their termination of service to the Company under specified circumstances.

Also on February 11, 2015, the Company entered into an indemnification agreement (“Indemnification Agreement”) with each of its two recently elected directors, Messrs. O’Brien and Chung, as well as its existing directors and executive officers. The Indemnification Agreement confirms the Company’s obligation to indemnify its directors and executive officers against liability arising out of the performance of their duties. The Indemnification Agreement provides mandatory indemnification, on the terms and conditions set forth in the agreement, for expenses and losses actually and reasonably incurred by directors and executive officers in defending legal proceedings in which they are parties by reason of their service to the Company or other entities to which they provide services at the Company’s request or on its behalf. Pursuant to the Indemnification Agreement, the Company will advance reasonable expenses incurred by directors and executive officers in defending these legal proceedings, on the terms and conditions set forth in the Indemnification Agreement, and subject to repayment in the event of a determination that a director or executive officer is not entitled to indemnification for those expenses.

On February 12, 2015, the Company announced that its common stock had been approved for listing on The NASDAQ Capital Market and began trading under the ticker symbol NHTC on February 17, 2015.

On February 27, 2015, the Board of Directors declared a cash dividend of $0.02 on each share of common stock outstanding. Such dividends are payable on March 27, 2015 to stockholders of record on March 17, 2015. Payment of any future dividends on shares of common stock will be at the discretion of the Company’s Board of Directors.


Item 9.

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

Not applicable.

Item 9A.

CONTROLS AND PROCEDURES

Item 9A. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

Management, with the participation of the Company’sour principal executive officer and principal financial officer, evaluated the effectiveness of the design and operation of the Company’sour disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) as of December 31, 2014. The Company’s2016. Our disclosure controls and procedures are designed to ensure that information required to be disclosed by the Companyus in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to management, including the Company’sour principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. Based on this evaluation, the principal executive officer and principal financial officer concluded that, as of December 31, 2014, the Company’s2016, our disclosure controls and procedures were effective.

Management’s Annual Report on Internal Control over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed by, or under the supervision of, the Company’sour principal executive and principal financial officers and effected by the Company’sour Board of Directors, management and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:

pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company;

provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and

provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.

pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;

provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and

provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.
 Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management evaluates the effectiveness of the Company’sour internal control over financial reporting by using the criteria established in Internal Control – Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO ”)COSO”).  Based on this criteria, management concluded that the Company’sour internal control over financial reporting as of December 31, 20142016 was effective.

This Annual

Attestation Report does not include an attestation report of the Company’sCompany's Independent Registered Public Accounting Firm

The effectiveness of our internal control over financial reporting as of December 31, 2016, has been audited by Lane Gorman Trubitt, LLC, an independent registered public accounting firm, regarding internal control over financial reporting. Management’s report was not subject toas stated in their attestation by the Company’s independent registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in “Item 8. Financial Statements and Supplementary Data” of this Annual Report.

Report on Form 10-K.

Changes in Internal Control over Financial Reporting

There were no changes in internal control over financial reporting that occurred during the fiscal quarter ended December 31, 20142016 that have materially affected, or are reasonably likely to materially affect, internal control over financial reporting.



Item 9B.

OTHER INFORMATION

Item 9B. OTHER INFORMATION

None.

Part III

Item 10.

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The information required by this Item is incorporated by reference from the definitive proxy statement to be filed with the SEC within 120 days after December 31, 2014.

2016.

Item 11.

EXECUTIVE COMPENSATION

Item 11. EXECUTIVE COMPENSATION

The information required by this Item is incorporated by reference from the definitive proxy statement to be filed with the SEC within 120 days after December 31, 2014.

2016.

Item 12.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
The information required by this Item is incorporated by reference from the definitive proxy statement to be filed with the SEC within 120 days after December 31, 2014.

2016.

Item 13.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
The information required by this Item is incorporated by reference from the definitive proxy statement to be filed with the SEC within 120 days after December 31, 2014.

2016.

Item 14.

PRINCIPAL ACCOUNTING FEES AND SERVICES

Item 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

The information required by this Item is incorporated by reference from the definitive proxy statement to be filed with the SEC within 120 days after December 31, 2014.

2016.

Part IV

Item 15.

EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

Documents filed as part of this Form 10-K:

1.

Financial Statements. See Index to Consolidated Financial Statements under Item 8“Item 8. Financial Statements and Supplementary Data” of Part II.

this report.

2.

Financial Statement Schedules. Financial statement schedules have been omitted because they are not required, not applicable, or because the required information is shown in the financial statements or notes thereto.

3.

Exhibits. The exhibits listed on the accompanying Exhibit Index are filed as a part of, and are incorporated by reference into, this report.

We will furnish any of the exhibits referenced in the accompanying Exhibit Index to a requesting shareholder upon payment of a fee equal to our reasonable expenses in furnishing such exhibit(s).


Item 16. FORM 10-K SUMMARY

None.


SIGNATURES
 

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.

NATURAL HEALTH TRENDS CORP.

Date: March 6, 2015

10, 2017

/s/ Chris T. Sharng

Chris T. Sharng

President

 (Principal Executive Officer)

POWER OF ATTORNEY

KNOW ALL MEN BY THESE PRESENTS that each of Natural Health Trends Corp., a Delaware corporation, and the undersigned directors and officers of Natural Health Trends Corp., hereby constitutes and appoints Chris T. Sharng and Timothy S. Davidson, or any one of them, its, his or her true and lawful attorney-in-fact and agent, for it, him or her and in its, his or her name, place and stead, in any and all capacities, with full power to act alone, to sign any and all amendments to this report, and to file each such amendment to the report, with all exhibits thereto, and any and all other documents in connection therewith, with the Securities and Exchange Commission, hereby granting unto said attorney-in-fact and agent full power and authority to do and perform any and all acts and things requisite and necessary to be done in and about the premises as fully to all intents and purposes as it, he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature

 

Title

 

Date

     

/s/ Chris T. Sharng

 

President and Director

 

March 6, 2015

10, 2017
Chris T. Sharng (Principal Executive Officer)  
     

/s/ Timothy S. Davidson

 

Senior Vice President and Chief Financial Officer

 

March 6, 2015

10, 2017
Timothy S. Davidson (Principal Financial and Accounting Officer)  
     

/s/ Randall A. Mason

 

Chairman of the Board and Director

 

March 6, 2015

10, 2017
Randall A. Mason    
     

/s/ George K. Broady

 

Director

 

March 6, 2015

10, 2017
George K. Broady    
     

/s/ Christopher R. O’Brien

Kin Y. Chung
 

Director

 

March 6, 2015

10, 2017
Christopher R. O’BrienKin Y. Chung    
     

/s/ Kin Y. Chung

Yiu T. Chan
 

Director

 

March 6, 2015

10, 2017
Kin Y. ChungYiu T. Chan    


EXHIBIT INDEX

(Pursuant to Item 601 of Regulation S-K)

Exhibit

Number

Exhibit Description

3.1

Exhibit
Number
Exhibit Description
3.1Certificate of Incorporation of Natural Health Trends Corp. (incorporated by reference to Exhibit 3.01 to Current Report on Form 8-K filed on July 12, 2005).

3.3

By-Laws of Natural Health Trends Corp. (incorporated by reference to Exhibit 3.02 to Current Report on Form 8-K filed on July 12, 2005).

4.1

Specimen Certificate for shares of common stock, $.001 par value per share, of Natural Health Trends Corp. (incorporated by reference to Exhibit 4.01 to Annual Report on Form 10-K filed on May 8, 2006).

+10.1

 

Natural Health Trends Corp. 2016 Equity Incentive Plan (incorporated by reference to Appendix C to Definitive Proxy Statement filed on March 4, 2016).

+10.2Form of Seven Year Warrants to Purchase Shares of CommonRestricted Stock ofAward Agreement under the Company issued by the Company to certain purchasers2016 Equity Incentive Plan (incorporated by reference to Exhibit 10.410.2 to CurrentAnnual Report on Form 8-K10-K filed on October 22, 2007)March 4, 2016).

+10.2

10.3
 

2007Natural Health Trends Corp. Annual Incentive Plan (Restated as of January 1, 2016) (incorporated by reference to Appendix A to Definitive Proxy Statement filed on October 20, 2006)March 4, 2016).

+10.3

10.4
 

2007 Equity Incentive Plan, as amended and restated as of November 13, 2008 (incorporated by reference to Appendix A to Definitive Proxy Statement filed on November 25, 2008).

+10.4

Form of Notice of Restricted Stock Grant and Restricted Stock Agreement under the Company’s 2007 Equity Incentive Plan (incorporated by reference to Exhibit 10.5 to Quarterly Report on Form 10-Q filed on May 11, 2007).

+10.5

Natural Health Trends Corp. Annual Incentive Plan (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed on April 8, 2014).

+10.6

Natural Health Trends Corp. 2014 Long-Term Incentive Plan (Restated as of January 1, 2016) (incorporated by reference to Exhibit 10.2Appendix B to Current Report on Form 8-KDefinitive Proxy Statement filed on April 8, 2014)March 4, 2016).

+10.7

10.5
 

First Amendment to the Natural Health Trends Corp. 2014 Long-Term Incentive Plan (Restated as of January 1, 2016) (filed herewith).

+10.6Employment Agreement (including form of Non-Competition and Proprietary Rights Assignment Agreement) for Chris T. Sharng, dated April 23, 2007 (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed on April 26, 2007).

+10.8

10.7
 

Employment Agreement (including form of Non-Competition and Proprietary Rights Assignment Agreement) for Timothy S. Davidson dated April 23, 2007 (incorporated by reference to Exhibit 10.2 to Current Report on Form 8-K filed on April 26, 2007).

+10.9

10.8
 

Form of Restricted Stock Notice of Grant and Award Agreement for shares of restricted stock granted on (1) January 20, 2015 to each of Chris T. Sharng, Timothy S. Davidson, Randall A. Mason anyand George K. Broady, and (2) February 11, 2015 to each of Christopher R. O’Brien and Kin Y. Chung (filed herewith)(incorporated by reference to Exhibit 10.9 to Annual Report on Form 10-K filed on March 6, 2015).

+10.10

10.9
 

Form of Indemnification Agreement dated February 11, 2015, between Natural Health Trends Corp. and each of its directors (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed on February 12, 2015).

10.11

10.10
 

Stock Repurchase Agreement dated November 14, 2014 by and between Natural Health Trends Corp. and George K. Broady (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed November 17, 2014).

10.12

Stock Repurchase Agreement dated January 22, 2015 by and between Natural Health Trends Corp. and George K. Broady (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed January 26, 2015).

14.1

10.11
 

Stock Repurchase Agreement dated May 7, 2015 by and between Natural Health Trends Corp. and George K. Broady (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed May 7, 2015).

10.12Stock Repurchase Agreement dated July 31, 2015 by and between Natural Health Trends Corp. and George K. Broady (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed July 31, 2015).
10.13Stock Repurchase Agreement dated October 28, 2015 by and between Natural Health Trends Corp. and George K. Broady (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed October 28, 2015).
14.1Worldwide Code of Business Conduct, as revised on February 11,November 5, 2015 (incorporated by reference to Exhibit 14.1 to Current Report on Form 8-K filed on February 12, 2015).

21.1

Subsidiaries of the Company (filed herewith).

24.1

 

Subsidiaries of Natural Health Trends Corp. (filed herewith).

23.1Consent of Lane Gorman Trubitt, LLC (filed herewith).
24.1Power of Attorney (see signature page).

31.1

 

Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).

31.2

 

Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).

32.1

 

Certifications of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).

   

101.INS

 

XBRL Instance


101.SCH

101.INS 

Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

101.SCHXBRL Taxonomy Extension Schema

101.CAL

 

XBRL Taxonomy Extension Calculation

101.DEF

 

XBRL Taxonomy Extension Definition

101.LAB

 

XBRL Taxonomy Extension Labels

101.PRE

 

XBRL Taxonomy Extension Presentation

  

+ Management contract or compensatory plan